a18221780.s6	Across IN 0	the DT 0	doses NNS B-noun.artifact	and CC 0	pretreatment JJ B-adj.all	times NNS B-noun.event	examined VBD B-verb.communication	, , 0	enhancement NN B-noun.person	was VBD B-verb.stative	not RB B-adv.all	observed VBN B-verb.perception	in IN 0	females NNS B-noun.person	. . 0	. . 0
a435349.s9	Total JJ B-adj.all	fasciculation NN B-noun.act	scores NNS B-noun.cognition	in IN 0	the DT 0	30-mg JJ 0	bolus JJ B-adj.all	group NN B-noun.motive	and CC 0	the DT 0	5-mg JJ B-noun.artifact	s-1 NN I-noun.artifact	and CC 0	20-mg JJ 0	s-1 JJ 0	infusion NN B-adj.all	groups NNS B-noun.group	were VBD B-verb.stative	not RB B-adv.all	significantly RB B-adv.all	different JJ B-adv.all	. . 0	. . 0
a2273650.s1	Amnesia NNP B-noun.person	produced VBN B-verb.creation	by IN 0	scopolamine NN B-noun.person	and CC 0	cycloheximide NN B-noun.person	were VBD 0	reversed VBN B-verb.change	by IN 0	morphine NN B-noun.person	given VBN B-verb.possession	30 CD B-adj.all	min NN B-noun.quantity	before IN 0	the DT 0	test NN B-adj.all	trial NN B-noun.cognition	( ( 0	pre FW 0	- : 0	test NN 0	) ) 0	, , 0	and CC 0	pre VBP B-verb.stative	- : 0	test NN B-adj.all	morphine NN B-noun.person	also RB B-adv.all	facilitated VBD B-verb.communication	the DT 0	memory NN B-noun.artifact	retrieval NN I-noun.artifact	in IN 0	the DT 0	animals NNS B-noun.person	administered VBN B-verb.possession	naloxone NN 0	during IN 0	the DT 0	training NN B-noun.act	trial NN B-noun.act	. . 0	. . 0
a15036754.s7	The DT 0	rats NNS B-noun.plant	treated VBN B-verb.change	with IN 0	DFP NNP B-noun.group	- : 0	atropine NN B-noun.person	showed VBD B-verb.communication	severe JJ 0	typical JJ B-adj.all	OP NNP 0	- : 0	induced VBN B-verb.creation	toxicity NN B-noun.attribute	signs NNS B-noun.communication	. . 0	. . 0
a2071257.s4	and CC 0	on IN 0	the DT 0	eleventh JJ B-adj.all	day NN B-noun.person	either CC 0	scopolamine NN B-noun.state	or CC 0	placebo NN B-noun.substance	, , 0	i.m RB 0	. . 0	. . 0
a18261172.s1	Calcineurin SYM 0	- : 0	inhibitor NN B-noun.person	therapy NN B-noun.person	can MD 0	lead VB B-verb.cognition	to TO 0	renal_dysfunction VB B-verb.possession	in IN 0	heart NN 0	transplantation NN 0	patients NNS B-noun.person	. . 0	. . 0
a891050.s0	Late JJ B-adj.all	recovery NN B-noun.process	of IN 0	renal JJ B-adj.all	function NN B-noun.act	in IN 0	a DT 0	woman NN B-noun.person	with IN 0	the DT 0	hemolytic_uremic_syndrome NN B-noun.location	. . 0	. . 0
a230316.s6	This DT 0	was VBD B-verb.stative	most RBS B-adv.all	frequently RB B-adv.all	found VBN B-verb.possession	in IN 0	children NNS B-noun.animal	, , 0	many JJ 0	of IN 0	whom WP 0	had VBD 0	received VBN B-verb.possession	clioquinol NN B-noun.person	as IN 0	treatment NN B-noun.communication	for IN 0	acrodermatitis_enteropathica NNP B-noun.person	. . 0	. . 0
a16330766.s7	We PRP 0	found VBD B-verb.cognition	that IN 0	( ( 0	i NN 0	) ) 0	gabapentin NN B-noun.substance	reduced VBD B-verb.change	the DT 0	activations NNS B-noun.person	in IN 0	the DT 0	bilateral JJ B-adj.all	operculoinsular JJ B-adj.all	cortex NN B-noun.artifact	, , 0	independently RB 0	of IN 0	the DT 0	presence NN B-noun.person	of IN 0	central JJ B-noun.body	sensitization NN I-noun.body	, , 0	( ( 0	ii NN 0	) ) 0	gabapentin NN B-noun.substance	reduced VBD B-verb.change	the DT 0	activation NN B-noun.act	in IN 0	the DT 0	brainstem NN B-noun.communication	, , 0	only RB B-adv.all	during IN 0	central JJ B-adj.all	sensitization NN B-noun.feeling	, , 0	( ( 0	iii NN 0	) ) 0	gabapentin NN B-noun.substance	suppressed VBD B-verb.contact	stimulus NN B-noun.artifact	- : 0	induced VBN B-verb.creation	deactivations NNS B-noun.person	, , 0	only RB B-adv.all	during IN 0	central JJ B-adj.all	sensitization NN B-noun.feeling	, , 0	this DT 0	effect NN B-noun.cognition	was VBD B-verb.stative	more RBR B-adv.all	robust JJ 0	than IN 0	the DT 0	effect NN B-noun.cognition	on IN 0	brain NN B-noun.food	activation NN B-noun.act	. . 0	. . 0
a1732369.s3	Echocardiographic JJ B-adj.all	data NNS B-noun.cognition	from IN 0	the DT 0	experimental JJ B-adj.all	group NN B-noun.group	of IN 0	21 CD B-adj.all	patients NNS B-noun.person	( ( 0	mean JJ B-adj.all	age NN B-noun.time	16 CD B-adj.all	+ CD 0	/- $ 0	5 CD B-adj.all	years NNS B-noun.event	) ) 0	treated VBN B-verb.change	from IN 0	1.6 CD 0	to TO 0	14.3 CD 0	years NNS B-noun.quantity	( ( 0	median JJ 0	5.3 CD 0	) ) 0	before IN 0	this DT 0	study NN B-noun.artifact	with IN 0	27 CD 0	to TO 0	532 CD 0	mg IN 0	/ $ 0	m2 CD 0	of IN 0	doxorubicin NN B-noun.substance	( ( 0	mean VB B-verb.stative	196 CD 0	) ) 0	were VBD 0	compared VBN B-verb.change	with IN 0	echocardiographic JJ B-adj.all	data NNS B-noun.cognition	from IN 0	12 CD B-adj.all	normal JJ B-adj.all	age NN B-noun.person	- : 0	matched VBN B-verb.possession	control NN B-noun.act	subjects NNS B-noun.artifact	. . 0	. . 0
a3125768.s4	Following VBG 0	instrumentation NN B-noun.communication	, , 0	halothane NN B-noun.person	was VBD 0	discontinued VBN B-verb.stative	and CC 0	alfentanil NN B-noun.person	( ( 0	125 CD 0	mu IN 0	/ : 0	kg LS 0	) ) 0	administered VBN B-verb.possession	iv RP 0	during IN 0	emergence NN B-noun.person	from IN 0	halothane NN 0	anesthesia NN 0	. . 0	. . 0
a2951327.s0	Inhibition NNP B-noun.person	of IN 0	sympathoadrenal JJ B-adj.all	activity NN B-noun.process	by IN 0	atrial JJ B-adj.all	natriuretic JJ B-adj.all	factor NN B-noun.person	in IN 0	dogs NNS B-noun.animal	. . 0	. . 0
a17854040.s7	HBV NNP 0	lamivudine NN 0	- : 0	resistant JJ B-adj.all	strains NNS B-noun.person	were VBD 0	detected VBN B-verb.perception	in IN 0	3 CD 0	of IN 0	15 CD B-adj.all	mono NN B-noun.substance	- : 0	infected JJ B-adj.all	chronic NN B-noun.artifact	hepatitis NN 0	B NN 0	patients NNS B-noun.person	and CC 0	10 CD B-adj.all	of IN 0	20 CD B-adj.all	HBV NNP B-noun.group	- : 0	HIV_co SYM 0	- : 0	infected JJ B-adj.all	patients NNS B-noun.person	. . 0	. . 0
a20882060.s1	OBJECTIVE NNP B-noun.group	, , 0	The DT 0	globus JJ B-adj.all	pallidus NN B-noun.person	plays VBZ B-verb.creation	a DT 0	critical JJ B-adj.all	role NN B-noun.attribute	in IN 0	movement NN B-noun.phenomenon	regulation NN I-noun.phenomenon	. . 0	. . 0
a20621845.s4	MMP NNP B-noun.group	- : 0	TIMP NNP B-noun.group	and CC 0	ADAM NNP B-noun.person	mRNAs NNS I-noun.person	were VBD 0	semi VBN B-verb.communication	- : 0	quantitatively RB B-adv.all	analyzed JJ B-verb.cognition	and CC 0	protein NN B-noun.person	expressions NNS I-noun.person	were VBD 0	determined VBN B-verb.communication	by IN 0	immunohistochemistry NN B-noun.person	. . 0	. . 0
a3358181.s4	Delaying VBG 0	induction NN 0	of IN 0	anesthesia NN B-noun.object	should MD 0	be VB 0	considered VBN B-verb.cognition	whenever WRB 0	possible JJ B-adj.all	. . 0	. . 0
a7516729.s2	Basal JJ B-adj.all	frequency NN B-noun.quantity	( ( 0	BF NNP 0	) ) 0	evaluated VBN B-verb.communication	by IN 0	surface NN B-noun.location	electrogram NN B-noun.person	was VBD B-verb.stative	223 CD 0	+ . 0	/- $ 0	4 CD B-adj.all	beats NNS B-noun.communication	/ POS 0	min NN B-noun.person	. . 0	. . 0
a2887062.s4	Morphometric JJ B-adj.all	analysis NN B-noun.communication	revealed VBD B-verb.communication	that IN 0	the DT 0	volume NN B-noun.artifact	density NN B-noun.process	of IN 0	secretory JJ B-adj.all	granules NNS B-noun.artifact	increased VBN B-verb.change	, , 0	while IN 0	the DT 0	volume NN B-noun.artifact	density NN B-noun.process	of IN 0	cytoplasmic JJ B-adj.all	microtubules NNS B-noun.body	decreased VBD B-verb.change	. . 0	. . 0
a10807237.s0	Intracranial_aneurysms NNS B-noun.artifact	and CC 0	cocaine_abuse NN 0	, , 0	analysis NN 0	of IN 0	prognostic JJ B-adj.all	indicators NNS B-noun.person	. . 0	. . 0
a3358181.s0	Ventricular_tachyarrhythmias NNS B-noun.artifact	during IN 0	cesarean JJ B-adj.all	section NN B-noun.location	after IN 0	ritodrine NN B-noun.person	therapy NN B-noun.person	, , 0	interaction NN B-noun.act	with IN 0	anesthetics NNS B-noun.person	. . 0	. . 0
a6133211.s4	The DT 0	first JJ B-adj.all	twin NN B-noun.communication	, , 0	a DT 0	female NN B-noun.person	, , 0	had VBD 0	a DT 0	left VBN B-verb.stative	Potter NNP B-noun.person	- : 0	type_IIa_polycystic_kidney NN B-noun.person	and CC 0	a DT 0	rudimentary_left_uterine_cornu NNP B-noun.person	. . 0	. . 0
a7468724.s3	Potential JJ B-adj.all	mechanisms NNS B-noun.person	of IN 0	the DT 0	pathophysiology NN B-noun.person	are VBP 0	briefly RB B-adv.all	discussed VBN B-verb.communication	. . 0	. . 0
a1987816.s6	CONCLUSIONS NNS B-noun.artifact	, , 0	Urine NNP B-noun.person	volume NN B-noun.artifact	can MD 0	be VB 0	reduced VBN B-verb.change	by IN 0	giving VBG B-verb.possession	lithium NN B-noun.phenomenon	once RB B-adv.all	daily JJ B-adj.pert	and/or NN 0	by IN 0	lowering VBG B-verb.motion	the DT 0	total JJ B-adj.all	daily JJ B-adj.pert	dose NN B-noun.person	. . 0	. . 0
a3187073.s10	The DT 0	most RBS 0	common JJ B-noun.person	signs NNS I-noun.person	of IN 0	cardiotoxicity NN B-noun.state	were VBD B-verb.stative	chest_pain JJ B-adj.all	, , 0	ST NNP 0	- : 0	T PRP 0	wave VB B-verb.communication	changes NNS B-noun.phenomenon	and CC 0	atrial_fibrillation NN B-noun.act	. . 0	. . 0
a9034419.s3	After IN 0	the DT 0	ingestion NN B-noun.act	of IN 0	26 CD B-adj.all	venlafaxine NN B-noun.quantity	50-mg JJ B-adj.all	tablets NNS B-noun.artifact	, , 0	the DT 0	patient NN B-noun.person	experienced VBD B-verb.perception	a DT 0	witnessed VBN 0	generalized JJ B-adj.all	seizure NN B-noun.act	. . 0	. . 0
a3187073.s9	The DT 0	incidence NN B-noun.relation	of IN 0	cardiotoxicity NN B-noun.phenomenon	was VBD B-verb.stative	not RB B-adv.all	higher JJR B-adj.all	in IN 0	patients NNS B-noun.person	with IN 0	signs NNS B-noun.communication	of IN 0	cardiovascular_disease NN 0	than IN 0	in IN 0	those DT 0	without IN 0	in IN 0	the DT 0	pre NN B-noun.person	- : 0	treatment NN B-verb.social	evaluation NN B-noun.act	. . 0	. . 0
a11569530.s8	Infusion NN 0	regimens NNS 0	were VBD 0	designed VBN B-verb.cognition	that IN 0	rapidly RB B-adv.all	achieved VBD B-verb.social	and CC 0	maintained VBD B-verb.consumption	target NN I-verb.consumption	- : 0	free JJ B-noun.person	concentrations NNS I-noun.person	of IN 0	these DT 0	drugs NNS B-noun.artifact	in IN 0	plasma NN B-noun.substance	and CC 0	data NNS B-noun.cognition	on IN 0	the DT 0	relationship NN B-noun.state	between IN 0	free JJ B-adj.all	concentration NN B-noun.act	and CC 0	changes NNS B-noun.artifact	in IN 0	MAPD NNP B-noun.group	were VBD 0	obtained VBN B-verb.social	for IN 0	these DT 0	compounds NNS B-noun.person	. . 0	. . 0
a12907309.s1	The DT 0	aim NN 0	of IN 0	this DT 0	study NN B-noun.artifact	was VBD 0	to TO 0	examine VB B-verb.communication	the DT 0	role NN B-noun.attribute	of IN 0	metabotropic NN B-noun.attribute	glutamate NN I-noun.attribute	receptor NN B-noun.communication	5 CD 0	( ( 0	mGluR5 NNP 0	) ) 0	in IN 0	the DT 0	toxic JJ B-adj.all	action NN B-noun.state	of IN 0	methamphetamine NN B-noun.attribute	on IN 0	dopaminergic JJ B-adj.all	neurones NNS B-noun.object	in IN 0	rats NNS B-noun.animal	. . 0	. . 0
a11679859.s0	Intravenous JJ B-adj.all	administration NN B-noun.event	of IN 0	prochlorperazine NN B-noun.person	by IN 0	15-minute JJ 0	infusion NN B-noun.cognition	versus IN 0	2-minute JJ B-noun.cognition	bolus NN I-noun.cognition	does VBZ 0	not RB B-adv.all	affect VB B-verb.change	the DT 0	incidence NN B-noun.event	of IN 0	akathisia NN B-noun.location	, , 0	a DT 0	prospective JJ B-adj.all	, , 0	randomized VBD B-verb.cognition	, , 0	controlled VBN B-verb.social	trial NN B-noun.act	. . 0	. . 0
a17175308.s7	Proteinuria NNP B-noun.person	increased VBD B-verb.change	from IN 0	0.445 CD 0	( ( 0	0 CD B-noun.quantity	to TO 0	1.5 CD 0	) ) 0	g PRP 0	/ : 0	d PRP 0	before IN 0	conversion NN 0	to TO 0	3.2 CD 0	g PRP 0	/ : 0	dL PRP 0	( ( 0	0.2 CD 0	to TO 0	12 CD 0	) ) 0	after IN 0	conversion NN B-noun.cognition	( ( 0	P UH 0	= SYM 0	0.001 CD 0	) ) 0	. . 0	. . 0
a20621845.s1	PURPOSE NN B-noun.attribute	, , 0	This DT 0	study NN B-noun.artifact	was VBD 0	designed VBN B-verb.creation	to TO 0	establish VB B-verb.cognition	a DT 0	rat NN B-noun.artifact	model NN B-noun.person	of IN 0	thoracic_aortic_aneurysm NNP B-noun.other	( ( 0	TAA NNP 0	) ) 0	by IN 0	calcium_chloride JJ 0	( ( 0	CaCl(2))-induced VBN B-verb.contact	arterial_injury NN B-noun.possession	and CC 0	to TO 0	explore VB B-verb.communication	the DT 0	potential JJ B-adj.all	role NN B-noun.attribute	of IN 0	a DT 0	disintegrin NN B-noun.person	and CC 0	metalloproteinase NN B-noun.attribute	( ( 0	ADAM NNP B-noun.group	) ) 0	, , 0	matrix NN B-noun.person	metalloproteinases NNS B-noun.person	( ( 0	MMPs NNP 0	) ) 0	and CC 0	their PRP$ 0	endogenous JJ B-adj.all	inhibitors NNS B-noun.person	( ( 0	TIMPs NNP 0	) ) 0	in IN 0	TAA NNP 0	formation NN B-noun.act	. . 0	. . 0
a19300402.s5	It PRP 0	was VBD B-verb.stative	also RB B-adv.all	shown VBN B-verb.perception	that IN 0	both DT 0	products NNS B-noun.person	of IN 0	inducible JJ B-adj.all	NO DT 0	synthase NN 0	and CC 0	neuronal JJ B-adj.all	NO NNP 0	synthase NN 0	activation NN 0	as RB 0	well RB 0	as IN 0	bradykinin NN B-noun.person	are VBP 0	involved VBN B-verb.stative	in IN 0	hyperalgesia NN 0	produced VBN B-verb.creation	by IN 0	vincristine NN B-noun.person	. . 0	. . 0
a2348231.s10	We PRP 0	conclude VBP B-verb.cognition	that IN 0	pentoxyifylline NN B-noun.person	does VBZ 0	not RB B-adv.all	inhibit JJ B-adj.all	dipyridamole NN B-noun.person	- : 0	induced VBN B-verb.creation	coronary JJ B-adj.all	hyperemia NN B-noun.person	even RB B-adv.all	at IN 0	high JJ B-adj.all	doses NNS B-noun.artifact	. . 0	. . 0
a12483326.s5	However RB 0	, , 0	we PRP 0	experienced VBD B-verb.perception	a DT 0	case NN B-noun.state	of IN 0	severe JJ B-adj.all	ocular_and_orbital_toxicity NN B-noun.state	after IN 0	intracarotid JJ B-adj.all	injection NN B-noun.event	of IN 0	carboplatin NN B-noun.communication	, , 0	which WDT 0	is VBZ B-verb.stative	infrequently RB B-adv.all	reported VBN B-verb.communication	. . 0	. . 0
a3192036.s2	Based VBN B-verb.cognition	on IN 0	this DT 0	principle NN B-noun.event	a DT 0	27-year JJ 0	old JJ B-adj.all	woman NN B-noun.person	, , 0	classified VBD B-verb.cognition	as IN 0	being VBG B-verb.stative	in IN 0	the DT 0	high JJ B-noun.group	- : 0	risk NN 0	group NN 0	( ( 0	Goldstein NNP B-noun.person	and CC 0	Berkowitz NNP B-noun.person	score NN B-noun.group	, , 0	11 CD 0	) ) 0	, , 0	was VBD 0	treated VBN B-verb.change	with IN 0	multiple JJ B-adj.all	cytotoxic JJ B-adj.all	drugs NNS B-noun.artifact	. . 0	. . 0
a3782049.s4	Physicians NNS B-noun.person	who WP 0	prescribe VBP B-verb.communication	molindone NN B-noun.person	should MD 0	be VB B-verb.stative	aware JJ B-adj.all	of IN 0	this DT 0	reaction NN B-noun.cognition	. . 0	. . 0
a9334596.s19	Bromocriptine NNP B-noun.person	was VBD B-verb.stative	definitely RB B-adv.all	effective JJ B-adj.all	in IN 0	cases NNS B-noun.state	with IN 0	prolactin NN B-noun.person	greater JJR B-adj.all	than IN 0	35 CD 0	ng./ml NNP B-noun.person	. . 0	( ( 0	. . 0
a7862923.s3	None NN 0	of IN 0	the DT 0	patients NNS B-noun.person	showed VBD B-verb.communication	any DT 0	clinical JJ B-adj.all	deteriotation NN B-noun.process	during IN 0	the DT 0	following VBG 0	3 CD 0	- : 0	6 CD B-adj.all	months NNS B-noun.person	. . 0	. . 0
a6387529.s6	These DT 0	results NNS B-noun.communication	are VBP B-verb.stative	similar JJ B-adj.all	to TO 0	those DT 0	previously RB B-adv.all	found VBN B-verb.possession	in IN 0	healthy JJ B-adj.all	subjects NNS B-noun.person	. . 0	. . 0
a12483326.s11	Finally RB B-adv.all	, , 0	6 CD B-adj.all	weeks NNS B-noun.time	later RB B-adv.all	, , 0	diffuse VB B-verb.creation	chorioretinal_atrophy NN I-verb.creation	with IN 0	optic_atrophy NN B-noun.person	occurred VBD B-verb.contact	and CC 0	the DT 0	vision NN B-noun.person	in IN 0	his PRP$ 0	left JJ B-adj.all	eye NN B-noun.cognition	was VBD 0	lost VBN B-verb.possession	. . 0	. . 0
a17175308.s3	We PRP 0	retrospectively RB B-adv.all	examined VBD B-verb.communication	the DT 0	records NNS B-noun.communication	of IN 0	25 CD B-adj.all	renal JJ B-adj.all	transplant NN B-noun.person	patients NNS B-noun.person	, , 0	who WP 0	developed VBD B-verb.creation	or CC 0	displayed VBD 0	increased VBN B-verb.change	proteinuria NN I-verb.change	after IN 0	SRL NNP 0	conversion NN 0	. . 0	. . 0
a12695819.s2	Brain NNP B-noun.person	MR NNP I-noun.person	studies NNS I-noun.person	, , 0	including VBG B-verb.change	DW NNP 0	imaging NN B-verb.cognition	, , 0	were VBD B-verb.stative	prospectively RB B-adv.all	performed VBN B-verb.social	in IN 0	14 CD B-adj.all	organ NN B-noun.act	transplant NN I-noun.act	patients NNS B-noun.person	receiving VBG B-verb.communication	tacrolimus NN B-noun.person	who WP 0	developed VBD B-verb.creation	neurologic_complications NNS B-noun.artifact	. . 0	. . 0
a3629586.s2	There EX 0	is VBZ B-verb.stative	a DT 0	need NN B-noun.motive	for IN 0	a DT 0	well RB 0	- : 0	defined VBN B-verb.stative	animal NN B-adj.all	model NN B-noun.person	in IN 0	which WDT 0	these DT 0	blood_dyscrasias NNS B-noun.other	can MD 0	be VB 0	studied VBN B-verb.cognition	. . 0	. . 0
a9523805.s5	METHODS NNS B-noun.attribute	, , 0	Ninety CD 0	patients NNS B-noun.person	classified VBD B-verb.cognition	as IN 0	American NNP B-noun.other	Society NNP I-noun.other	of IN I-noun.other	Anesthesiologists NNPS I-noun.other	physical JJ B-noun.body	status NN I-noun.body	I PRP 0	or CC 0	II NNP 0	who WP 0	were VBD 0	scheduled VBN B-verb.communication	for IN 0	short JJ B-adj.all	gynecologic JJ B-adj.all	procedures NNS B-noun.person	under IN 0	spinal JJ B-adj.all	anesthesia NN B-noun.state	were VBD 0	randomly RB B-adv.all	allocated VBN B-verb.communication	to TO 0	receive VB B-verb.possession	2.5 CD 0	ml NN B-noun.quantity	2 CD B-adj.all	% NN 0	lidocaine NN B-noun.substance	in IN 0	7.5 CD 0	% NN 0	glucose NN B-noun.attribute	, , 0	2 CD B-adj.all	% NN 0	prilocaine NN B-noun.attribute	in IN 0	7.5 CD 0	% NN 0	glucose NN B-noun.attribute	, , 0	or CC 0	0.5 CD 0	% NN 0	bupivacaine NN B-noun.substance	in IN 0	7.5 CD 0	% NN 0	glucose NN B-noun.attribute	. . 0	. . 0
a869641.s10	decreased VBN B-verb.change	blood NN B-noun.act	pressure NN B-noun.act	and CC 0	heart NN B-noun.body	rate NN B-noun.time	and CC 0	decreased VBD B-verb.change	the DT 0	reflex JJ B-adj.all	bradycardia NNS B-noun.person	to TO 0	norepinephrine VB B-verb.communication	. . 0	. . 0
a3192036.s0	Death NN B-noun.person	from IN 0	chemotherapy NN B-noun.act	in IN 0	gestational_trophoblastic_disease NN 0	. . 0	. . 0
a7516729.s7	Dose SYM 0	- : 0	dependent JJ B-adj.all	bradycardia NNS B-noun.communication	induced VBN B-verb.creation	by IN 0	verapamil NN B-noun.person	was VBD 0	potentiated VBN B-verb.communication	by IN 0	LNa NNP B-noun.person	, , 0	LCa NNP B-noun.person	, , 0	and CC 0	HCa NNP B-noun.person	. . 0	. . 0
a3031535.s1	In IN 0	order NN 0	to TO 0	elucidate VB B-verb.communication	the DT 0	role NN B-noun.attribute	of IN 0	the DT 0	catecholaminergic NN B-noun.cognition	system NN B-noun.cognition	in IN 0	the DT 0	cataleptogenic JJ B-adj.all	effect NN B-noun.cognition	of IN 0	delta_9-tetrahydrocannabinol NNP B-noun.group	( ( 0	THC NNP 0	) ) 0	, , 0	the DT 0	effect NN B-noun.cognition	of IN 0	pretreatment NN B-noun.person	with IN 0	6-hydroxydopamine JJ B-noun.person	( ( I-noun.person	6-OHDA NNP I-noun.person	) ) 0	or CC 0	with IN 0	desipramine NN B-noun.person	and CC 0	6-OHDA NNP B-noun.person	and CC 0	lesions NNS B-noun.person	of IN 0	the DT 0	locus NN B-noun.artifact	coeruleus NN B-noun.person	were VBD 0	investigated VBN B-verb.communication	in IN 0	rats NNS B-noun.animal	. . 0	. . 0
a8421099.s6	In IN 0	8 CD B-adj.all	of IN 0	the DT 0	remaining VBG B-verb.stative	10 CD B-adj.all	patients NNS B-noun.person	who WP 0	developed VBD B-verb.creation	gallstones NNS B-noun.artifact	during IN 0	treatment NN B-noun.communication	, , 0	gallbladder NN B-noun.person	contractility NN B-noun.person	normalized VBN B-verb.communication	in IN 0	5 CD B-adj.all	patients NNS B-noun.person	( ( 0	3 CD 0	of IN 0	whom WP 0	has VBZ B-verb.possession	disappearance NN B-noun.attribute	of IN 0	their PRP$ 0	stones NNS B-noun.object	within IN 0	3 CD B-adj.all	weeks NNS B-noun.time	) ) 0	, , 0	and CC 0	remained VBD B-verb.stative	depressed JJ B-adj.all	in IN 0	3 CD 0	( ( 0	2 CD 0	of IN 0	whom WP 0	had VBD 0	stones NNS B-noun.object	present VBP B-verb.stative	at IN 0	6 CD B-adj.all	months NNS B-noun.quantity	) ) 0	. . 0	. . 0
a17175308.s9	In IN 0	28 CD B-adj.all	% NN 0	of IN 0	patients NNS B-noun.person	proteinuria NNS B-noun.person	remained VBD B-verb.stative	unchanged JJ B-adj.all	, , 0	whereas IN 0	it PRP 0	increased VBD B-verb.change	in IN 0	68 CD 0	% NN 0	of IN 0	patients NNS B-noun.person	. . 0	. . 0
a12615818.s7	CONCLUSIONS NNS B-noun.artifact	, , 0	We PRP 0	have VBP 0	demonstrated VBN B-verb.perception	an DT 0	increased VBN B-verb.change	risk NN 0	of IN 0	VTE NNP 0	associated VBN B-verb.cognition	with IN 0	the DT 0	use NN 0	of IN 0	CPA NNP 0	/ ( 0	EE NNP 0	in IN 0	women NNS B-noun.person	with IN 0	acne NN B-noun.person	, , 0	hirsutism NN B-noun.cognition	or CC 0	PCOS NNS B-noun.artifact	although IN 0	residual JJ B-adj.all	confounding NN B-noun.act	by IN 0	indication NN B-noun.communication	can MD 0	not RB B-adv.all	be VB 0	excluded VBN B-verb.social	. . 0	. . 0
a8690168.s2	Morphometric JJ B-noun.phenomenon	analysis NN I-noun.phenomenon	at IN 0	the DT 0	ultrastructural JJ B-adj.all	level NN B-noun.state	was VBD 0	performed VBN B-verb.change	using VBG B-verb.consumption	a DT 0	computerized JJ B-adj.all	image NN B-noun.attribute	processor NN I-noun.attribute	. . 0	. . 0
a6386793.s6	Dothiepin NNP B-noun.person	thus RB I-noun.person	was VBD 0	found VBN B-verb.cognition	to TO 0	be VB B-verb.stative	an DT 0	effective JJ B-adj.all	antidepressant JJ B-adj.all	drug NN B-noun.person	associated VBN B-verb.cognition	with IN 0	fewer JJR B-adj.all	side NN B-noun.location	effects NNS B-noun.phenomenon	than IN 0	amitriptyline NN B-noun.person	in IN 0	the DT 0	treatment NN B-noun.communication	of IN 0	depressed JJ B-adj.all	outpatients NNS B-noun.person	. . 0	. . 0
a2887062.s0	Immunohistochemical JJ B-adj.all	, , 0	electron NN B-noun.person	microscopic NN B-noun.person	and CC 0	morphometric JJ B-adj.all	studies NNS B-noun.group	of IN 0	estrogen NN B-noun.act	- : 0	induced JJ B-verb.creation	rat NN 0	prolactinomas NNS B-noun.communication	after IN 0	bromocriptine JJ B-noun.relation	treatment NN I-noun.relation	. . 0	. . 0
a11027905.s10	A DT 0	significant JJ B-adj.all	difference NN B-noun.cognition	in IN 0	MMSE NNP B-noun.other	was VBD 0	observed VBN B-verb.perception	at IN 0	T30 NN 0	in IN 0	patients NNS B-noun.person	who WP 0	received VBD B-verb.possession	0.50 CD 0	mg NN B-noun.quantity	/ CD 0	kg NN B-noun.quantity	of IN 0	ketamine NN B-noun.person	. . 0	. . 0
a1436384.s10	The DT 0	data NNS B-noun.cognition	strengthen VBP B-verb.change	the DT 0	evidence NN B-noun.communication	that IN 0	the DT 0	neurotoxic JJ B-adj.all	effect NN B-noun.cognition	of IN 0	amphetamine NN B-noun.person	and CC 0	related JJ B-adj.all	compounds NNS B-noun.person	toward IN 0	nigrostriatal JJ B-adj.all	dopamine NN B-noun.act	neurons NNS I-noun.act	involves VBZ B-verb.stative	NMDA NNP B-noun.group	receptors NNS B-noun.person	and CC 0	that DT 0	LY274614 NN B-noun.person	is VBZ B-verb.stative	an DT 0	NMDA NNP B-noun.group	receptor NN B-noun.artifact	antagonist NN B-noun.person	with IN 0	long JJ B-noun.body	- : 0	lasting NN B-verb.contact	in IN 0	vivo JJ B-adj.all	effects NNS B-noun.phenomenon	in IN 0	rats NNS B-noun.animal	. . 0	. . 0
a12090760.s7	These DT 0	results NNS B-noun.communication	suggest VBP B-verb.communication	that IN 0	endothelial JJ B-adj.all	cells NNS B-noun.body	treated VBN B-verb.change	simultaneously RB B-adv.all	with IN 0	EPO NNP B-noun.group	and CC 0	IL-3 NN B-noun.group	have VB B-verb.stative	a DT 0	negative JJ B-adj.all	effect NN B-noun.cognition	on IN 0	erythroid JJ B-adj.all	cell NN B-noun.body	production NN I-noun.body	. . 0	. . 0
a8073369.s5	Concentrations NNS B-noun.person	of IN 0	coniine NN B-noun.act	and CC 0	nicotine JJ B-adj.all	sulfate NN B-noun.person	were VBD B-verb.stative	0.015 CD 0	% NN 0	, , 0	0.03 CD 0	% NN 0	, , 0	0.075 CD 0	% NN 0	, , 0	0.15 CD 0	% NN 0	, , 0	0.75 CD 0	% NN 0	, , 0	1.5 CD 0	% NN 0	, , 0	3 CD B-adj.all	% NN 0	, , 0	and CC 0	6 CD B-adj.all	% NN 0	and CC 0	1 CD B-adj.all	% NN 0	, , 0	5 CD B-adj.all	% NN 0	, , 0	and CC 0	10 CD B-adj.all	% NN 0	, , 0	respectively RB B-adv.all	. . 0	. . 0
a6229975.s2	The DT 0	follow NN B-noun.act	- : 0	up IN 0	period NN B-noun.person	was VBD B-verb.stative	12 CD B-adj.all	months NNS B-noun.person	. . 0	. . 0
a2312209.s2	After IN 0	detailing VBG B-verb.communication	the DT 0	course NN B-noun.location	of IN 0	events NNS B-noun.person	, , 0	we PRP 0	discuss VBP B-verb.cognition	the DT 0	role NN B-noun.attribute	of IN 0	paradoxical JJ B-adj.all	coronary JJ B-adj.all	spasm NN B-noun.artifact	and CC 0	hypotension NN B-noun.act	- : 0	mediated VBD B-verb.stative	myocardial_ischemia NN I-verb.stative	occurring VBG B-verb.stative	downstream NN 0	to TO 0	significant JJ B-adj.all	coronary_arterial_stenosis NN B-noun.cognition	in IN 0	the DT 0	pathophysiology NN B-noun.attribute	of IN 0	acute_coronary_insufficiency NN B-noun.person	. . 0	. . 0
a8421099.s5	After IN 0	withdrawal NN B-noun.person	of IN 0	octreotide NN B-noun.food	in IN 0	10 CD B-adj.all	patients NNS B-noun.person	without IN 0	gallstones NNS B-noun.animal	, , 0	8 CD B-adj.all	patients NNS B-noun.person	assessed VBN B-verb.communication	had VBD 0	return NN 0	of IN 0	normal JJ B-adj.all	gallbladder NN B-noun.person	contractility NN B-noun.phenomenon	within IN 0	1 CD B-adj.all	month NN B-noun.quantity	. . 0	. . 0
a6387529.s0	Behavioral JJ B-adj.pert	effects NNS B-noun.phenomenon	of IN 0	diazepam NN B-noun.person	and CC 0	propranolol NN B-noun.person	in IN 0	patients NNS B-noun.person	with IN 0	panic_disorder NN B-noun.person	and CC 0	agoraphobia NN B-noun.person	. . 0	. . 0
a9523805.s6	All DT 0	solutions NNS B-noun.group	were VBD 0	provided VBN B-verb.communication	in RP 0	blinded JJ B-adj.all	vials NNS B-noun.person	by IN 0	the DT 0	hospital NN B-noun.artifact	pharmacy NN B-noun.person	. . 0	. . 0
a6229975.s7	After IN 0	re SYM 0	- : 0	infarction NN B-noun.cognition	, , 0	heart NN 0	size NN B-noun.attribute	increased VBN B-verb.change	in IN 0	the DT 0	placebo NN B-noun.location	group NN B-noun.person	and CC 0	remained VBD B-verb.change	unchanged JJ B-adj.all	in IN 0	the DT 0	timolol NN 0	group NN 0	. . 0	. . 0
a9334596.s16	Only RB B-adv.all	1 CD B-adj.all	prolactinoma NN B-noun.person	was VBD 0	discovered VBN B-verb.creation	. . 0	. . 0
a11027905.s11	Ketamine NNP B-noun.person	can MD 0	improve VB B-verb.change	morphine JJR B-adj.all	analgesia NN B-noun.attribute	in IN 0	difficult JJ B-adj.all	pain NN B-noun.cognition	syndromes NNS I-noun.cognition	, , 0	such JJ 0	as IN 0	neuropathic_pain JJ B-noun.person	. . 0	. . 0
a18343374.s3	SETTING NN B-noun.artifact	, , 0	Ophthalmology NNP B-noun.person	clinic NN I-noun.person	of IN 0	an DT 0	academic JJ B-adj.all	hospital NN B-noun.artifact	. . 0	. . 0
a17042910.s8	Dexamethasone NNP B-noun.person	( ( 0	10 CD B-adj.all	microg NNS B-noun.quantity	/ : 0	kg FW 0	per FW 0	day NN 0	, , 0	s.c NNP B-noun.person	. . 0	) ) 0	. . 0
a1130930.s1	Two CD 0	patients NNS B-noun.person	developed VBD B-verb.communication	acute_tubular_necrosis NNP B-noun.person	, , 0	characterized VBD B-verb.communication	clinically RB B-adv.all	by IN 0	acute JJ B-adj.all	oliguric_renal_failure JJ B-noun.other	, , 0	while IN 0	they PRP 0	were VBD 0	receiving VBG B-verb.perception	a DT 0	combination NN B-noun.event	of IN 0	cephalothin_sodium NN B-noun.location	and CC 0	gentamicin_sulfate JJ B-adj.all	therapy NN B-noun.person	. . 0	. . 0
a7053303.s2	Cimetidine JJ B-adj.all	clearance NN B-noun.attribute	decreased VBD B-verb.change	with IN 0	age NN B-noun.person	. . 0	. . 0
a2440413.s5	Seizure NN B-noun.body	activity NN B-noun.process	due JJ 0	to TO 0	PTZ NNP B-noun.group	and CC 0	picrotoxin NN B-noun.communication	( ( 0	PTX NNP 0	) ) 0	was VBD B-verb.stative	significantly RB B-adv.all	decreased VBD B-verb.change	, , 0	however RB 0	, , 0	seizure NN B-noun.body	activity NN B-noun.process	due JJ 0	to TO 0	3-mercaptopropionic_acid JJ 0	( ( 0	MPA NNP 0	) ) 0	, , 0	bicuculline NN 0	( ( 0	BCC NNP 0	) ) 0	, , 0	methyl_6,7-dimethoxy-4-ethyl SYM 0	- : 0	B SYM 0	- : 0	carboline-3-carboxylate NN B-noun.time	( ( 0	DMCM NNP B-noun.group	) ) 0	, , 0	or CC 0	strychnine NN B-noun.substance	( ( 0	STR NNP 0	) ) 0	was VBD B-verb.stative	not RB B-adv.all	different JJ B-adv.all	from IN 0	control NN B-noun.act	. . 0	. . 0
a7248170.s0	Phenobarbitone NN B-noun.person	- : 0	induced VBN B-verb.creation	enlargement_of_the_liver RB 0	in IN 0	the DT 0	rat NN B-noun.artifact	, , 0	its PRP$ 0	relationship NN B-noun.state	to TO 0	carbon_tetrachloride VB B-verb.social	- : 0	induced VBN B-verb.creation	cirrhosis NN B-noun.cognition	. . 0	. . 0
a869641.s6	Pimozide NNP B-noun.person	did VBD 0	not RB B-adv.all	affect VB B-verb.change	the DT 0	actions NNS B-noun.act	of IN 0	L NNP 0	- : 0	dopa NN B-noun.person	on IN 0	blood NN B-noun.act	pressure NN B-noun.act	and CC 0	heart NN B-noun.body	rate NN B-noun.time	but CC 0	completely RB B-adv.all	blocked VBD B-verb.contact	the DT 0	enhancement NN B-noun.person	of IN 0	reflexes NNS B-noun.communication	. . 0	. . 0
a3560095.s0	Flurbiprofen NNP B-noun.person	in IN 0	the DT 0	treatment NN B-noun.communication	of IN 0	juvenile_rheumatoid_arthritis NN B-noun.location	. . 0	. . 0
a18182964.s10	Physicians NNS B-noun.person	prescribing VBG B-verb.creation	clonidine NN B-noun.attribute	should MD 0	monitor VB B-verb.perception	for IN 0	bradycardia NNS B-noun.person	and CC 0	advise NN B-noun.act	patients NNS B-noun.person	about IN 0	the DT 0	high JJ B-adj.all	likelihood NN B-noun.attribute	of IN 0	initial JJ B-adj.all	drowsiness NN B-noun.feeling	. . 0	. . 0
a11679859.s7	The DT 0	intensity NN B-noun.attribute	of IN 0	headache NN B-noun.state	and CC 0	nausea NN B-noun.person	was VBD 0	measured VBN B-verb.cognition	with IN 0	a DT 0	100-mm JJ 0	visual JJ B-adj.pert	analog NN 0	scale NN 0	. . 0	. . 0
a9195768.s1	Atypical_sensations NNS B-noun.artifact	following VBG B-verb.stative	the DT 0	use NN 0	of IN 0	subcutaneous JJ B-adj.all	sumatriptan NN B-noun.communication	are VBP B-verb.stative	common JJ B-noun.person	, , 0	but CC 0	of IN 0	uncertain JJ B-adj.all	origin NN B-noun.attribute	. . 0	. . 0
a3192036.s8	Patients NNS B-noun.person	with IN 0	large JJ B-adj.all	pelvic_tumor NN B-noun.person	loads NNS I-noun.person	are VBP B-verb.stative	, , 0	according VBG 0	to TO 0	existing VBG B-verb.stative	classifications NNS B-noun.person	, , 0	at IN 0	high JJ B-adj.all	risk NN 0	to TO 0	die VB B-verb.change	and CC 0	to TO 0	develop VB B-verb.communication	drug NN B-noun.phenomenon	resistance NN B-noun.phenomenon	. . 0	. . 0
a11679859.s14	CONCLUSION NN B-noun.group	, , 0	A DT 0	50 CD B-adj.all	% NN 0	reduction NN B-noun.act	in IN 0	the DT 0	incidence NN B-noun.event	of IN 0	akathisia NN B-noun.time	when WRB 0	prochlorperazine NN B-noun.person	was VBD 0	administered VBN B-verb.possession	by IN 0	means NNS B-noun.person	of IN 0	15-minute JJ 0	intravenous JJ B-adj.all	infusion NN B-noun.cognition	versus IN 0	a DT 0	2-minute JJ B-adj.all	intravenous JJ B-adj.all	push NN B-noun.person	was VBD B-verb.stative	not RB B-adv.all	detected VBN B-verb.perception	. . 0	. . 0
a19300402.s8	In IN 0	streptozotocin NN B-noun.substance	- : 0	induced VBN B-verb.creation	hyperalgesia NN 0	, , 0	inducible JJ B-adj.all	NO DT 0	synthase NN B-noun.object	participates NNS I-noun.object	in IN 0	pronociceptive JJ B-adj.all	activity NN B-noun.process	of IN 0	bradykinin NN B-noun.food	, , 0	whereas IN 0	in IN 0	vincristine NN 0	- : 0	induced VBN B-verb.creation	hyperalgesia NN 0	bradykinin NN B-noun.person	seemed VBD B-verb.perception	to TO 0	activate VB B-verb.stative	neuronal JJ B-adj.all	NO NNP 0	synthase NN 0	pathway NN B-noun.location	. . 0	. . 0
a1639466.s5	Renal NNP B-noun.person	tissue NN I-noun.person	was VBD 0	obtained VBN B-verb.social	for IN 0	determination NN B-noun.cognition	of IN 0	glomerular JJ B-adj.all	size NN B-noun.attribute	and CC 0	sclerosis NN B-noun.person	. . 0	. . 0
a17042910.s14	In IN 0	rats NNS 0	treated VBN B-verb.change	with IN 0	Dex NNP B-noun.person	alone RB 0	, , 0	SBP NNP 0	was VBD 0	increased VBN B-verb.change	from IN 0	109 CD 0	+ : 0	/- # 0	2 CD B-adj.all	to TO 0	133 CD 0	+ : 0	/- # 0	2 CD B-adj.all	mmHg CD B-noun.other	on IN I-noun.other	Days NNPS I-noun.other	4 CD I-noun.other	and CC I-noun.other	Day NNP I-noun.other	14 CD I-noun.other	, , 0	respectively RB B-adv.all	( ( 0	P NNP 0	< $ 0	0.001 CD 0	) ) 0	. . 0	. . 0
a17042910.s15	In IN 0	the DT 0	Ato NNP B-noun.person	+ NNP I-noun.person	Dex NNP I-noun.person	group NN I-noun.person	, , 0	SBP NNP 0	was VBD 0	increased VBN B-verb.change	from IN 0	113 CD 0	+ : 0	/- # 0	2 CD B-adj.all	to TO 0	119 CD 0	+ : 0	/- # 0	2 CD B-adj.all	mmHg CD B-noun.quantity	on IN 0	Days NNPS 0	4 CD 0	to TO 0	14 CD B-adj.all	, , 0	respectively RB B-adv.all	( ( 0	P NNP 0	< $ 0	0.001 CD 0	) ) 0	, , 0	but CC 0	was VBD B-verb.stative	significantly RB B-adv.all	lower JJR B-adj.all	than IN 0	SBP NNP 0	in IN 0	the DT 0	group NN 0	treated VBN B-verb.change	with IN 0	Dex NNP B-noun.person	alone RB B-adv.all	( ( 0	P NNP 0	< $ 0	0.05 CD 0	) ) 0	. . 0	. . 0
a12695819.s6	Among IN 0	the DT 0	5 CD B-adj.all	patients NNS B-noun.person	with IN 0	white_matter_abnormalities NNS B-noun.food	, , 0	4 CD B-adj.all	patients NNS B-noun.person	( ( 0	80.0 CD 0	% NN 0	) ) 0	showed VBD B-verb.communication	higher JJR B-adj.all	than IN 0	normal JJ B-adj.all	ADC NNP B-noun.group	values NNS B-noun.attribute	on IN 0	initial JJ B-adj.all	MR NNP 0	images NNS B-noun.artifact	, , 0	and CC 0	all DT 0	showed VBD B-verb.communication	complete JJ B-adj.all	resolution NN B-noun.communication	on IN 0	follow NN B-noun.act	- : 0	up IN 0	images NNS B-noun.person	. . 0	. . 0
a6103707.s9	injection NN B-noun.act	of IN 0	flunitrazepam NN B-noun.phenomenon	significantly RB B-adv.all	more RBR B-adv.all	often RB 0	than IN 0	with IN 0	isotonic JJ B-adj.all	saline NN B-noun.act	. . 0	. . 0
a2070391.s3	Twenty CD 0	patients NNS B-noun.person	were VBD 0	asked VBN B-verb.communication	to TO 0	quantify VB B-verb.change	the DT 0	severity NN B-noun.attribute	of IN 0	pain NN B-noun.cognition	after IN 0	receiving VBG B-verb.social	standard JJ B-adj.all	lidocaine NN B-noun.act	in IN 0	one CD 0	femoral JJ B-adj.all	area NN B-noun.body	and CC 0	buffered VBN B-verb.change	lidocaine NN I-verb.change	in IN 0	the DT 0	opposite JJ B-adj.all	femoral JJ B-adj.all	area NN B-noun.cognition	. . 0	. . 0
a20470218.s6	CNS NNS 0	complications NNS 0	included VBD B-verb.stative	posterior JJ B-adj.all	reversible JJ B-adj.all	leukoencephalopathy JJ B-adj.all	syndrome NN 0	( ( 0	n UH 0	= $ 0	10 CD B-adj.all	) ) 0	, , 0	stroke NN B-noun.person	( ( 0	n UH 0	= $ 0	5 CD B-adj.all	) ) 0	, , 0	temporal_lobe_epilepsy JJ 0	( ( 0	n UH 0	= : 0	2 LS 0	) ) 0	, , 0	high JJ B-noun.group	- : 0	dose NN B-noun.person	methotrexate NN B-noun.person	toxicity NN B-noun.person	( ( 0	n UH 0	= : 0	2 LS 0	) ) 0	, , 0	syndrome NN 0	of IN 0	inappropriate_antidiuretic_hormone_secretion NN B-noun.cognition	( ( 0	n UH 0	= : 0	1 LS 0	) ) 0	, , 0	and CC 0	other JJ 0	unclassified JJ B-adj.all	events NNS B-noun.person	( ( 0	n UH 0	= $ 0	7 CD B-adj.all	) ) 0	. . 0	. . 0
a1436384.s7	A DT 0	10 CD B-adj.all	mg FW B-noun.quantity	/ FW 0	kg FW 0	dose NN 0	of IN 0	LY274614 NN B-noun.location	was VBD B-verb.stative	effective JJ B-adj.all	in IN 0	antagonizing VBG B-verb.communication	the DT 0	depletion NN B-noun.act	of IN 0	dopamine NN B-noun.act	in IN 0	the DT 0	striatum NN B-noun.artifact	, , 0	when WRB 0	given VBN B-verb.possession	as RB 0	long RB 0	as IN 0	8 CD B-adj.all	hr NN B-noun.time	prior RB 0	to TO 0	amphetamine VB B-verb.social	but CC 0	not RB B-adv.all	when WRB 0	given VBN B-verb.possession	24 CD B-adj.all	hr NN B-noun.time	prior RB 0	to TO 0	amphetamine VB B-verb.social	. . 0	. . 0
a8073369.s2	The DT 0	major JJ B-adj.all	teratogenic JJ B-adj.pert	outcome NN B-noun.person	is VBZ B-verb.stative	arthrogryposis NN B-noun.state	, , 0	presumably RB 0	due JJ 0	to TO 0	nicotinic JJ B-adj.all	receptor NN B-noun.person	blockade NN B-noun.person	. . 0	. . 0
a8669433.s0	Habitual JJ 0	use NN 0	of IN 0	acetaminophen NN B-noun.person	as IN 0	a DT 0	risk NN B-noun.person	factor NN B-noun.person	for IN 0	chronic_renal_failure NN B-noun.act	, , 0	a DT 0	comparison NN B-noun.person	with IN 0	phenacetin NN B-noun.food	. . 0	. . 0
a8690168.s7	At IN 0	the DT 0	same JJ B-adj.all	time NN B-noun.time	, , 0	the DT 0	number NN B-noun.quantity	of IN 0	heparan_sulphate JJ B-adj.all	anionic NN B-noun.animal	sites NNS B-noun.location	and CC 0	the DT 0	total JJ B-adj.all	anionic JJ 0	site NN 0	surface NN B-noun.location	( ( 0	number NN B-noun.quantity	of IN 0	anionic JJ B-adj.all	sites NNS B-noun.location	x TO 0	mean VB B-verb.stative	anionic JJ 0	site NN 0	surface NN B-noun.location	) ) 0	in IN 0	the DT 0	lamina NN B-noun.artifact	rara JJ B-adj.all	externa NN B-noun.group	of IN 0	the DT 0	glomerular JJ B-adj.all	basement NN B-noun.shape	membrane NN B-noun.person	was VBD 0	reduced VBN B-verb.change	by IN 0	19 CD B-adj.all	% NN 0	( ( 0	p<0.021 JJ 0	) ) 0	and CC 0	by IN 0	26 CD B-adj.all	% NN 0	( ( 0	p<0.02 NNP 0	) ) 0	, , 0	respectively RB B-adv.all	. . 0	. . 0
a7423039.s5	Such JJ B-adj.all	disparity NN B-noun.person	suggests VBZ B-verb.communication	an DT 0	inhibition NN B-noun.attribute	of IN 0	creatine NN B-noun.location	phosphokinase NN B-noun.artifact	. . 0	. . 0
a7516729.s0	Interactive JJ B-adj.all	effects NNS B-noun.phenomenon	of IN 0	variations NNS B-noun.artifact	in IN 0	[ PRP$ 0	Na]o JJ B-noun.group	and CC 0	[ : 0	Ca]o NN B-noun.artifact	on IN 0	rat NN 0	atrial JJ B-adj.all	spontaneous JJ B-adj.all	frequency NN B-noun.person	. . 0	. . 0
a19300402.s1	PURPOSE NN B-noun.attribute	, , 0	The DT 0	influence NN B-noun.cognition	of IN 0	an DT 0	irreversible JJ B-adj.all	inhibitor NN B-noun.person	of IN 0	constitutive JJ B-adj.all	NO DT 0	synthase NN 0	( ( 0	L SYM 0	- : 0	NOArg NN B-noun.person	, , 0	1.0 CD 0	mg FW B-noun.quantity	/ FW 0	kg FW 0	ip NN 0	) ) 0	, , 0	a DT 0	relatively RB B-adv.all	selective JJ B-adj.all	inhibitor NN B-noun.person	of IN 0	inducible JJ B-adj.all	NO DT 0	synthase NN 0	( ( 0	L SYM 0	- : 0	NIL NNP B-noun.group	, , 0	1.0 CD 0	mg FW B-noun.quantity	/ FW 0	kg FW 0	ip NN 0	) ) 0	and CC 0	a DT 0	relatively RB B-adv.all	specific JJ B-adj.all	inhibitor NN B-noun.attribute	of IN 0	neuronal JJ B-adj.all	NO NNP 0	synthase NN 0	( ( 0	7-NI NNS 0	, , 0	0.1 CD 0	mg FW B-noun.quantity	/ FW 0	kg FW 0	ip NN 0	) ) 0	, , 0	on IN 0	antihyperalgesic JJ B-adj.all	action NN B-noun.state	of IN 0	selective JJ B-adj.all	antagonists NNS B-noun.person	of IN 0	B2 NN 0	and CC 0	B1 JJ B-adj.all	receptors NNS B-noun.person	, , 0	D NNP 0	- : 0	Arg-[Hyp3,Thi5,D SYM 0	- : 0	Tic7,Oic8 VB B-verb.cognition	] DT 0	bradykinin NN B-noun.substance	( ( 0	HOE_140 JJ 0	, , 0	70 CD B-adj.all	nmol NN B-noun.quantity	/ : 0	kg PRP 0	ip MD 0	) ) 0	or CC 0	des_Arg10_HOE_140 JJ 0	( ( 0	70 CD B-adj.all	nmol NN B-noun.quantity	/ : 0	kg PRP 0	ip MD 0	) ) 0	respectively RB B-adv.all	, , 0	in IN 0	model NN 0	of IN 0	diabetic_(streptozotocin NN B-noun.person	- : 0	induced)_and_toxic_(vincristine JJ 0	- : 0	induced)_neuropathy JJ 0	was VBD 0	investigated VBN B-verb.communication	. . 0	. . 0
a19631624.s3	Using VBG B-verb.consumption	functional JJ B-adj.all	imaging NN B-noun.attribute	and CC 0	a DT 0	face NN B-noun.act	- : 0	learning VBG B-verb.cognition	task NN 0	, , 0	we PRP 0	investigated VBD B-verb.communication	neural JJ B-noun.body	correlates NNS I-noun.body	of IN 0	encoding VBG B-verb.social	and CC 0	recalling VBG B-verb.communication	face NN B-noun.act	- : 0	name NN B-noun.group	associations NNS B-noun.person	in IN 0	20 CD B-adj.all	recreational JJ B-adj.all	drug NN B-noun.person	users NNS B-noun.person	whose WP$ 0	predominant JJ B-adj.all	drug NN B-noun.artifact	use NN I-noun.artifact	was VBD B-verb.stative	ecstasy JJ B-adj.all	and CC 0	20 CD B-adj.all	controls NNS B-noun.artifact	. . 0	. . 0
a3412544.s0	Does VBZ 0	paracetamol NN B-noun.act	cause NN B-noun.act	urothelial_cancer NN B-noun.other	or CC 0	renal_papillary_necrosis NN B-noun.act	? . 0	. . 0
a1987816.s4	RESULTS NNS B-noun.artifact	, , 0	Multiple JJ 0	daily JJ B-adj.all	doses NNS B-noun.event	of IN 0	lithium NN B-noun.food	were VBD 0	associated VBN B-verb.cognition	with IN 0	higher JJR B-adj.all	urine NN B-noun.location	volumes NNS B-noun.artifact	. . 0	. . 0
a19356307.s2	These DT 0	lemon JJ B-adj.all	essential JJ B-adj.all	oils NNS B-noun.person	showed VBD B-verb.communication	strong JJ B-adj.all	ability NN B-noun.cognition	to TO 0	improve VB B-verb.communication	memory_impaired VBN B-verb.cognition	by IN 0	scopolamine NN B-noun.person	, , 0	however RB 0	, , 0	s PRP 0	- : 0	perillyl_alcohol NN B-noun.person	relieved VBD B-verb.body	the DT 0	deficit_of_associative_memory NN B-noun.communication	in IN 0	PA NNP B-adv.all	only RB I-adv.all	, , 0	and CC 0	did VBD 0	not RB B-adv.all	improve VB B-verb.change	non RB B-adv.all	- : 0	associative JJ B-adj.all	memory NN B-noun.person	significantly RB B-adv.all	in IN 0	OFH NNP 0	. . 0	. . 0
a1732369.s1	Doxorubicin NNP B-noun.person	is VBZ B-verb.stative	an DT 0	effective JJ B-adj.all	anticancer NN B-noun.attribute	chemotherapeutic JJ B-adj.all	agent NN B-noun.person	known VBN B-verb.cognition	to TO 0	cause VB B-verb.communication	acute NN B-noun.person	and CC 0	chronic JJ B-adj.all	cardiomyopathy NN B-noun.group	. . 0	. . 0
a3714122.s4	Those DT 0	dosages NNS B-noun.communication	( ( 0	greater JJR B-adj.all	than IN 0	or CC 0	equal JJ B-adj.all	to TO 0	10 CD B-adj.all	mg PRP B-noun.quantity	/ : 0	kg LS 0	) ) 0	that WDT 0	inhibited VBD B-verb.stative	mean JJ B-adj.all	NTE NNP 0	activity NN B-noun.process	in IN 0	the DT 0	spinal JJ B-adj.all	cord NN 0	greater JJR B-adj.all	than IN 0	or CC 0	equal JJ B-adj.all	to TO 0	73 CD 0	% NN 0	and CC 0	brain NN B-noun.person	greater JJR B-adj.all	than IN 0	or CC 0	equal JJ B-adj.all	to TO 0	67 CD 0	% NN 0	of IN 0	control NN B-noun.act	values NNS B-noun.attribute	produced VBD B-verb.creation	severe JJ 0	( ( 0	greater JJR B-adj.all	than IN 0	or CC 0	equal JJ B-adj.all	to TO 0	3 CD 0	) ) 0	cervical JJ B-adj.all	cord NN B-noun.artifact	pathology NN I-noun.artifact	in IN 0	85 CD 0	% NN 0	of IN 0	the DT 0	rats NNS B-noun.plant	. . 0	. . 0
a8231633.s2	For IN 0	each DT 0	of IN 0	the DT 0	three CD 0	tested VBN B-verb.social	calcium NN 0	channel NN 0	blockers NNS 0	( ( 0	diltiazem NN B-noun.person	, , 0	verapamil RB B-adv.all	and CC 0	bepridil NN B-noun.body	) ) 0	6 CD B-adj.all	groups NNS B-noun.group	of IN 0	mice NNS B-noun.person	were VBD 0	treated VBN B-verb.change	by IN 0	two CD 0	different JJ B-adj.all	doses NNS B-noun.artifact	, , 0	i.e. FW 0	2 CD 0	and CC 0	10 CD B-adj.all	mg FW B-noun.quantity	/ FW 0	kg FW 0	/ FW 0	i.p FW 0	. . 0	, , 0	. . 0
a6861444.s3	Intrarenal JJ 0	compared VBN B-verb.possession	with IN 0	intravenous JJ B-adj.all	infusion NN B-noun.cognition	of IN 0	noradrenaline NN B-noun.person	caused VBD B-verb.communication	higher JJR B-adj.all	plasma NN B-noun.plant	noradrenaline NN B-noun.body	concentrations NNS B-noun.attribute	and CC 0	a DT 0	shift NN B-noun.act	of IN 0	the DT 0	plasma NN B-noun.plant	noradrenaline NN B-noun.body	concentration NN B-noun.event	- : 0	blood NN B-noun.group	pressure NN B-noun.act	effect NN B-noun.cognition	curve NN B-noun.communication	towards IN 0	lower JJR B-adj.all	plasma NN B-noun.plant	noradrenaline NN B-noun.body	levels NNS B-noun.attribute	. . 0	. . 0
a435349.s3	The DT 0	infusion NN B-noun.cognition	was VBD 0	discontinued VBN B-verb.stative	either RB 0	when WRB 0	there EX 0	was VBD B-verb.stative	no DT 0	muscular JJ B-adj.all	response NN B-noun.communication	to TO 0	tetanic JJ B-adj.all	stimulation NN B-noun.cognition	of IN 0	the DT 0	ulnar NN B-noun.group	nerve NN B-noun.attribute	or CC 0	when WRB 0	Sch NNP 0	120 CD 0	mg NN B-noun.quantity	was VBD 0	exceeded VBN B-verb.change	. . 0	. . 0
a11166519.s3	Seizure NN B-noun.body	end NN 0	points NNS B-noun.cognition	included VBD B-verb.stative	latency NN 0	to TO 0	forelimb VB B-verb.communication	or CC 0	hindlimb VB B-verb.consumption	clonus NN I-verb.consumption	, , 0	latency NN B-noun.person	to TO 0	clonic JJ B-adj.all	running NN B-noun.act	seizure NN B-noun.act	and CC 0	latency NN B-noun.person	to TO 0	jumping VBG B-verb.motion	bouncing VBG B-verb.motion	seizure NN B-noun.act	. . 0	. . 0
a3031535.s3	On IN 0	the DT 0	contrary NN B-noun.communication	, , 0	the DT 0	cataleptogenic JJ B-adj.all	effect NN B-noun.cognition	of IN 0	haloperidol NN B-noun.person	was VBD B-verb.stative	significantly RB B-adv.all	reduced VBN B-verb.change	in IN 0	rats NNS B-noun.animal	treated VBN B-verb.change	with IN 0	desipramine NN B-noun.person	and CC 0	6-OHDA NNP B-noun.person	but CC 0	not RB B-adv.all	in IN 0	rats NNS B-noun.animal	treated VBN B-verb.change	with IN 0	6-OHDA NNP B-noun.person	or CC 0	in IN 0	rats NNS B-noun.animal	with IN 0	lesions NNS B-noun.person	of IN 0	the DT 0	locus NN B-noun.body	coeruleus NN I-noun.body	. . 0	. . 0
a9293063.s0	Bile_duct_hamartoma CD 0	occurring VBG B-verb.stative	in IN 0	association NN 0	with IN 0	long JJ B-noun.body	- : 0	term NN B-noun.time	treatment NN 0	with IN 0	danazol NN B-noun.person	. . 0	. . 0
a1436384.s5	This DT 0	prolonged JJ B-adj.all	depletion NN B-noun.process	of IN 0	dopamine NN B-noun.act	in IN 0	the DT 0	striatum NN B-noun.artifact	was VBD 0	antagonized VBN B-verb.cognition	by IN 0	dizocilpine NN B-noun.person	( ( 0	MK-801 NN 0	, , 0	a DT 0	non NN B-noun.person	- : 0	competitive JJ B-adj.all	antagonist NN B-noun.attribute	of IN 0	NMDA NNP B-noun.group	receptors NNS I-noun.group	) ) 0	or CC 0	by IN 0	LY274614 NNP B-noun.person	( ( 0	a DT 0	competitive JJ B-adj.all	antagonist NN B-noun.attribute	of IN 0	NMDA NNP B-noun.group	receptors NNS I-noun.group	) ) 0	. . 0	. . 0
a9334596.s3	Every DT 0	patient NN B-noun.person	was VBD 0	screened VBN B-verb.contact	for IN 0	testosterone NN 0	and CC 0	451 CD 0	were VBD 0	screened VBN B-verb.contact	for IN 0	prolactin NN B-noun.person	on IN 0	the DT 0	basis NN B-noun.cognition	of IN 0	low_sexual_desire JJ B-noun.location	, , 0	gynecomastia NN B-noun.person	or CC 0	testosterone VB B-verb.social	less JJR 0	than IN 0	4 CD B-adj.all	ng./ml NNP B-noun.person	. . 0	. . 0
a7862923.s2	This DT 0	change NN B-noun.communication	resulted VBD B-verb.stative	within IN 0	2 CD B-adj.all	- : 0	4 CD B-adj.all	weeks NNS B-noun.time	in IN 0	the DT 0	50 CD B-adj.all	- : 0	200 CD 0	% NN 0	increase NN B-noun.event	in IN 0	the DT 0	plasma NN B-noun.plant	levels NNS B-noun.state	of IN 0	these DT 0	neuroleptics NNS B-noun.person	and CC 0	the DT 0	appearance NN B-noun.act	of IN 0	extrapyramidal_symptoms NNS B-noun.location	. . 0	. . 0
a8231633.s1	The DT 0	purpose NN B-noun.attribute	of IN 0	this DT 0	study NN B-noun.artifact	was VBD 0	to TO 0	investigate VB B-verb.communication	the DT 0	influence NN B-noun.cognition	of IN 0	calcium NN 0	channel NN 0	blockers NNS B-noun.person	on IN 0	bupivacaine NN B-noun.act	- : 0	induced VBN B-verb.creation	acute JJ B-adj.all	toxicity NN B-noun.attribute	. . 0	. . 0
a6387529.s2	Both DT 0	drugs NNS B-noun.artifact	impaired_immediate_free_recall VBP 0	but CC 0	the DT 0	decrease NN B-noun.time	was VBD B-verb.stative	greater JJR B-adj.all	for IN 0	diazepam NN B-noun.person	than IN 0	propranolol NN B-noun.person	. . 0	. . 0
a19581773.s0	Development NN B-noun.process	of IN 0	ocular_myasthenia NNP B-noun.location	during IN 0	pegylated_interferon NNP B-noun.person	and CC 0	ribavirin VB B-verb.social	treatment NN I-verb.social	for IN 0	chronic_hepatitis NNP B-noun.group	C. NNP I-noun.group	. . 0
a6103707.s7	Dizziness NN B-noun.person	was VBD B-verb.stative	less RBR B-adv.all	marked JJ B-adj.all	than IN 0	sedation NN B-noun.person	, , 0	but CC 0	increased VBN B-verb.change	with IN 0	the DT 0	dose NN B-noun.person	. . 0	. . 0
a15278670.s4	l(-1 LS 0	) ) 0	when WRB 0	the DT 0	end NN B-noun.person	- : 0	tidal JJ B-adj.all	concentration NN B-noun.event	of IN 0	sevoflurane NN B-noun.person	was VBD B-verb.stative	0.8 CD 0	% NN 0	. . 0	. . 0
a18261172.s3	In IN 0	cardiac JJ B-adj.all	transplantation NN B-noun.act	, , 0	the DT 0	incidence NN B-noun.event	of IN 0	proteinuria NN B-noun.person	associated VBN B-verb.cognition	with IN 0	Srl NNP B-noun.person	is VBZ B-verb.stative	unknown JJ B-adj.all	. . 0	. . 0
a2071257.s3	They PRP 0	were VBD 0	given VBN B-verb.possession	a DT 0	ten JJ B-adj.all	day NN B-noun.person	pretreatment NN B-noun.person	with IN 0	either DT 0	L NNP 0	- : 0	alpha NN B-noun.person	- : 0	GFC NNP B-noun.group	or CC 0	placebo NN B-noun.substance	, , 0	p.o RB 0	. . 0	, , 0	. . 0
a6103707.s6	administration NN B-noun.person	were VBD 0	apparent JJ B-noun.person	earlier JJR I-noun.person	and CC 0	sometimes RB B-adv.all	lasted VBN B-verb.contact	longer RBR B-adv.all	than IN 0	those DT 0	following VBG B-verb.stative	oral JJ B-adj.all	administration NN B-noun.time	. . 0	. . 0
a12090760.s3	We PRP 0	tested VBD B-verb.social	the DT 0	hypothesis NN B-noun.cognition	that IN 0	the DT 0	antagonistic JJ B-adj.all	effect NN B-noun.cognition	of IN 0	IL-3 NN B-noun.food	and CC 0	EPO NNP 0	on IN 0	erythroid JJ B-noun.body	cells NNS I-noun.body	may MD 0	be VB 0	mediated VBN B-verb.cognition	by IN 0	endothelial JJ B-adj.all	cells NNS B-noun.body	. . 0	. . 0
a15957009.s0	The DT 0	selective JJ B-adj.all	5-HT6 NN B-noun.group	receptor NN B-noun.person	antagonist RB B-adv.all	Ro4368554 JJ B-adj.all	restores NNS B-noun.person	memory NN B-noun.person	performance NN B-noun.person	in IN 0	cholinergic NN B-noun.animal	and CC 0	serotonergic JJ B-adj.all	models NNS B-noun.artifact	of IN 0	memory_deficiency NN B-noun.food	in IN 0	the DT 0	rat NN B-noun.artifact	. . 0	. . 0
a3997294.s2	He PRP 0	developed VBD B-verb.creation	pneumonitis NN 0	, , 0	pleural_and_pericardial_effusions NNS B-noun.person	, , 0	and CC 0	a DT 0	predominantly RB B-adv.all	proximal_motor_neuropathy JJ B-adj.all	. . 0	. . 0
a18261172.s0	Development NN B-noun.process	of IN 0	proteinuria NN B-noun.communication	after IN 0	switch VB B-verb.social	to TO 0	sirolimus VB B-verb.communication	- : 0	based VBN B-verb.cognition	immunosuppression NN 0	in IN 0	long JJ B-adj.all	- : 0	term NN B-noun.time	cardiac NN 0	transplant NN 0	patients NNS B-noun.person	. . 0	. . 0
a1420741.s0	Treatment NN B-noun.other	of IN I-noun.other	Crohn's_disease NN I-noun.other	with IN I-noun.other	fusidic_acid JJ I-noun.other	, , 0	an DT 0	antibiotic JJ B-adj.all	with IN 0	immunosuppressive JJ B-adj.all	properties NNS B-noun.attribute	similar JJ B-adj.all	to TO 0	cyclosporin VB B-verb.motion	. . 0	. . 0
a1468485.s1	We PRP 0	report VBP B-verb.communication	a DT 0	case NN B-noun.state	of IN 0	intractable JJ B-adj.all	hemorrhagic_cystitis NNS B-noun.location	due JJ 0	to TO 0	cyclophosphamide VB B-verb.social	therapy NN I-verb.social	for IN 0	Wegener's_granulomatosis NN B-noun.event	. . 0	. . 0
a1639466.s9	In IN 0	contrast NN 0	, , 0	in IN 0	the DT 0	nitrendipine NN B-noun.person	- : 0	treated VBN B-verb.social	group NN 0	albuminuria IN 0	increased VBN B-verb.change	from IN 0	12.8 CD 0	+ : 0	/- # 0	2 CD B-adj.all	progressively RB B-adv.all	to TO 0	163 CD 0	+ . 0	/- $ 0	55 CD 0	compared VBN B-verb.possession	with IN 0	19.2 CD 0	+ CD 0	/- $ 0	9 CD B-adj.all	mg/24 CD B-noun.quantity	hr NN B-noun.time	in IN 0	the DT 0	hypertensive JJ B-adj.all	controls NNS B-noun.artifact	. . 0	. . 0
a3629586.s6	Upon IN 0	rechallenge NN B-noun.act	with IN 0	either DT 0	cephalosporin NN B-noun.location	, , 0	the DT 0	hematologic_syndrome NN B-noun.location	was VBD 0	reproduced VBN B-verb.social	in IN 0	most JJS 0	dogs NNS 0	tested VBN B-verb.social	, , 0	cefonicid NN 0	( ( 0	but CC 0	not RB B-adv.all	cefazedone)-treated JJ B-adj.all	dogs NNS B-noun.person	showed VBD B-verb.communication	a DT 0	substantially RB B-adv.all	reduced VBN B-verb.change	induction NN 0	period NN 0	( ( 0	15 CD B-adj.all	+ SYM 0	/- $ 0	5 CD B-adj.all	days NNS B-noun.act	) ) 0	compared VBN B-verb.cognition	to TO 0	that DT 0	of IN 0	the DT 0	first JJ B-adj.all	exposure NN B-noun.communication	to TO 0	the DT 0	drug NN B-noun.person	( ( 0	61 CD 0	+ SYM 0	/- $ 0	24 CD B-adj.all	days NNS B-noun.artifact	) ) 0	. . 0	. . 0
a7444978.s3	Beginning VBG B-verb.change	at IN 0	8 CD B-adj.all	days NNS B-noun.time	of IN 0	age NN B-noun.time	, , 0	body NN 0	movement NN B-noun.communication	and CC 0	hearing NN B-verb.perception	were VBD 0	examined VBN B-verb.communication	for IN 0	6 CD B-adj.all	and CC 0	up RB 0	to TO 0	17 CD B-adj.all	weeks NNS B-noun.time	, , 0	respectively RB B-adv.all	. . 0	. . 0
a7444978.s2	was VBD 0	injected VBN B-verb.change	for IN 0	various JJ B-adj.all	periods NNS B-noun.person	into IN 0	preweanling VBG B-verb.creation	rats NNS B-noun.plant	and CC 0	for IN 0	3 CD B-adj.all	weeks NNS B-noun.time	into IN 0	weanling VBG B-verb.body	rats NNS I-verb.body	. . 0	. . 0
a26094.s0	Antihypertensive JJ B-adj.all	drugs NNS B-noun.artifact	and CC 0	depression NN B-noun.act	, , 0	a DT 0	reappraisal NN B-noun.person	. . 0	. . 0
a8302922.s9	These DT 0	results NNS B-noun.communication	suggest VBP B-verb.communication	that IN 0	PGE1 NN B-noun.location	may MD 0	be VB B-verb.stative	preferable JJ B-adj.all	to TO 0	TMP NNP 0	for IN 0	hypotensive JJ B-adj.all	anaesthesia NN B-noun.object	in IN 0	spinal JJ B-adj.all	surgery NN B-noun.cognition	because IN 0	TMP NNP 0	decreased VBD B-verb.change	EBF NNP 0	. . 0	. . 0
a3031535.s0	Noradrenergic JJ B-adj.all	involvement NN B-noun.relation	in IN 0	catalepsy NN B-noun.artifact	induced VBN B-verb.creation	by IN 0	delta_9-tetrahydrocannabinol NN 0	. . 0	. . 0
a2440413.s9	The DT 0	in FW 0	vitro FW 0	data NNS B-noun.cognition	suggest VBP B-verb.communication	that IN 0	the DT 0	site NN B-noun.location	responsible JJ B-adj.all	for IN 0	the DT 0	decrease NN B-noun.state	in IN 0	seizure NN B-noun.body	activity NN B-noun.process	24 CD B-adj.all	h NN 0	after IN 0	gamma NN B-noun.act	- : 0	HCH NN B-noun.group	may MD 0	be VB B-verb.stative	the DT 0	GABA NNP B-noun.other	- : 0	A DT 0	receptor NN B-noun.person	- : 0	linked VBN B-verb.cognition	chloride NN 0	channel NN 0	. . 0	. . 0
a7453952.s2	Amiloride NNP B-noun.person	reduced VBD B-verb.change	the DT 0	drinking NN B-noun.act	and CC 0	urine NN B-noun.act	volume NN B-noun.attribute	of IN 0	rats NNS B-noun.animal	in IN 0	an DT 0	acute NN B-noun.person	( ( 0	6 CD B-adj.all	or CC 0	12 CD B-adj.all	h NN 0	) ) 0	and CC 0	a DT 0	subacute NN B-noun.person	( ( 0	3 CD B-adj.all	days NNS B-noun.artifact	) ) 0	experiment NN B-noun.quantity	. . 0	. . 0
a7053303.s7	Thus RB 0	, , 0	high JJ B-adj.all	cimetidine NN B-noun.body	levels NNS B-noun.state	alone RB 0	do VBP 0	not RB 0	always RB B-adv.all	induce VB B-verb.cognition	dementia NN B-noun.person	. . 0	. . 0
a17242861.s4	We PRP 0	report VBP B-verb.communication	QTLs NNP B-noun.person	identified VBD B-verb.cognition	using VBG B-verb.consumption	a DT 0	B6 NN 0	( ( 0	host NN B-noun.animal	) ) 0	x IN 0	A DT 0	/ JJ 0	J NNP 0	( ( 0	donor NN 0	) ) 0	CSS NNP 0	panel NN 0	to TO 0	localize VB B-verb.change	genes NNS B-noun.communication	involved VBN B-verb.stative	in IN 0	susceptibility NN 0	to TO 0	pilocarpine VB B-verb.social	- : 0	induced VBN B-verb.creation	seizures NNS B-noun.feeling	. . 0	. . 0
a1987816.s7	Lithium NNP B-noun.person	- : 0	induced VBN B-verb.creation	polyuria NN B-noun.animal	seems VBZ B-verb.perception	to TO 0	be VB 0	related VBN B-verb.cognition	to TO 0	extrarenal JJ 0	as RB 0	well RB 0	as IN 0	to TO 0	renal JJ B-adj.all	effects NNS B-noun.phenomenon	. . 0	. . 0
a6692345.s2	An DT 0	autoradiographic JJ B-adj.all	study NN B-noun.artifact	was VBD 0	performed VBN B-verb.social	on IN 0	male NN B-adj.all	F-344 NN B-noun.other	rats NNS B-noun.substance	fed VBN B-verb.consumption	diet NN 0	containing VBG B-verb.stative	FANFT NNP B-noun.group	at IN 0	a DT 0	level NN B-noun.state	of IN 0	0.2 CD 0	% NN 0	and/or CC 0	aspirin NN B-noun.person	at IN 0	a DT 0	level NN B-noun.state	of IN 0	0.5 CD 0	% NN 0	to TO 0	evaluate VB B-verb.communication	the DT 0	effect NN B-noun.cognition	of IN 0	aspirin NN B-noun.person	on IN 0	the DT 0	increased VBN B-adj.all	cell NN B-noun.body	proliferation NN 0	induced VBN B-verb.creation	by IN 0	FANFT NNP B-noun.group	in IN 0	the DT 0	forestomach NN B-noun.act	and CC 0	bladder NN B-noun.person	. . 0	. . 0
a19631624.s5	Deficits_in_learning_and_memory JJ B-adj.all	, , 0	parahippocampal JJ B-adj.all	hyperactivity NN B-noun.attribute	and CC 0	frontocortical JJ B-adj.all	hypoactivity NN B-noun.attribute	in IN 0	cannabis NN 0	users NNS 0	. . 0	. . 0
a7423039.s4	The DT 0	adenylate JJ B-adj.all	energy NN B-noun.phenomenon	charge NN B-noun.phenomenon	was VBD 0	found VBN B-verb.cognition	to TO 0	be VB B-verb.stative	significantly RB B-adv.all	decreased VBD B-verb.change	, , 0	while IN 0	the DT 0	phophorylcreatine NN B-noun.artifact	mole NN B-noun.artifact	fraction NN B-noun.artifact	was VBD B-verb.stative	unchanged JJ B-adj.all	. . 0	. . 0
a12090760.s1	Azidothymidine NNP B-noun.person	( ( 0	AZT)-induced JJ B-adj.all	anemia NN B-noun.state	in IN 0	mice NNS B-noun.animal	can MD 0	be VB 0	reversed VBN B-verb.change	by IN 0	the DT 0	administration NN B-noun.time	of IN 0	IGF NNP B-noun.group	- : 0	IL-3 NN B-noun.other	( ( 0	fusion NN 0	protein NN 0	of IN 0	insulin NN B-noun.person	- : 0	like IN 0	growth NN B-noun.process	factor NN 0	II NNP 0	( ( 0	IGF NNP 0	II NNP 0	) ) 0	and CC 0	interleukin JJ B-noun.communication	3 CD B-adj.all	) ) 0	. . 0	. . 0
a18261172.s8	ACE_inhibitor NN B-noun.quantity	and CC 0	angiotensin NN B-noun.person	- : 0	releasing_blocker NN B-noun.other	( ( 0	ARB NNP 0	) ) 0	therapy NN 0	reduced VBN B-verb.change	proteinuria NN B-noun.person	development NN B-noun.person	. . 0	. . 0
a19300402.s0	Bradykinin NNP B-noun.person	receptors VBZ B-verb.communication	antagonists NNS B-noun.person	and CC 0	nitric_oxide JJ B-adj.all	synthase NN B-noun.event	inhibitors NNS B-noun.person	in IN 0	vincristine NN B-noun.location	and CC 0	streptozotocin NN B-noun.communication	induced VBN B-verb.creation	hyperalgesia NN 0	in IN 0	chemotherapy NN B-noun.animal	and CC 0	diabetic_neuropathy JJ B-adj.all	rat NN B-noun.artifact	model NN B-noun.person	. . 0	. . 0
a12627929.s4	PATIENTS NNS B-noun.artifact	, , 0	Seventy CD 0	men NNS B-noun.person	, , 0	aged VBN B-verb.consumption	50 CD B-adj.all	- : 0	80 CD B-adj.all	years NNS B-noun.time	, , 0	with IN 0	advanced JJ B-adj.all	androgen NN B-noun.person	- : 0	independent JJ B-adj.all	prostate_cancer NN B-noun.person	. . 0	. . 0
a12443032.s1	The DT 0	recreational JJ B-adj.all	use NN 0	of IN 0	cocaine NN 0	is VBZ B-verb.stative	on IN 0	the DT 0	increase NN B-noun.event	. . 0	. . 0
a10342929.s0	Angioedema NNP 0	due JJ 0	to TO 0	ACE_inhibitors NNS B-noun.person	, , 0	common JJ B-noun.person	and CC 0	inadequately RB B-adv.all	diagnosed VBN B-verb.communication	. . 0	. . 0
a20621845.s8	TIMP NNP B-noun.group	mRNA NNP I-noun.group	and CC 0	tissue NN B-noun.body	levels NNS B-noun.state	did VBD 0	not RB B-adv.all	differ VB B-verb.change	obviously RB B-adv.all	among IN 0	the DT 0	three CD 0	aortic JJ B-adj.all	segments NNS B-noun.person	. . 0	. . 0
a10807237.s12	Contrary JJ 0	to TO 0	the DT 0	published VBN B-verb.creation	literature NN B-noun.act	, , 0	this DT 0	group NN B-noun.group	did VBD 0	reasonably RB B-adv.all	well RB 0	with IN 0	aggressive JJ B-adj.all	management NN B-noun.group	. . 0	. . 0
a16181582.s4	The DT 0	EEG NNP B-noun.group	shows VBZ B-verb.change	characteristic JJ B-adj.all	triphasic JJ B-adj.all	waves NNS B-noun.event	in IN 0	most JJS 0	patients NNS B-noun.person	with IN 0	this DT 0	complication NN B-noun.communication	. . 0	. . 0
a2348231.s8	pentoxifylline NN B-noun.attribute	( ( 0	p IN 0	less JJR B-noun.quantity	than IN 0	0.002 CD 0	) ) 0	. . 0	. . 0
a8421099.s0	Prospective JJ B-adj.all	study NN B-noun.artifact	of IN 0	the DT 0	long JJ B-noun.body	- : 0	term NN B-noun.time	effects NNS B-noun.phenomenon	of IN 0	somatostatin NN 0	analog NN 0	( ( 0	octreotide NN 0	) ) 0	on IN 0	gallbladder NN B-noun.artifact	function NN B-noun.act	and CC 0	gallstone NN B-noun.artifact	formation NN B-noun.act	in IN 0	Chinese JJ 0	acromegalic JJ 0	patients NNS B-noun.person	. . 0	. . 0
a1992636.s7	After IN 0	she PRP 0	discontinued VBD B-verb.stative	the DT 0	omeprazole NN B-noun.artifact	, , 0	her PRP$ 0	hemoglobin NN B-noun.person	and CC 0	hematocrit NN 0	gradually RB B-adv.all	returned VBN B-verb.change	to TO 0	normal JJ B-adj.all	. . 0	. . 0
a9401499.s5	Agranulocytosis NNP B-noun.person	occurred VBD B-verb.competition	3 CD 0	- : 0	20 CD B-adj.all	weeks NNS B-noun.time	after IN 0	initiation NN B-noun.time	of IN 0	ticlopidine NN B-noun.location	, , 0	so RB B-adv.all	frequent JJ B-adj.all	examination NN B-noun.act	of IN 0	white JJ B-adj.all	cell NN B-noun.body	count NN 0	during IN 0	treatment NN B-noun.communication	is VBZ 0	recommended VBN B-verb.communication	. . 0	. . 0
a12443032.s5	Finally RB B-adv.all	, , 0	moral JJ B-adj.all	issues NNS B-noun.communication	relating VBG B-verb.stative	to TO 0	the DT 0	testing NN B-noun.communication	of IN 0	potential JJ B-adj.all	cocaine NN B-noun.person	users NNS B-noun.person	will MD 0	be VB 0	addressed VBN B-verb.communication	. . 0	. . 0
a9034419.s0	Seizure NN B-noun.person	resulting VBG B-verb.stative	from IN 0	a DT 0	venlafaxine NN B-noun.artifact	overdose NN I-noun.artifact	. . 0	. . 0
a15120741.s4	In IN 0	SE NNP 0	survivors NNS 0	, , 0	similar JJ B-adj.all	stimulation NN B-noun.artifact	resulted VBD B-verb.stative	in IN 0	a DT 0	population NN B-noun.person	spike NN B-noun.person	followed VBD B-verb.motion	, , 0	at IN 0	a DT 0	variable JJ B-adj.all	latency NN B-noun.location	, , 0	by IN 0	negative JJ B-adj.all	DC NNP 0	shifts NNS B-noun.artifact	and CC 0	repetitive JJ B-adj.all	afterdischarges NNS B-noun.time	of IN 0	3 CD B-adj.all	- : 0	60 CD B-adj.all	s DT 0	duration NN B-noun.act	, , 0	which WDT 0	were VBD 0	blocked VBN B-verb.contact	by IN 0	ionotropic JJ B-adj.pert	glutamate NN B-noun.person	receptor NN B-noun.person	antagonists NNS B-noun.person	. . 0	. . 0
a18221780.s2	The DT 0	purpose NN B-noun.attribute	of IN 0	this DT 0	investigation NN B-noun.act	was VBD B-verb.stative	to TO 0	extend VB B-verb.communication	these DT 0	findings NNS B-noun.act	to TO 0	a DT 0	persistent JJ B-adj.all	pain NN B-noun.cognition	model NN B-noun.attribute	which WDT 0	could MD 0	be VB 0	distinguished VBN B-verb.cognition	from IN 0	acute_pain JJ B-adj.all	models NNS B-noun.artifact	on IN 0	the DT 0	basis NN B-noun.cognition	of IN 0	the DT 0	nociceptive JJ B-adj.all	fibers NNS B-noun.person	activated VBN B-verb.social	, , 0	neurochemical JJ B-adj.all	substrates NNS B-noun.person	, , 0	and CC 0	duration NN B-noun.act	of IN 0	the DT 0	nociceptive JJ B-adj.all	stimulus NN B-noun.artifact	. . 0	. . 0
a15036754.s0	Organophosphate NNP B-noun.person	- : 0	induced VBN B-verb.creation	convulsions NNS B-noun.artifact	and CC 0	prevention NN B-noun.person	of IN 0	neuropathological_damages NNS B-noun.person	. . 0	. . 0
a12820454.s0	Combined VBN B-verb.change	androgen NN B-adj.all	blockade NN B-noun.attribute	- : 0	induced VBN B-verb.creation	anemia NN B-noun.state	in IN 0	prostate_cancer NN B-noun.location	patients NNS B-noun.person	without IN 0	bone NN 0	involvement NN B-noun.artifact	. . 0	. . 0
a15632880.s6	Clinical JJ B-noun.person	characteristics NNS I-noun.person	, , 0	medications NNS B-noun.person	, , 0	and CC 0	serum NN B-noun.body	chemistries NNS I-noun.body	at IN 0	baseline NN B-noun.act	and CC 0	follow VB B-verb.possession	- : 0	up IN 0	time NN B-noun.person	periods NNS B-noun.person	were VBD 0	compared VBN B-verb.change	. . 0	. . 0
a9195768.s2	They PRP 0	are VBP B-verb.stative	almost RB B-adv.all	always RB B-adv.all	benign JJ B-adj.all	, , 0	but CC 0	can MD 0	be VB 0	mistaken VBN B-verb.cognition	for IN 0	a DT 0	serious JJ B-adj.all	adverse JJ B-adj.all	event NN 0	by IN 0	the DT 0	patient NN B-noun.person	. . 0	. . 0
a17175308.s16	Five CD 0	patients NNS B-noun.person	displayed VBD B-verb.communication	CAN NNP B-noun.person	and CC 0	Kaposi's_sarcoma NNP B-noun.person	. . 0	. . 0
a3341566.s5	Analysis NN 0	of IN 0	the DT 0	respiratory NN B-noun.body	changes NNS I-noun.body	in IN 0	the DT 0	arterial JJ B-adj.all	pressure NN B-noun.act	waveform NN B-noun.event	enabled VBD B-verb.communication	differentiation NN B-noun.person	between IN 0	the DT 0	two CD 0	groups NNS B-noun.group	. . 0	. . 0
a3629586.s8	We PRP 0	conclude VBP B-verb.cognition	that IN 0	the DT 0	administration NN B-noun.time	of IN 0	high JJ B-adj.all	doses NNS B-noun.attribute	of IN 0	cefonicid NN B-noun.possession	or CC 0	cefazedone NN 0	to TO 0	dogs NNS B-noun.animal	can MD 0	induce VB B-verb.cognition	hematotoxicity NN B-noun.attribute	similar JJ B-adj.all	to TO 0	the DT 0	cephalosporin NN B-noun.body	- : 0	induced VBN B-verb.creation	blood_dyscrasias NNS 0	described VBN B-verb.communication	in IN 0	man NN B-noun.animal	and CC 0	thus RB B-adv.all	provides VBZ B-verb.communication	a DT 0	useful JJ B-adj.all	model NN B-noun.person	for IN 0	studying VBG B-verb.cognition	the DT 0	mechanisms NNS B-noun.person	of IN 0	these DT 0	disorders NNS B-noun.person	. . 0	. . 0
a17042910.s16	Endothelial JJ B-adj.all	- : 0	dependent JJ B-adj.all	relaxation NN B-noun.communication	and CC 0	eNOS RB B-adv.all	mRNA JJ B-adj.all	expression NN B-noun.communication	were VBD B-verb.stative	greater JJR B-adj.all	in IN 0	the DT 0	Dex NNP B-noun.person	+ NNP I-noun.person	Ato NNP I-noun.person	group NN 0	than IN 0	in IN 0	the DT 0	Dex NNP B-noun.person	only RB B-adv.all	group NN 0	( ( 0	P NNP 0	< $ 0	0.05 CD 0	and CC 0	P NNP 0	< $ 0	0.0001 CD 0	, , 0	respectively RB B-adv.all	) ) 0	. . 0	. . 0
a6861444.s2	Intrarenal JJ B-adj.all	infusion NN B-noun.cognition	of IN 0	noradrenaline NN B-noun.person	caused VBD B-verb.communication	hypertension NN B-noun.person	at IN 0	doses NNS B-noun.act	which WDT 0	did VBD 0	not RB B-adv.all	do VB B-verb.social	so RB B-adv.all	when WRB 0	infused VBN B-verb.communication	intravenously RB B-adv.all	. . 0	. . 0
a12695819.s3	In IN 0	each DT 0	patient NN B-noun.person	who WP 0	had VBD 0	abnormalities NNS B-noun.person	on IN 0	the DT 0	initial JJ B-adj.all	MR NNP 0	study NN B-noun.artifact	, , 0	a DT 0	follow NN B-noun.person	- : 0	up IN 0	MR NNP 0	study NN B-noun.artifact	was VBD 0	performed VBN B-verb.social	1 CD B-adj.all	month NN 0	later RB B-adv.all	. . 0	. . 0
a18503483.s6	Symptoms NNS B-noun.person	persisted VBD B-verb.communication	for IN 0	three CD 0	months NNS B-noun.person	despite IN 0	TAC NNP B-noun.other	dose NN B-noun.process	reduction NN B-noun.process	, , 0	administration NN B-noun.person	of IN 0	IVIG NNP B-noun.group	and CC 0	four CD 0	doses NNS B-noun.quantity	of IN 0	methylprednisolone NN B-noun.artifact	pulse NN B-noun.artifact	therapy NN 0	. . 0	. . 0
a7449470.s1	Cardiac_toxicity NN B-noun.state	is VBZ B-verb.stative	a DT 0	major JJ B-adj.all	complication NN B-noun.act	which WDT 0	limits VBZ B-verb.change	the DT 0	use NN 0	of IN 0	adriamycin NN B-noun.communication	as IN 0	a DT 0	chemotherapeutic JJ B-adj.all	agent NN B-noun.person	. . 0	. . 0
a17175308.s0	Proteinuria NNP B-noun.person	after IN 0	conversion NN B-noun.person	to TO 0	sirolimus NN B-noun.act	in IN 0	renal JJ B-adj.all	transplant NN B-noun.person	recipients NNS B-noun.person	. . 0	. . 0
a11569530.s10	These DT 0	data NNS B-noun.cognition	indicate VBP B-verb.communication	that IN 0	the DT 0	free JJ B-noun.person	ED50 NN I-noun.person	in IN 0	plasma NN B-noun.substance	for IN 0	terfenadine NN 0	( ( 0	1.9 CD 0	nM CD B-noun.quantity	) ) 0	, , 0	terodiline NN B-noun.person	( ( 0	76 CD 0	nM CD 0	) ) 0	, , 0	cisapride NN 0	( ( 0	11 CD B-adj.all	nM CD B-noun.quantity	) ) 0	and CC 0	E4031 NNP B-noun.person	( ( 0	1.9 CD 0	nM CD B-noun.quantity	) ) 0	closely RB B-adv.all	correlate VB B-verb.stative	with IN 0	the DT 0	free JJ B-adj.all	concentration NN B-noun.act	in IN 0	man NN 0	causing VBG B-verb.communication	QT NNP 0	effects NNS B-noun.phenomenon	. . 0	. . 0
a8302922.s4	After IN 0	starting VBG B-verb.change	PGE1 JJ B-noun.substance	or CC 0	TMP NNP B-noun.group	, , 0	MAP NNP B-noun.person	and CC 0	rate NN B-noun.time	pressure NN B-noun.act	product NN B-noun.cognition	( ( 0	RPP NNP 0	) ) 0	decreased VBD B-verb.change	significantly RB B-adv.all	compared VBN B-verb.cognition	with IN 0	preinfusion NN B-noun.possession	values NNS B-noun.attribute	( ( 0	P NNP 0	< $ 0	0.01 CD 0	) ) 0	, , 0	and CC 0	the DT 0	degree NN B-noun.communication	of IN 0	hypotension NN 0	due JJ 0	to TO 0	PGE1 NNP B-noun.person	remained VBD B-verb.stative	constant JJ B-adj.all	until IN 0	60 CD B-adj.all	min NN B-noun.quantity	after IN 0	its PRP$ 0	discontinuation NN B-noun.act	. . 0	. . 0
a8669433.s6	A DT 0	lower RBR B-adj.all	relative JJ B-adj.all	risk NN B-noun.person	would MD 0	be VB 0	expected VBN B-verb.cognition	for IN 0	acetaminophen NN B-noun.person	if IN 0	the DT 0	risk NN 0	of IN 0	both DT 0	drugs NNS B-noun.artifact	in IN 0	combination NN 0	with IN 0	other JJ 0	analgesics NNS B-noun.person	was VBD B-verb.stative	higher JJR B-adj.all	than IN 0	the DT 0	risk NN 0	of IN 0	either DT 0	agent NN B-noun.person	alone RB 0	. . 0	. . 0
a3341566.s8	It PRP 0	is VBZ 0	concluded VBN B-verb.cognition	that IN 0	increases NNS B-noun.person	in IN 0	the DT 0	SPV NNP B-noun.group	and CC 0	the DT 0	delta NN 0	down RB 0	are VBP B-verb.stative	characteristic JJ B-adj.all	of IN 0	a DT 0	hypotensive JJ B-adj.all	state NN B-noun.state	due JJ 0	to TO 0	a DT 0	predominant JJ B-adj.all	decrease NN B-noun.state	in IN 0	preload NN B-noun.animal	. . 0	. . 0
a9034419.s7	CONCLUSIONS NNS B-noun.artifact	, , 0	The DT 0	venlafaxine NN B-noun.artifact	overdose NN I-noun.artifact	in IN 0	our PRP$ 0	patient NN B-noun.person	resulted VBD B-verb.body	in IN 0	a DT 0	single JJ B-adj.all	episode NN B-noun.communication	of IN 0	generalized JJ B-adj.all	seizure NN B-noun.person	but CC 0	elicited VBD B-verb.emotion	no DT 0	further JJ B-adj.all	sequelae NN B-noun.person	. . 0	. . 0
a17042910.s6	2 LS 0	. . 0	. . 0
a3187073.s7	During IN 0	treatment NN B-noun.communication	, , 0	adverse JJ B-adj.all	cardiac JJ B-adj.pert	effects NNS B-noun.phenomenon	were VBD 0	observed VBN B-verb.perception	in IN 0	14 CD B-adj.all	patients NNS B-noun.person	( ( 0	18 CD B-adj.all	% NN 0	) ) 0	. . 0	. . 0
a10807237.s1	OBJECTIVE NNP B-noun.group	, , 0	The DT 0	outcome NN 0	of IN 0	subarachnoid_hemorrhage NN B-noun.artifact	associated VBN B-verb.cognition	with IN 0	cocaine_abuse NN 0	is VBZ B-verb.stative	reportedly RB B-adv.all	poor JJ B-adj.all	. . 0	. . 0
a9401499.s3	All DT 0	but IN 0	one CD 0	of IN 0	the DT 0	patients NNS B-noun.person	were VBD B-verb.stative	over IN 0	60 CD B-adj.all	years NNS B-noun.time	old JJ B-adj.all	, , 0	and CC 0	the DT 0	6 CD 0	who WP 0	died VBD B-verb.change	were VBD B-verb.stative	all DT 0	older JJR B-adj.all	than IN 0	65 CD 0	. . 0	. . 0
a1987816.s0	Less RBR B-adv.all	frequent JJ B-adj.all	lithium NN B-noun.artifact	administration NN I-noun.artifact	and CC 0	lower JJR B-adj.all	urine NN B-noun.communication	volume NN B-noun.artifact	. . 0	. . 0
a10520387.s3	The DT 0	haemodynamic JJ B-adj.all	effects NNS B-noun.phenomenon	of IN 0	adding VBG B-verb.competition	15 CD 0	, , 0	20 CD B-adj.all	or CC 0	25 CD B-adj.all	mg NN B-noun.quantity	of IN 0	ephedrine NN 0	to TO 0	200 CD 0	mg NN B-noun.quantity	of IN 0	propofol NN B-noun.person	were VBD 0	compared VBN B-verb.change	to TO 0	control VB B-verb.social	in IN 0	40 CD B-adj.all	ASA NNP 0	3/4 CD 0	patients NNS B-noun.person	over IN 0	60 CD B-adj.all	years NNS B-noun.time	presenting VBG B-verb.communication	for IN 0	genito NN B-noun.person	- : 0	urinary NN B-noun.person	surgery NN B-noun.person	. . 0	. . 0
a3187073.s3	In IN 0	the DT 0	present JJ B-adj.all	study NN B-noun.artifact	, , 0	cis SYM 0	- : 0	platin NN B-noun.substance	( ( 0	80 CD 0	- : 0	120 CD 0	mg NN B-noun.quantity	/ '' 0	m2BSA NNP B-noun.location	) ) 0	and CC 0	5-FU NN B-noun.person	( ( 0	1000 CD 0	mg NN B-noun.quantity	/ '' 0	m2BSA NNP B-noun.group	daily RB I-noun.group	as IN 0	a DT 0	continuous JJ B-adj.all	infusion NN B-noun.act	during IN 0	5 CD B-adj.all	days NNS B-noun.act	) ) 0	were VBD 0	given VBN B-verb.possession	to TO 0	76 CD 0	patients NNS B-noun.person	before IN 0	radiotherapy NN B-noun.act	and CC 0	surgery NN B-noun.location	. . 0	. . 0
a3070035.s3	This DT 0	indicates VBZ B-verb.communication	reversibility NN B-noun.attribute	in IN 0	captopril NN B-noun.act	- : 0	induced VBN B-verb.creation	renal_failure NN B-noun.person	even RB B-adv.all	after IN 0	its PRP$ 0	prolonged VBN B-noun.artifact	use NN I-noun.artifact	and CC 0	suggests VBZ B-verb.communication	that IN 0	no DT 0	organic JJ B-adj.all	damage NN B-noun.plant	occurs VBZ B-verb.stative	to TO 0	glomerular JJ B-adj.all	arterioles NNS B-noun.artifact	following VBG B-verb.stative	chronic JJ B-adj.all	ACE NNP 0	inhibition NN 0	. . 0	. . 0
a11391224.s7	These DT 0	13 CD 0	included VBD B-verb.stative	cases NNS B-noun.state	of IN 0	malignant_hypertension NN B-noun.act	, , 0	thrombotic_microangiopathy JJ 0	, , 0	lupus_nephritis NN 0	, , 0	Henoch NNP B-noun.person	- : 0	Schonlein_nephritis NN B-noun.time	, , 0	crescentic JJ B-adj.all	glomerulonephritis NN B-noun.food	, , 0	and CC 0	cocaine NN B-noun.person	- : 0	related VBN B-verb.cognition	acute_renal_failure NN B-noun.act	. . 0	. . 0
a26094.s3	Hypertensive JJ B-adj.all	patients NNS B-noun.person	with IN 0	psychiatric JJ B-adj.all	histories NNS B-noun.person	had VBD 0	a DT 0	higher JJR B-adj.all	prevalence NN B-noun.person	of IN 0	depression NN B-noun.feeling	than IN 0	the DT 0	comparison NN B-noun.person	patients NNS B-noun.person	. . 0	. . 0
a7053303.s4	The DT 0	ratio NN B-noun.time	of IN 0	cimetidine JJ B-adj.all	clearance NN B-noun.person	to TO 0	creatinine VB B-verb.cognition	clearance NN B-noun.attribute	( ( 0	Rc NNP 0	) ) 0	averaged VBD B-verb.stative	4.8 CD 0	+ : 0	/- $ 0	2.0 CD B-noun.quantity	, , 0	indicating VBG B-verb.communication	net JJ B-adj.all	tubular JJ B-adj.all	secretion NN B-noun.act	for IN 0	cimetidine NN B-noun.act	. . 0	. . 0
a11419773.s2	This DT 0	case NN B-noun.state	highlights VBZ B-verb.change	the DT 0	need NN B-noun.object	for IN 0	adequate JJ B-adj.all	labelling NN B-noun.act	and CC 0	regulation NN B-noun.act	of IN 0	such JJ B-adj.all	products NNS B-noun.person	. . 0	. . 0
a15458908.s2	METHODS NNS B-noun.attribute	, , 0	The DT 0	Multiple NNP B-noun.other	Outcomes NNP I-noun.other	of IN I-noun.other	Raloxifene NNP I-noun.other	Evaluation NNP I-noun.other	, , 0	a DT 0	multicenter NN B-noun.person	, , 0	randomized VBD B-verb.cognition	, , 0	double RB 0	- : 0	blind JJ B-adj.all	trial NN B-noun.act	, , 0	enrolled VBD B-verb.social	7,705 CD 0	postmenopausal JJ B-adj.all	women NNS B-noun.person	with IN 0	osteoporosis NN B-noun.food	. . 0	. . 0
a12907309.s0	Neuroprotective JJ B-adj.all	action NN B-noun.process	of IN 0	MPEP NNP B-noun.group	, , 0	a DT 0	selective JJ B-adj.all	mGluR5 JJ B-adj.all	antagonist NN B-noun.person	, , 0	in IN 0	methamphetamine NN B-noun.attribute	- : 0	induced VBN B-verb.creation	dopaminergic JJ B-adj.all	neurotoxicity NN B-noun.person	is VBZ 0	associated VBN B-verb.cognition	with IN 0	a DT 0	decrease NN B-noun.event	in IN 0	dopamine NN 0	outflow NN 0	and CC 0	inhibition NN B-noun.attribute	of IN 0	hyperthermia NN B-noun.food	in IN 0	rats NNS B-noun.animal	. . 0	. . 0
a16160878.s5	In IN 0	the DT 0	present JJ B-adj.all	study NN B-noun.artifact	, , 0	we PRP 0	tested VBD B-verb.social	the DT 0	effects NNS B-noun.phenomenon	of IN 0	i.c.v NNP B-noun.person	. . 0	. . 0
a2008831.s0	Effect NN 0	of IN 0	direct JJ B-verb.creation	intracoronary JJ B-adj.all	administration NN B-noun.time	of IN 0	methylergonovine NN B-noun.attribute	in IN 0	patients NNS B-noun.person	with IN 0	and CC 0	without IN 0	variant_angina NNP B-noun.location	. . 0	. . 0
a9523805.s0	Transient_neurologic_symptoms NNS B-noun.body	after IN 0	spinal JJ B-adj.all	anesthesia NN B-noun.location	, , 0	a DT 0	lower JJR B-adj.all	incidence NN B-noun.relation	with IN 0	prilocaine NN B-noun.person	and CC 0	bupivacaine NN 0	than IN 0	with IN 0	lidocaine NN B-noun.person	. . 0	. . 0
a2096243.s0	Carmofur NNP B-noun.person	- : 0	induced VBN B-verb.creation	organic_mental_disorders NNS 0	. . 0	. . 0
a12596116.s2	Pulmonary_hypertension NN B-noun.artifact	developed VBN B-verb.creation	after IN 0	administration NN B-noun.time	of IN 0	a DT 0	somatostatin NN 0	analogue NN 0	, , 0	octreotide NN 0	, , 0	to TO 0	enhance VB B-verb.social	resolution NN B-noun.act	of IN 0	the DT 0	fistula NN B-noun.person	. . 0	. . 0
a3693336.s2	Features NNS B-noun.person	of IN 0	organic_mental_disorder NNP B-noun.other	( ( 0	delirium NN 0	) ) 0	were VBD B-verb.stative	not RB B-adv.all	present JJ B-adj.all	. . 0	. . 0
a6103707.s2	routes NNS B-noun.artifact	to TO 0	groups NNS B-noun.group	of IN 0	volunteers NNS B-noun.person	and CC 0	its PRP$ 0	effects NNS B-noun.phenomenon	compared VBN B-verb.communication	. . 0	. . 0
a2887062.s8	Electron NNP B-noun.person	microscopical JJ B-adj.all	immunohistochemistry NN B-noun.person	revealed VBD B-verb.perception	positive JJ B-adj.all	reaction NN B-noun.process	products NNS B-noun.artifact	noted VBN B-verb.perception	on IN 0	the DT 0	secretory JJ B-noun.body	granules NNS I-noun.body	, , 0	Golgi NNP B-noun.person	cisternae NN I-noun.person	, , 0	and CC 0	endoplasmic JJ B-adj.all	reticulum NN B-noun.state	of IN 0	the DT 0	untreated JJ B-adj.all	rat NN 0	prolactinoma NN B-noun.body	cells NNS B-noun.body	. . 0	. . 0
a2673163.s0	Stroke NN B-noun.person	associated VBN B-verb.cognition	with IN 0	cocaine NN 0	use NN 0	. . 0	. . 0
a6308277.s1	A DT 0	patient NN B-noun.person	who WP 0	allegedly RB B-adv.all	consumed VBD B-verb.consumption	100 CD 0	tablets NNS B-noun.quantity	of IN 0	an DT 0	over IN 0	- : 0	the SYM 0	- : 0	counter RB 0	analgesic JJ 0	containing VBG B-verb.stative	sodium_acetylsalicylate JJ B-adj.all	, , 0	caffeine NN B-noun.person	, , 0	and CC 0	acetaminophen NN B-noun.person	displayed VBD B-verb.social	no DT 0	significant JJ 0	CNS NNP 0	stimulation NN 0	despite IN 0	the DT 0	presence NN B-noun.person	of IN 0	175 CD 0	micrograms NNS B-noun.quantity	of IN 0	caffeine NN 0	per IN 0	mL CD B-noun.quantity	of IN 0	serum NN B-noun.person	. . 0	. . 0
a6666578.s7	The DT 0	aorta NN B-noun.communication	/ : 0	serum NN B-noun.person	- : 0	ratio NN B-noun.time	and CC 0	the DT 0	radioactive JJ 0	build VBN B-verb.creation	- : 0	up RB B-adv.all	24 CD B-adj.all	and CC 0	48 CD 0	hours NNS 0	after IN 0	injection NN B-noun.time	of IN 0	131I NNP B-noun.person	- : 0	HSA NNP B-noun.person	was VBD 0	reduced VBN B-verb.change	in IN 0	animals NNS 0	treated VBN B-verb.change	with IN 0	D NNP 0	- : 0	pen NN B-noun.person	for IN 0	42 CD 0	days NNS B-noun.person	, , 0	indicating VBG B-verb.communication	an DT 0	impeded VBN B-verb.social	transmural JJ B-adj.all	transport NN B-noun.act	of IN 0	tracer NN B-noun.act	which WDT 0	may MD 0	be VB 0	caused VBN B-verb.communication	by IN 0	a DT 0	steric JJ B-adj.all	exclusion NN B-noun.act	effect NN 0	of IN 0	abundant JJ B-adj.all	hyaluronate NN B-noun.person	. . 0	. . 0
a16160878.s4	However RB 0	, , 0	the DT 0	behavioral JJ B-adj.pert	effects NNS B-noun.phenomenon	of IN 0	centrally RB B-adv.all	administered VBN B-verb.perception	U NNP 0	- : 0	II NNP 0	have VBP 0	received VBN B-verb.possession	little JJ 0	attention NN 0	. . 0	. . 0
a8073369.s3	However RB 0	, , 0	coniine NN B-noun.person	has VBZ 0	failed VBN B-verb.social	to TO 0	produce VB B-verb.contact	arthrogryposis NN B-noun.food	in IN 0	rats NNS B-noun.animal	or CC 0	mice NNS B-noun.animal	and CC 0	is VBZ B-verb.stative	only RB B-adv.all	weakly RB B-adj.all	teratogenic JJ I-adj.all	in IN 0	rabbits NNS B-noun.location	. . 0	. . 0
a18503483.s2	Neurotoxicity NN B-noun.person	is VBZ B-verb.stative	a DT 0	potentially RB B-adv.all	serious JJ B-adj.all	toxic JJ B-adj.all	effect NN B-noun.cognition	. . 0	. . 0
a11256525.s1	We PRP 0	report VBP B-verb.communication	the DT 0	case NN B-noun.state	of IN 0	a DT 0	70-year JJ 0	- : 0	old JJ B-adj.all	hypertensive JJ B-adj.all	man NN 0	with IN 0	a DT 0	solitary JJ B-adj.all	kidney NN B-noun.person	and CC 0	chronic_renal_insufficiency NN 0	who WP 0	developed VBD B-verb.creation	two CD 0	episodes NNS B-noun.communication	of IN 0	transient NN B-noun.act	anuria NN I-noun.act	after IN 0	losartan JJ B-adj.all	administration NN B-noun.person	. . 0	. . 0
a7423039.s1	The DT 0	cardiotoxic JJ B-adj.all	effects NNS B-noun.phenomenon	of IN 0	adriamycin NN B-noun.food	were VBD 0	studied VBN B-verb.cognition	in IN 0	mammalian JJ B-adj.all	myocardial JJ B-noun.body	cells NNS I-noun.body	in IN 0	culture NN B-noun.cognition	as IN 0	a DT 0	model NN 0	system NN 0	. . 0	. . 0
a3031535.s2	The DT 0	cataleptogenic JJ B-adj.all	effect NN B-noun.cognition	of IN 0	THC NNP 0	was VBD B-verb.stative	significantly RB B-adv.all	reduced VBN B-verb.change	in IN 0	rats NNS B-noun.animal	treated VBN B-verb.change	with IN 0	6-OHDA NNP B-noun.person	and CC 0	in IN 0	rats NNS B-noun.animal	with IN 0	lesions NNS B-noun.person	of IN 0	the DT 0	locus NN B-noun.artifact	coeruleus NN B-noun.person	but CC 0	not RB B-adv.all	in IN 0	rats NNS B-noun.animal	treated VBN B-verb.change	with IN 0	desipramine NN B-noun.person	and CC 0	6-OHDA NNP B-noun.person	, , 0	as IN 0	compared VBN B-verb.creation	with IN 0	control NN B-noun.food	rats NNS I-noun.food	. . 0	. . 0
a3031535.s4	These DT 0	results NNS B-noun.communication	indicate VBP B-verb.communication	that IN 0	noradrenergic JJ B-adj.all	neurons NNS B-noun.artifact	have VBP 0	an DT 0	important JJ B-adj.all	role NN B-noun.attribute	in IN 0	the DT 0	manifestation NN B-noun.group	of IN 0	catalepsy NN B-noun.artifact	induced VBN B-verb.creation	by IN 0	THC NNP 0	, , 0	whereas IN 0	dopaminergic JJ B-adj.all	neurons NNS B-noun.artifact	are VBP B-verb.stative	important JJ B-adj.all	in IN 0	catalepsy NN B-noun.artifact	induced VBN B-verb.creation	by IN 0	haloperidol NN B-noun.person	. . 0	. . 0
a15957009.s4	Initial JJ B-adj.all	testing NN B-noun.act	in IN 0	a DT 0	time NN B-noun.time	- : 0	dependent JJ B-adj.all	forgetting JJ 0	task NN 0	employing VBG B-verb.change	a DT 0	24-h JJ B-adj.all	delay NN B-noun.act	between IN 0	training NN B-noun.act	and CC 0	testing NN B-noun.person	showed VBD B-verb.communication	that IN 0	metrifonate NN B-noun.person	improved VBD B-verb.change	object JJ B-adj.all	recognition NN B-noun.cognition	( ( 0	at IN 0	10 CD B-adj.all	and CC 0	30 CD 0	mg FW 0	/ FW 0	kg FW 0	, , 0	p.o RB 0	. . 0	) ) 0	, , 0	. . 0
a18343374.s1	OBJECTIVE NNP B-noun.group	, , 0	To TO 0	report VB B-verb.communication	a DT 0	case NN B-noun.state	of IN 0	central JJ B-adj.pert	retinal_vein_occlusion NN B-noun.group	associated VBN B-verb.cognition	with IN 0	clomiphene_citrate JJ B-noun.other	( ( 0	CC NNP 0	) ) 0	. . 0	. . 0
a7449470.s2	Cardiomyopathy NNP B-noun.person	is VBZ B-verb.stative	frequent JJ B-adj.all	when WRB 0	the DT 0	total JJ B-adj.all	dose NN B-noun.act	exceeds VBZ B-verb.stative	600 CD 0	mg NN B-noun.quantity	/ '' 0	m2 : 0	and CC 0	occurs VBZ B-verb.stative	within IN 0	one CD 0	to TO 0	six CD 0	months NNS B-noun.person	after IN 0	cessation NN B-noun.time	of IN 0	therapy NN B-noun.act	. . 0	. . 0
a7468724.s0	Cardiovascular_complications NNS B-noun.artifact	associated VBN B-verb.cognition	with IN 0	terbutaline NN 0	treatment NN B-noun.location	for IN I-noun.location	preterm_labor NNP I-noun.location	. . 0	. . 0
a12820454.s5	Patients NNS B-noun.person	with IN 0	stage NN B-noun.artifact	D2 SYM 0	- : 0	3 CD B-adj.all	disease NN B-noun.act	, , 0	abnormal JJ B-adj.all	hemoglobin NN B-noun.state	level NN B-noun.state	or CC 0	renal JJ B-noun.body	and CC 0	liver NN B-noun.food	function NN B-noun.act	tests NNS B-noun.cognition	that WDT 0	were VBD B-verb.stative	higher JJR B-adj.all	than IN 0	the DT 0	upper JJ B-noun.location	limits NNS B-noun.person	were VBD 0	excluded VBN B-verb.stative	from IN 0	the DT 0	study NN B-noun.artifact	. . 0	. . 0
a8690168.s6	Diabetic JJ B-adj.all	rats NNS B-noun.animal	progressively RB B-adv.all	developed VBN B-verb.creation	albuminuria IN 0	reaching VBG B-verb.motion	40.3 CD 0	( ( 0	32.2 CD 0	- : 0	62.0 CD 0	) ) 0	mg/24 NN B-noun.quantity	h IN 0	after IN 0	8 CD B-adj.all	months NNS B-noun.person	in IN 0	contrast NN 0	to TO 0	the DT 0	control NN B-noun.cognition	animals NNS I-noun.cognition	( ( 0	0.8 CD 0	( ( 0	0.2 CD 0	- : 0	0.9 CD 0	) ) 0	mg/24 NN 0	h NN 0	, , 0	p<0.002 NNP 0	) ) 0	. . 0	. . 0
a3192036.s10	Close JJ B-adj.all	observation NN B-noun.act	of IN 0	the DT 0	response NN B-noun.communication	status NN 0	both DT 0	clinically RB B-noun.communication	and CC 0	with IN 0	beta JJ B-noun.body	- : 0	hCG JJ B-adj.all	values NNS B-noun.possession	may MD 0	indicate VB B-verb.communication	whether IN 0	and CC 0	when WRB 0	more RBR B-adv.all	agressive JJ B-adj.all	combination NN B-noun.person	chemotherapy NN B-noun.group	should MD 0	be VB B-verb.stative	started.(ABSTRACT JJ B-adj.all	TRUNCATED VBN I-adj.all	AT IN 0	250 CD 0	WORDS NNS B-noun.quantity	) ) 0	. . 0
a6133211.s5	The DT 0	second JJ B-adj.all	twin NN B-noun.communication	, , 0	a DT 0	male NN B-noun.person	, , 0	had VBD 0	some DT 0	features NNS B-noun.cognition	of IN 0	Potter's_facies NNS B-noun.person	, , 0	hypoplastic_lungs NNS B-noun.artifact	, , 0	absent_kidneys_and_ureters NNS B-noun.person	, , 0	and CC 0	talipes_equinovarus NN B-noun.other	. . 0	. . 0
a6503301.s3	At IN 0	autopsy NN B-verb.communication	the DT 0	liver NN B-noun.person	was VBD 0	enlarged VBN B-verb.change	and CC 0	firm NN 0	with IN 0	signs NNS B-noun.communication	of IN 0	venous_congestion NN B-noun.time	. . 0	. . 0
a10704919.s12	These DT 0	effects NNS B-noun.phenomenon	suggest VBP B-verb.communication	that IN 0	the DT 0	protection NN B-noun.possession	from IN 0	hemolysis NN B-noun.location	by IN 0	tocopherols NNS B-noun.artifact	is VBZ 0	related VBN B-verb.cognition	to TO 0	a DT 0	decreased VBN B-verb.change	TAM NNP 0	incorporation NN 0	in IN 0	condensed JJ B-adj.all	membranes NNS B-noun.communication	and CC 0	the DT 0	structural JJ B-adj.all	damage NN B-noun.act	of IN 0	the DT 0	erythrocyte NN B-noun.person	membrane NN B-noun.person	is VBZ B-verb.stative	consequently RB B-adv.all	avoided VBN B-verb.social	. . 0	. . 0
a6103707.s10	Plasma NNP B-noun.person	concentrations NNS I-noun.person	varied VBN B-verb.stative	with IN 0	dose NN B-noun.person	and CC 0	route NN B-noun.artifact	and CC 0	corresponded VBD B-verb.contact	qualitatively RB B-adv.all	with IN 0	the DT 0	subjective JJ B-adj.all	effects NNS B-noun.phenomenon	. . 0	. . 0
a15036754.s8	When WRB 0	CPA NNP 0	, , 0	diazepam NN B-noun.person	or CC 0	2PAM NN B-noun.person	was VBD 0	given VBN B-verb.possession	immediately RB B-adv.all	after IN 0	DFP NNP B-noun.group	- : 0	atropine NN B-noun.person	, , 0	these DT 0	treatments NNS B-noun.plant	prevented VBN B-verb.communication	, , 0	delayed VBN B-verb.change	or CC 0	shortened VBN B-verb.change	the DT 0	occurrence NN B-noun.state	of IN 0	serious JJ B-adj.all	signs NNS B-noun.communication	of IN 0	poisoning NN B-noun.cognition	. . 0	. . 0
a26094.s1	Eighty CD 0	- : 0	nine CD B-verb.stative	new JJ B-adj.all	referral JJ B-adj.all	hypertensive NN 0	out IN 0	- : 0	patients NNS B-noun.person	and CC 0	46 CD 0	new JJ B-adj.all	referral JJ B-adj.pert	non NN B-noun.person	- : 0	hypertensive NN 0	chronically RB B-adv.all	physically RB B-adv.all	ill VB B-verb.stative	out RP I-verb.stative	- : 0	patients NNS B-noun.person	completed VBD B-verb.change	a DT 0	mood NN 0	rating NN 0	scale NN 0	at IN 0	regular JJ B-adj.all	intervals NNS B-noun.food	for IN 0	one CD 0	year NN B-noun.time	. . 0	. . 0
a891050.s4	Therefore RB 0	, , 0	in IN 0	adult NN B-noun.act	patients NNS B-noun.person	affected VBN B-verb.change	by IN 0	HUS NNP 0	, , 0	dialysis NN B-noun.person	should MD 0	not RB 0	be VB 0	discontinued VBN B-verb.stative	prematurely RB B-adv.all	, , 0	moreover RB B-adv.all	, , 0	bilateral JJ B-adj.all	nephrectomy NN B-noun.person	, , 0	for IN 0	treatment NN B-noun.act	of IN 0	severe JJ B-adj.all	hypertension NN B-noun.person	and CC 0	microangiopathic_hemolytic_anemia NNP B-noun.location	, , 0	should MD 0	be VB 0	performed VBN B-verb.social	with IN 0	caution NN B-noun.cognition	. . 0	. . 0
a10807237.s6	RESULTS NNS B-noun.artifact	, , 0	The DT 0	patients NNS B-noun.person	in IN 0	the DT 0	study NN B-noun.artifact	group NN 0	were VBD 0	significantly RB B-adv.all	younger JJR B-adj.all	than IN 0	the DT 0	patients NNS B-noun.person	in IN 0	the DT 0	control NN B-noun.location	group NN 0	( ( 0	P NNP 0	< $ 0	0.002 CD 0	) ) 0	. . 0	. . 0
a435349.s6	Fasciculations NNS B-noun.person	in IN 0	six CD 0	areas NNS B-noun.location	of IN 0	the DT 0	body NN B-noun.object	were VBD 0	scored VBN B-verb.communication	from IN 0	0 CD B-noun.quantity	to TO 0	3 CD B-adj.all	and CC 0	summated VBD B-verb.communication	as IN 0	a DT 0	total JJ B-adj.all	fasciculation NN B-noun.act	score NN B-noun.group	. . 0	. . 0
a18221780.s4	For IN 0	comparison NN B-noun.person	, , 0	tests NNS B-noun.person	were VBD 0	conducted VBN B-verb.communication	in IN 0	two CD 0	acute_pain JJ B-adj.all	models NNS B-noun.artifact	, , 0	the DT 0	hotplate NN B-noun.communication	and CC 0	warm JJ B-adj.all	water NN 0	tail NN B-noun.body	- : 0	withdrawal NN B-noun.animal	procedures NNS I-noun.animal	. . 0	. . 0
a1786266.s2	Its PRP$ 0	occurrence NN B-noun.motive	in IN 0	a DT 0	patient NN B-noun.person	being VBG 0	treated VBN B-verb.change	with IN 0	imipramine NN B-noun.person	is VBZ 0	described VBN B-verb.communication	, , 0	representing VBG B-verb.social	the DT 0	first JJ B-adj.all	reported VBN B-verb.communication	case NN B-noun.state	of IN 0	this DT 0	syndrome NN B-noun.cognition	in IN 0	conjunction NN 0	with IN 0	antidepressants NNS B-noun.person	. . 0	. . 0
a7199841.s7	The DT 0	spinal JJ B-adj.all	cords NNS B-noun.quantity	of IN 0	the DT 0	animals NNS B-noun.artifact	that WDT 0	received VBD B-verb.possession	bupivacaine NN B-noun.person	, , 0	low JJ B-adj.all	pH IN 0	normal JJ B-adj.all	saline NN B-noun.act	( ( 0	pH $ 0	3.0 CD 0	) ) 0	, , 0	or CC 0	normal JJ B-adj.all	saline NN B-noun.person	did VBD 0	not RB B-adv.all	show VB B-verb.communication	abnormal JJ B-adj.all	findings NNS B-noun.act	. . 0	. . 0
a15458908.s4	Outcomes NNS B-noun.person	included VBD B-verb.stative	venous_thromboembolism NN B-noun.artifact	, , 0	cataracts NNS B-noun.location	, , 0	gallbladder_disease NNP B-noun.person	, , 0	and CC 0	endometrial_hyperplasia_or_cancer NN B-noun.person	. . 0	. . 0
a17491223.s5	In IN 0	19 CD 0	of IN 0	the DT 0	40 CD B-adj.all	patients NNS B-noun.person	perfusion NN B-noun.person	defects VBZ B-verb.stative	compatible JJ B-adj.all	with IN 0	ischemia NN B-noun.food	were VBD 0	detected VBN B-verb.perception	on IN 0	SPECT NNP B-noun.location	. . 0	. . 0
a15957009.s5	whereas IN 0	Ro4368554 NN B-noun.person	was VBD B-verb.stative	inactive JJ B-adj.all	. . 0	. . 0
a9401499.s4	Therefore RB 0	, , 0	old JJ B-adj.all	age NN B-noun.person	may MD 0	be VB B-verb.stative	a DT 0	risk NN B-noun.person	factor NN B-noun.person	for IN 0	developing VBG B-verb.communication	this DT 0	complication NN B-noun.communication	. . 0	. . 0
a16181582.s2	It PRP 0	may MD 0	even RB B-adv.all	present JJ B-adj.all	in IN 0	patients NNS B-noun.person	who WP 0	have VBP 0	tolerated VBN B-verb.communication	this DT 0	medicine NN B-noun.location	well RB 0	in IN 0	the DT 0	past NN B-noun.person	. . 0	. . 0
a869641.s8	However RB 0	, , 0	L NNP 0	- : 0	dopa NN B-noun.person	restored VBD B-verb.social	the DT 0	bradycardia NNS B-noun.location	caused VBN B-verb.communication	by IN 0	norepinephrine NN B-noun.person	in IN 0	addition NN 0	to TO 0	decreasing VBG B-verb.change	blood NN B-noun.act	pressure NN B-noun.act	and CC 0	heart NN B-noun.body	rate NN B-noun.time	. . 0	. . 0
a15278670.s6	l(-1 LS 0	) ) 0	) ) 0	during IN 0	1.6 CD 0	% NN 0	sevoflurane NN 0	was VBD B-verb.stative	not RB B-adv.all	significant JJ B-adj.all	from IN 0	that DT 0	during IN 0	0.8 CD 0	% NN 0	sevoflurane NN 0	, , 0	indicating VBG B-verb.communication	a DT 0	celling JJ B-adj.all	effect NN B-noun.cognition	. . 0	. . 0
a869641.s1	L SYM 0	- : 0	Dopa NN B-noun.person	( ( 0	5 CD 0	mg FW 0	/ FW 0	kg FW 0	i.v FW 0	. . 0	) ) 0	. . 0
a11569530.s2	Torsades_de_pointes NNS B-noun.time	( ( 0	TDP NNP 0	) ) 0	is VBZ B-verb.stative	a DT 0	potentially RB B-adv.all	fatal JJ B-adj.all	ventricular_tachycardia NNS B-noun.object	associated VBN B-verb.cognition	with IN 0	increases NNS B-noun.food	in IN 0	QT NNP 0	interval NN 0	and CC 0	monophasic JJ B-adj.all	action NN B-noun.state	potential JJ B-adj.all	duration NN 0	( ( 0	MAPD NNP B-noun.group	) ) 0	. . 0	. . 0
a6888657.s0	Characterization NN 0	of IN 0	estrogen NN B-noun.act	- : 0	induced VBN B-verb.creation	adenohypophyseal_tumors NNS B-noun.person	in IN 0	the DT 0	Fischer NNP B-noun.other	344 CD 0	rat NN B-noun.quantity	. . 0	. . 0
a435349.s0	Suxamethonium NN 0	infusion NN 0	rate NN B-noun.time	and CC 0	observed JJ B-verb.perception	fasciculations NNS B-noun.person	. . 0	A DT 0	dose NN B-noun.person	- : 0	response NN B-noun.communication	study NN B-noun.artifact	. . 0	. . 0
a11569530.s5	The DT 0	potential NN B-noun.state	of IN 0	compounds NNS B-noun.person	to TO 0	cause VB B-verb.communication	TDP NNP B-noun.person	was VBD 0	evaluated VBN B-verb.change	by IN 0	monitoring VBG B-verb.perception	their PRP$ 0	effects NNS B-noun.phenomenon	on IN 0	MAPD NNP B-noun.group	in IN 0	dog NN B-noun.animal	. . 0	. . 0
a12483326.s1	BACKGROUND NN 0	, , 0	Glioblastoma NNP B-noun.person	is VBZ B-verb.stative	a DT 0	malignant_tumor NN B-noun.person	that WDT 0	occurs VBZ B-verb.stative	in IN 0	the DT 0	cerebrum NN B-noun.artifact	during IN 0	adulthood NN B-noun.act	. . 0	. . 0
a1728522.s1	We PRP 0	report VBP B-verb.communication	the DT 0	case NN B-noun.state	of IN 0	a DT 0	patient NN B-noun.person	with IN 0	amoxicillin NN B-noun.person	- : 0	clavulanic_acid SYM 0	- : 0	induced VBN B-verb.creation	hepatitis NN 0	with IN 0	histologic JJ B-adj.all	multiple JJ B-adj.all	granulomas NNS B-noun.location	. . 0	. . 0
a2024540.s5	Patients NNS B-noun.person	who WP 0	received VBD B-verb.possession	enalapril NN B-noun.person	experienced VBN B-verb.perception	clinically RB B-adv.all	and CC 0	statistically RB B-adv.all	significantly RB B-adv.all	less RBR B-adv.all	symptomatic JJ B-adj.all	hypotension NN B-noun.relation	( ( 0	5.2 CD 0	% NN 0	) ) 0	than IN 0	the DT 0	patients NNS B-noun.person	who WP 0	received VBD B-verb.possession	prazosin NN B-noun.communication	( ( 0	12.9 CD 0	% NN 0	) ) 0	. . 0	. . 0
a8690168.s3	The DT 0	heparan_sulphate JJ B-adj.all	specificity NN B-noun.attribute	of IN 0	the DT 0	cuprolinic_blue NN B-noun.artifact	staining VBG B-verb.stative	was VBD 0	demonstrated VBN B-verb.cognition	by IN 0	glycosaminoglycan JJ B-adj.pert	- : 0	degrading JJ B-verb.communication	enzymes NNS B-noun.person	, , 0	showing VBG B-verb.cognition	that IN 0	pretreatment NN B-noun.person	of IN 0	the DT 0	sections NNS B-noun.object	with IN 0	heparitinase NN B-noun.person	abolished VBD B-verb.contact	all DT 0	staining NN B-noun.act	, , 0	whereas IN 0	chondroitinase NN B-noun.act	ABC NNP 0	had VBD 0	no DT 0	effect NN B-noun.phenomenon	. . 0	. . 0
a12820454.s10	At IN 0	six CD B-adj.all	months NNS B-noun.person	post RB B-adv.all	- : 0	CAB NN B-noun.group	, , 0	patients NNS B-noun.person	with IN 0	severe JJ B-adj.all	anemia NN B-noun.state	had VBD 0	a DT 0	Hb NNP 0	mean JJ B-adj.all	value NN B-noun.attribute	of IN 0	10.2 CD 0	+ CD 0	/- $ 0	0.1 CD 0	g FW 0	/ FW 0	dl FW 0	( ( 0	X NNP 0	+ : 0	/- '' 0	SE NNP 0	) ) 0	, , 0	whereas IN 0	the DT 0	other JJ 0	patients NNS B-noun.person	had VBD 0	mild JJ B-adj.all	anemia NN B-noun.person	with IN 0	Hb NNP 0	mean JJ B-adj.all	value NN B-noun.attribute	of IN 0	13.2 CD 0	+ CD 0	/- $ 0	0.17 CD 0	( ( 0	X NNP 0	+ : 0	/- '' 0	SE NNP 0	) ) 0	. . 0	. . 0
a1130930.s2	Patients NNS B-noun.person	who WP 0	are VBP 0	given VBN B-verb.possession	this DT 0	drug NN B-noun.person	regimen NNS B-noun.person	should MD 0	be VB 0	observed VBN B-verb.perception	very RB B-adv.all	carefully RB B-adv.all	for IN 0	early JJ B-adj.all	signs NNS B-noun.communication	of IN 0	nephrotoxicity NN B-noun.phenomenon	. . 0	. . 0
a3187073.s0	Adverse JJ B-adj.all	cardiac JJ B-adj.pert	effects NNS B-noun.phenomenon	during IN 0	induction NN B-noun.communication	chemotherapy NN B-noun.communication	treatment NN B-noun.communication	with IN 0	cis SYM 0	- : 0	platin NN B-noun.substance	and CC 0	5-fluorouracil NN B-noun.act	. . 0	. . 0
a3714122.s0	The DT 0	correlation NN B-noun.shape	between IN 0	neurotoxic JJ B-adj.all	esterase NN B-noun.communication	inhibition NN B-noun.communication	and CC 0	mipafox NN B-noun.person	- : 0	induced VBN B-verb.creation	neuropathic_damage NN B-noun.artifact	in IN 0	rats NNS B-noun.animal	. . 0	. . 0
a6287825.s9	In IN 0	26.5 CD 0	% NN 0	of IN 0	all PDT 0	the DT 0	cases NNS B-noun.artifact	, , 0	the DT 0	aetiology NN B-noun.attribute	of IN 0	the DT 0	neuropathy NN B-noun.person	was VBD B-verb.stative	undetermined JJ B-adj.all	. . 0	. . 0
a20470218.s0	Central_nervous_system_complications NNS B-noun.artifact	during IN 0	treatment NN B-noun.communication	of IN 0	acute_lymphoblastic_leukemia NNP B-noun.person	in IN 0	a DT 0	single JJ B-adj.all	pediatric JJ B-noun.relation	institution NN I-noun.relation	. . 0	. . 0
a6103707.s4	The DT 0	most RBS 0	striking JJ B-adj.all	effect NN B-noun.cognition	was VBD B-verb.stative	sedation NN B-noun.act	which WDT 0	increased VBD B-verb.change	with IN 0	the DT 0	dose NN B-noun.person	, , 0	2 CD 0	mg IN 0	producing VBG B-verb.stative	deep JJ B-adj.all	sleep NN B-noun.food	although IN 0	the DT 0	subjects NNS B-noun.person	could MD 0	still RB 0	be VB 0	aroused VBN B-verb.emotion	. . 0	. . 0
a6387529.s5	After IN 0	2 CD B-adj.all	weeks NNS B-noun.time	of IN 0	treatment NN B-noun.communication	, , 0	patients NNS B-noun.person	tested VBD B-verb.social	5 CD 0	- : 0	8 CD B-adj.all	h NN B-noun.quantity	after IN 0	the DT 0	last JJ B-adj.all	dose NN B-noun.person	of IN 0	medication NN B-noun.artifact	did VBD 0	not RB B-adv.all	show VB B-verb.change	any DT 0	decrement NN B-noun.attribute	of IN 0	performance NN B-noun.act	. . 0	. . 0
a1992636.s4	We PRP 0	report VBP B-verb.communication	the DT 0	first JJ B-noun.artifact	case NN I-noun.artifact	of IN 0	a DT 0	serious JJ B-adj.all	short JJ B-noun.body	- : 0	term NN B-noun.time	adverse JJ B-adj.all	reaction NN B-noun.process	with IN 0	the DT 0	use NN 0	of IN 0	omeprazole NN B-noun.shape	, , 0	hemolytic_anemia NNP B-noun.location	. . 0	. . 0
a1468485.s5	No DT 0	side NN 0	effect NN 0	was VBD 0	noted VBN B-verb.perception	during IN 0	the DT 0	course NN B-noun.location	of IN 0	therapy NN B-noun.act	. . 0	. . 0
a2549018.s1	Five CD 0	patients NNS B-noun.person	receiving VBG B-verb.communication	fluoxetine NN B-noun.person	for IN 0	the DT 0	treatment NN B-noun.communication	of IN 0	obsessive_compulsive_disorder JJ B-noun.other	or CC 0	major_depression NN B-noun.group	developed VBD B-verb.creation	akathisia NN B-noun.artifact	. . 0	. . 0
a12695819.s5	Of IN 0	the DT 0	14 CD B-adj.all	patients NNS B-noun.person	, , 0	5 CD 0	( ( 0	35.7 CD 0	% NN 0	) ) 0	had VBD B-verb.stative	white_matter_abnormalities NNS I-verb.stative	, , 0	1 CD 0	( ( 0	7.1 CD 0	% NN 0	) ) 0	had VBD 0	putaminal_hemorrhage NN B-noun.other	, , 0	and CC 0	8 CD B-adj.all	( ( 0	57.1 CD 0	% NN 0	) ) 0	had VBD B-verb.stative	normal JJ B-adj.all	findings NNS B-noun.act	on IN 0	initial JJ B-adj.all	MR NNP 0	images NNS B-noun.artifact	. . 0	. . 0
a9334596.s9	in IN 0	107 CD 0	patients NNS B-noun.person	but CC 0	normal JJ B-adj.all	in IN 0	40 CD B-adj.all	% NN 0	at IN 0	repeat NN B-noun.artifact	determination NN I-noun.artifact	. . 0	. . 0
a17175308.s1	Sirolimus NNP B-noun.person	( ( 0	SRL NNP 0	) ) 0	is VBZ B-verb.stative	a DT 0	new JJ B-adj.all	, , 0	potent JJ B-adj.all	immunosuppressive JJ B-adj.all	agent NN B-noun.person	. . 0	. . 0
a3629586.s3	In IN 0	four CD 0	subacute NN B-noun.substance	toxicity NN B-noun.phenomenon	studies NNS B-noun.artifact	, , 0	the DT 0	intravenous JJ B-adj.all	administration NN B-noun.time	of IN 0	cefonicid NN B-noun.possession	or CC 0	cefazedone NN 0	to TO 0	beagle VB B-verb.contact	dogs NNS B-noun.person	caused VBD B-verb.communication	a DT 0	dose NN B-noun.person	- : 0	dependent JJ B-adj.all	incidence NN B-noun.relation	of IN 0	anemia NN B-noun.state	, , 0	neutropenia NN B-noun.person	, , 0	and CC 0	thrombocytopenia NN B-noun.communication	after IN 0	1 CD B-adj.all	- : 0	3 CD B-adj.all	months NNS B-noun.quantity	of IN 0	treatment NN B-noun.plant	. . 0	. . 0
a11391224.s2	Although IN 0	such JJ 0	an DT 0	association NN B-noun.communication	is VBZ B-verb.stative	of IN 0	practical JJ B-adj.all	and CC 0	theoretical JJ B-adj.all	importance NN B-noun.state	, , 0	only RB 0	one CD 0	prospective JJ B-adj.all	study NN B-noun.group	has VBZ 0	tried VBN B-verb.social	to TO 0	confirm VB B-verb.cognition	it PRP 0	. . 0	. . 0
a6666578.s9	These DT 0	observations NNS B-noun.act	support VBP B-verb.stative	the DT 0	hypothesis NN B-noun.communication	that WDT 0	treatment NN B-noun.person	with IN 0	high JJ B-adj.all	doses NNS B-noun.attribute	of IN 0	D NNP 0	- : 0	pen NN B-noun.person	may MD 0	induce VB B-verb.cognition	a DT 0	fibroproliferative JJ B-adj.all	response NN B-noun.communication	in IN 0	rat NN 0	aorta NN 0	, , 0	possibly RB B-adv.all	by IN 0	an DT 0	inhibitory JJ B-adj.all	effect NN B-noun.cognition	on IN 0	the DT 0	cross NN B-noun.person	- : 0	linking NN B-verb.cognition	of IN 0	collagen NN B-noun.person	and CC 0	elastin NN B-noun.person	. . 0	. . 0
a17175308.s11	Twenty CD 0	- : 0	eight CD B-adj.all	percent NN B-noun.person	of IN 0	patients NNS B-noun.person	showed VBD B-verb.communication	increased VBN B-verb.change	proteinuria NN I-verb.change	to TO 0	the DT 0	nephrotic JJ B-adj.all	range NN B-noun.artifact	. . 0	. . 0
a19581773.s2	Ophthalmologic JJ B-adj.all	examinations NNS B-noun.person	showed VBD B-verb.communication	ptosis_on_the_right_upper_lid JJ B-noun.person	and CC 0	restricted_right_eye_movement NN B-noun.act	without IN 0	any DT 0	other JJ 0	neurological JJ B-adj.all	signs NNS B-noun.communication	. . 0	. . 0
a15278670.s12	l(-1 LS 0	) ) 0	) ) 0	but CC 0	this DT 0	was VBD B-verb.stative	not RB B-adv.all	statistically RB B-adv.all	significant JJ B-adj.all	. . 0	. . 0
a9401499.s6	There EX 0	seemed VBD B-verb.perception	to TO 0	be VB B-verb.stative	no DT 0	direct JJ 0	correlation NN 0	between IN 0	the DT 0	dose NN B-noun.communication	or CC 0	duration NN 0	used VBN B-verb.consumption	and CC 0	the DT 0	severity NN B-noun.attribute	of IN 0	bone_marrow_suppression NN 0	. . 0	. . 0
a18503483.s4	Here RB 0	, , 0	we PRP 0	describe VBP B-verb.communication	an DT 0	eight CD 0	- : 0	and CC 0	- : 0	a SYM 0	- : 0	half NN B-noun.person	- : 0	yr SYM 0	- : 0	old JJ B-adj.all	male NN B-noun.person	renal JJ B-adj.all	transplant NN B-noun.act	recipient NN I-noun.act	with IN 0	right JJ B-noun.group	BN NNP 0	. . 0	. . 0
a18221780.s8	These DT 0	findings NNS B-noun.act	demonstrate VBP B-verb.stative	a DT 0	sexually RB B-adv.all	- : 0	dimorphic JJ B-adj.all	interaction NN B-noun.act	between IN 0	NMDA NNP B-noun.group	antagonists NNS B-noun.attribute	and CC 0	morphine NN B-noun.person	in IN 0	a DT 0	persistent JJ B-adj.all	pain NN B-noun.cognition	model NN I-noun.cognition	that WDT 0	can MD 0	be VB 0	distinguished VBN B-verb.cognition	from IN 0	those DT 0	observed VBN B-verb.perception	in IN 0	acute_pain JJ B-adj.all	models NNS B-noun.artifact	. . 0	. . 0
a8690168.s1	Heparan_sulphate SYM 0	- : 0	associated VBN B-verb.cognition	anionic JJ B-adj.all	sites NNS B-noun.location	in IN 0	the DT 0	glomerular JJ B-adj.all	basement NN B-noun.shape	membrane NN B-noun.person	were VBD 0	studied VBN B-verb.cognition	in IN 0	rats NNS B-noun.communication	8 CD B-adj.all	months NNS B-noun.person	after IN 0	induction NN B-noun.time	of IN 0	diabetes NN B-noun.food	by IN 0	streptozotocin NN B-noun.communication	and CC 0	in IN 0	age- JJ 0	adn NN 0	sex NN B-noun.act	- : 0	matched VBN B-verb.possession	control NN B-noun.possession	rats NNS B-noun.location	, , 0	employing VBG B-verb.change	the DT 0	cationic NN B-noun.artifact	dye NN B-noun.artifact	cuprolinic_blue NN I-noun.artifact	. . 0	. . 0
a3187073.s8	The DT 0	mean JJ B-adj.all	age NN 0	of IN 0	these DT 0	patients NNS B-noun.person	was VBD B-verb.stative	the DT 0	same JJ 0	as IN 0	for IN 0	the DT 0	entire JJ B-adj.all	group NN B-noun.person	, , 0	64 CD 0	years NNS B-noun.time	. . 0	. . 0
a16181582.s5	A DT 0	case NN B-noun.state	of IN 0	valproate NN B-noun.attribute	- : 0	induced VBN B-verb.creation	encephalopathy JJ B-adj.all	is VBZ 0	presented VBN B-verb.possession	. . 0	. . 0
a6888657.s4	Total JJ B-adj.all	cell NN B-noun.body	yields NNS I-noun.body	from IN 0	DES NNP B-noun.group	- : 0	treated VBN B-verb.communication	pituitaries NNS B-noun.person	increased VBN B-verb.change	from IN 0	1.3 CD 0	times NNS B-noun.event	control VBP B-verb.stative	yields NNS I-verb.stative	at IN 0	8 CD B-adj.all	days NNS B-noun.time	of IN 0	treatment NN B-noun.plant	to TO 0	58.9 CD 0	times NNS B-noun.event	control NN B-noun.phenomenon	values NNS B-noun.attribute	by IN 0	day NN 0	150 CD 0	. . 0	. . 0
a18182964.s4	Groups NNS B-noun.group	were VBD 0	compared VBN B-verb.change	regarding VBG B-verb.stative	adverse JJ B-adj.all	events NNS B-noun.person	and CC 0	changes NNS B-noun.artifact	from IN 0	baseline NN B-noun.person	to TO 0	week VB B-verb.social	16 CD 0	in IN 0	electrocardiograms NNS B-noun.animal	and CC 0	vital JJ B-adj.all	signs NNS B-noun.communication	. . 0	. . 0
a2024540.s0	Design NN B-noun.person	and CC 0	analysis NN B-noun.act	of IN 0	the DT 0	HYPREN NNP B-noun.other	- : 0	trial NN B-noun.act	, , 0	safety NN B-noun.person	of IN 0	enalapril NN B-noun.person	and CC 0	prazosin NN B-noun.person	in IN 0	the DT 0	initial JJ B-adj.all	treatment NN B-noun.state	phase NN B-noun.time	of IN 0	patients NNS B-noun.person	with IN 0	congestive_heart_failure NN B-noun.food	. . 0	. . 0
a4071154.s0	Indomethacin NNP B-noun.person	- : 0	induced VBN B-verb.creation	renal_insufficiency NN I-verb.creation	, , 0	recurrence NN B-noun.person	on IN 0	rechallenge NN B-noun.artifact	. . 0	. . 0
a17242861.s9	Latencies NNS B-noun.person	to TO 0	stages NNS B-noun.state	were VBD B-verb.stative	also RB B-adv.all	significantly RB B-adv.all	shorter JJR B-adj.all	for IN 0	CSS10 NN 0	and CC 0	CSS18 JJ B-noun.body	mice NNS I-noun.body	. . 0	. . 0
a9249847.s2	QRS NNS 0	without IN 0	preexcitation NN B-noun.time	, , 0	caused VBN B-verb.communication	by IN 0	junctional JJ B-adj.pert	escape NN B-noun.act	beats NNS B-noun.artifact	after IN 0	verapamil NN B-noun.time	or CC 0	unidirectional JJ B-adj.all	antegrade NN B-noun.attribute	block NN B-noun.process	of IN 0	accessory JJ B-adj.all	pathway NN B-noun.location	after IN 0	catheter NN B-noun.person	ablation NN B-noun.person	, , 0	established VBD B-verb.cognition	frequent JJ B-noun.person	AVRT NNP I-noun.person	attack NN I-noun.person	. . 0	. . 0
a3192036.s3	The DT 0	multiple JJ B-adj.all	drug NN B-noun.person	schema NN B-noun.person	consisted VBD B-verb.stative	of IN I-verb.stative	, , 0	Etoposide NNP 0	16.213 CD 0	, , 0	Methotrexate NNP B-noun.person	, , 0	Cyclophosphamide NNP B-noun.person	, , 0	Actomycin NNP B-noun.person	- : 0	D NNP 0	, , 0	and CC 0	Cisplatin NNP B-noun.person	. . 0	. . 0
a15957009.s2	Although IN 0	the DT 0	underlying VBG 0	mechanism(s NN 0	) ) 0	are VBP B-verb.stative	not RB B-adv.all	well RB 0	understood VBN B-verb.cognition	, , 0	these DT 0	effects NNS B-noun.phenomenon	may MD 0	involve VB B-verb.stative	an DT 0	increase NN B-noun.act	in IN 0	acetylcholine NN 0	( ( 0	ACh NNP 0	) ) 0	levels NNS B-noun.state	. . 0	. . 0
a2549018.s3	Three CD 0	patients NNS B-noun.person	who WP 0	had VBD 0	experienced VBN B-verb.emotion	neuroleptic JJ B-adj.all	- : 0	induced VBN B-verb.creation	akathisia NN B-noun.person	in IN 0	the DT 0	past NN B-noun.person	reported VBD B-verb.communication	that IN 0	the DT 0	symptoms NNS B-noun.location	of IN 0	fluoxetine NN B-noun.person	- : 0	induced VBN B-verb.creation	akathisia NNS B-noun.person	were VBD B-verb.stative	identical JJ B-adj.all	, , 0	although IN 0	somewhat DT 0	milder NN B-noun.person	. . 0	. . 0
a3714122.s1	The DT 0	correlation NN B-noun.shape	between IN 0	neuropathic_damage NN B-noun.act	and CC 0	inhibition NN B-noun.attribute	of IN 0	neurotoxic JJ B-adj.all	esterase NN B-noun.state	or CC 0	neuropathy JJ B-adj.all	target NN B-noun.location	enzyme NN B-noun.person	( ( 0	NTE NNP 0	) ) 0	was VBD 0	examined VBN B-verb.communication	in IN 0	rats NNS B-noun.animal	acutely RB B-adv.all	exposed VBN B-verb.perception	to TO 0	Mipafox NNP B-noun.person	( ( 0	N,_N'-diisopropylphosphorodiamidofluoridate JJ 0	) ) 0	, , 0	a DT 0	neurotoxic JJ B-adj.all	organophosphate NN B-noun.cognition	. . 0	. . 0
a2071257.s2	Thirty SYM 0	- : 0	two CD 0	healthy JJ B-adj.all	young JJ B-adj.all	volunteers NNS B-noun.person	were VBD B-verb.stative	randomly RB B-adv.all	allocated VBN B-verb.communication	to TO 0	four CD B-verb.perception	different JJ B-adj.all	groups NNS B-noun.group	. . 0	. . 0
a8302922.s7	30 CD B-adj.all	min NN B-noun.quantity	, , 0	32.3 CD 0	+ : 0	/- $ 0	9.9 CD 0	ml/100 CD 0	g PRP 0	/ `` 0	min NN 0	( ( 0	P NNP 0	< $ 0	0.05 CD 0	) ) 0	. . 0	. . 0
a12483326.s12	CONCLUSION NN B-noun.group	, , 0	When WRB 0	performing VBG B-verb.creation	intracarotid JJ B-adj.all	injection NN B-noun.event	of IN 0	carboplatin NN B-noun.communication	, , 0	we PRP 0	must MD 0	be VB B-verb.stative	aware JJ B-adj.all	of IN 0	its PRP$ 0	potentially RB B-adv.all	blinding JJ B-adj.all	ocular_toxicity NN B-noun.attribute	. . 0	. . 0
a19356307.s3	Analysis NN 0	of IN 0	neurotransmitter NN B-noun.person	concentration NN B-noun.person	in IN 0	some DT 0	brain NN B-noun.person	regions NNS B-noun.person	on IN 0	the DT 0	test NN B-adj.all	day NN B-noun.person	showed VBD B-verb.communication	that IN 0	dopamine NN 0	concentration NN B-noun.event	of IN 0	the DT 0	vehicle NN B-noun.communication	/ : 0	scopolamine NN B-noun.location	group NN B-noun.person	was VBD B-verb.stative	significantly RB B-adv.all	lower JJR B-adj.all	than IN 0	that DT 0	of IN 0	the DT 0	vehicle NN B-noun.communication	/ : 0	vehicle NN B-noun.communication	group NN B-noun.communication	, , 0	but CC 0	this DT 0	phenomenon NN B-noun.event	was VBD 0	reversed VBN B-verb.change	when WRB 0	s SYM 0	- : 0	limonene NN B-noun.person	or CC 0	s SYM 0	- : 0	perillyl_alcohol NN B-noun.person	were VBD 0	administered VBN B-verb.possession	before IN 0	the DT 0	injection NN B-noun.act	of IN 0	scopolamine NN B-noun.person	. . 0	. . 0
a6692345.s0	Effect NN 0	of IN 0	aspirin NN B-noun.person	on IN 0	N-[4-(5-nitro-2-furyl)-2-thiazolyl]-formamide JJ 0	- : 0	induced VBN B-verb.creation	epithelial JJ B-adj.all	proliferation NN B-noun.person	in IN 0	the DT 0	urinary JJ B-adj.all	bladder NN B-noun.person	and CC 0	forestomach NN B-noun.act	of IN 0	the DT 0	rat NN B-noun.artifact	. . 0	. . 0
a6287825.s3	Sensori SYM 0	- : 0	motor_neuropathy NN B-noun.person	was VBD B-verb.stative	the DT 0	commonest JJS B-adj.all	presentation NN B-noun.person	( ( 0	50 CD B-adj.all	% NN 0	) ) 0	. . 0	. . 0
a18503483.s5	MRI NNP B-noun.person	demonstrated VBD B-verb.cognition	hyperintense NN 0	T2 NN 0	signals NNS B-noun.communication	in IN 0	the DT 0	cervical JJ B-adj.all	cord NN B-noun.artifact	and CC 0	right JJ B-adj.all	brachial JJ 0	plexus NN 0	roots NNS 0	indicative JJ 0	of IN 0	both DT 0	myelitis NN B-noun.location	and CC 0	right JJ B-adj.all	brachial_plexitis NN B-noun.artifact	. . 0	. . 0
a11679859.s2	METHODS NNS B-noun.attribute	, , 0	We PRP 0	conducted VBD B-verb.creation	a DT 0	prospective JJ B-adj.all	, , 0	randomized VBD B-verb.cognition	, , 0	double RB 0	- : 0	blind JJ B-adj.all	study NN B-noun.artifact	in IN 0	the DT 0	emergency NN B-noun.person	department NN B-noun.person	of IN 0	a DT 0	central JJ B-noun.body	- : 0	city NN B-noun.phenomenon	teaching NN B-verb.communication	hospital NN I-verb.communication	. . 0	. . 0
a17042910.s10	Systolic JJ B-adj.all	blood NN B-noun.group	pressure NN B-noun.person	( ( 0	SBP NNP 0	) ) 0	was VBD 0	measured VBN B-verb.cognition	on IN 0	alternate JJ B-adj.all	days NNS B-noun.person	using VBG B-verb.consumption	the DT 0	tail NN B-noun.body	- : 0	cuff NN 0	method NN 0	. . 0	. . 0
a11391224.s4	In IN 0	addition NN 0	to TO 0	renal JJ B-adj.all	allografts NNS B-noun.person	with IN 0	TG NNP 0	, , 0	we PRP 0	also RB B-adv.all	examined VBD B-verb.communication	grafts NNS B-noun.person	with IN 0	acute JJ B-adj.all	rejection NN B-noun.person	, , 0	recurrent NN B-noun.person	glomerulonephritis NN 0	, , 0	chronic_allograft_nephropathy NNP B-noun.group	and CC 0	stable JJ B-adj.all	grafts NNS B-noun.person	( ( 0	" PRP$ 0	protocol NN B-noun.possession	biopsies NNS B-noun.cognition	" : 0	) ) 0	. . 0	. . 0
a15036754.s2	The DT 0	acute JJ B-adj.all	toxicity NN B-noun.attribute	of IN 0	OPs NNP B-noun.person	is VBZ B-verb.stative	the DT 0	result NN B-noun.act	of IN 0	their PRP$ 0	irreversible JJ B-adj.all	binding NN B-noun.act	with IN 0	AChEs NNP B-noun.person	in IN 0	the DT 0	central JJ B-noun.body	nervous JJ I-noun.body	system NN B-noun.cognition	( ( 0	CNS NNP 0	) ) 0	, , 0	which WDT 0	elevates VBZ B-verb.change	acetylcholine NN 0	( ( 0	ACh NNP 0	) ) 0	levels NNS B-noun.state	. . 0	. . 0
a11027905.s9	Significant JJ B-adj.all	increases NNS B-noun.event	in IN 0	drowsiness NN 0	were VBD 0	reported VBN B-verb.communication	in IN 0	patients NNS B-noun.person	treated VBD B-verb.social	with IN 0	ketamine NN B-noun.person	in IN 0	both DT 0	groups NNS B-noun.group	and CC 0	were VBD B-verb.stative	more RBR B-adv.all	marked VBN B-verb.communication	with IN 0	ketamine NN B-noun.attribute	0.50 CD 0	mg FW B-noun.quantity	/ FW 0	kg FW 0	. . 0	. . 0
a11256525.s10	This DT 0	case NN B-noun.state	report NN I-noun.state	highlights VBZ B-verb.change	the DT 0	fact NN B-noun.state	that IN 0	the DT 0	angiotensin_II JJ B-adj.all	receptor NN B-noun.person	antagonist JJ B-adj.all	losartan NN B-noun.animal	can MD 0	cause VB B-verb.communication	serious JJ B-adj.all	unexpected JJ B-adj.all	complications NNS B-noun.person	in IN 0	patients NNS B-noun.person	with IN 0	renovascular_disease NNP B-noun.person	and CC 0	should MD 0	be VB 0	used VBN B-verb.consumption	with IN 0	extreme JJ B-adj.all	caution NN B-noun.cognition	in IN 0	this DT 0	setting NN B-noun.act	. . 0	. . 0
a11569530.s1	1 LS 0	. . 0	. . 0
a16330766.s8	The DT 0	observed JJ B-adj.all	drug NN B-noun.person	- : 0	induced VBN B-verb.creation	effects NNS B-noun.phenomenon	were VBD 0	not RB 0	due JJ 0	to TO 0	changes NNS B-noun.act	in IN 0	the DT 0	baseline NN B-noun.person	fMRI NNP I-noun.person	signal NN I-noun.person	. . 0	. . 0
a16181582.s1	Valproate NNP B-noun.person	- : 0	induced VBN B-verb.creation	encephalopathy JJ B-adj.all	is VBZ B-verb.stative	a DT 0	rare JJ B-adj.all	syndrome NN 0	that WDT 0	may MD 0	manifest VB B-verb.social	in IN 0	otherwise RB 0	normal JJ B-adj.all	epileptic JJ B-adj.all	individuals NNS B-noun.person	. . 0	. . 0
a9653867.s2	When WRB 0	they PRP 0	do VBP 0	occur VB B-verb.cognition	they PRP 0	are VBP 0	often RB B-adv.all	unrecognized JJ B-adj.all	because IN 0	of IN 0	denial NN B-noun.process	but CC 0	when WRB 0	significant JJ 0	may MD 0	pose VB B-verb.possession	a DT 0	risk NN 0	to TO 0	both DT 0	the DT 0	mother NN B-noun.person	and CC 0	her PRP$ 0	fetus NN B-noun.animal	. . 0	. . 0
a19631624.s4	To TO 0	address VB B-verb.communication	the DT 0	potential JJ B-adj.all	confounding VBG B-verb.communication	effects NNS B-noun.phenomenon	of IN 0	the DT 0	cannabis NN B-noun.location	use NN 0	of IN 0	the DT 0	ecstasy NN B-noun.person	using VBG B-verb.consumption	group NN I-verb.consumption	, , 0	a DT 0	second JJ B-adj.all	analysis NN B-noun.communication	included VBD B-verb.stative	14 CD 0	previously RB B-adv.all	tested VBN B-verb.social	cannabis NN 0	users NNS 0	( ( 0	Nestor NNP B-noun.person	, , 0	L. NNP 0	, , 0	Roberts NNP B-noun.person	, , 0	G. NNP 0	, , 0	Garavan NNP B-noun.person	, , 0	H. NNP 0	, , 0	Hester NNP B-noun.person	, , 0	R. NNP 0	, , 0	2008 CD 0	. . 0	. . 0
a12202650.s7	Increased VBN B-verb.change	sensitivity NN B-noun.feeling	of IN 0	the DT 0	fusimotor NN 0	system NN 0	during IN 0	acute JJ B-adj.all	muscle_pain NN B-noun.person	could MD 0	be VB B-verb.stative	one CD 0	likely JJ B-adj.all	mechanism NN 0	to TO 0	explain VB B-verb.communication	the DT 0	findings NNS B-noun.act	. . 0	. . 0
a12907309.s7	The DT 0	results NNS B-noun.communication	of IN 0	this DT 0	study NN B-noun.communication	suggest VBP B-verb.communication	that IN 0	the DT 0	blockade NN B-noun.attribute	of IN 0	mGluR5 NNP B-noun.person	by IN 0	MPEP NNP B-noun.group	may MD 0	protect VB B-verb.creation	dopaminergic JJ B-adj.all	neurones NNS B-noun.object	against IN 0	methamphetamine NN B-noun.person	- : 0	induced VBN B-verb.creation	toxicity NN B-noun.attribute	. . 0	. . 0
a11166519.s4	A DT 0	range NN B-noun.attribute	of IN 0	strain NN B-noun.phenomenon	specific JJ B-adj.all	sensitivities NNS B-noun.person	was VBD 0	documented VBN B-verb.communication	with IN 0	A DT 0	/ JJ 0	J NNP 0	and CC 0	SJL NNP 0	mice NNS 0	being VBG B-verb.stative	most RBS B-adv.all	sensitive JJ B-adj.all	and CC 0	C57BL/6J NNP B-noun.person	most RBS B-adv.all	resistant JJ B-adj.all	. . 0	. . 0
a6103707.s8	There EX 0	was VBD 0	pain VBN B-verb.contact	on IN 0	i.m NNP 0	. . 0	. . 0
a1992636.s8	The DT 0	mechanism NN B-noun.object	by IN 0	which WDT 0	omeprazole NN B-noun.person	caused VBD B-verb.communication	the DT 0	patient NN B-noun.person	's POS 0	hemolytic_anemia NN B-noun.location	is VBZ B-verb.stative	uncertain JJ B-adj.all	, , 0	but CC 0	physicians NNS B-noun.person	should MD 0	be VB 0	alerted VBN B-verb.communication	to TO 0	this DT 0	possible JJ B-adj.all	adverse JJ B-adj.all	effect NN B-noun.cognition	. . 0	. . 0
a3412544.s3	By IN 0	contrast NN 0	, , 0	we PRP 0	were VBD B-verb.stative	unable JJ B-adj.all	to TO 0	substantiate VB B-verb.social	an DT 0	increased VBN B-adj.all	risk NN B-noun.person	from IN 0	paracetamol NN B-noun.act	consumption NN B-noun.act	for IN 0	renal_papillary_necrosis NN B-noun.act	or CC 0	any DT 0	of IN 0	these DT 0	cancers NNS B-noun.communication	although IN 0	there EX 0	was VBD B-verb.stative	a DT 0	suggestion NN B-noun.time	of IN 0	an DT 0	association NN B-noun.person	with IN 0	cancer_of_the_ureter NN B-noun.person	. . 0	. . 0
a15036754.s6	All DT 0	rats NNS B-noun.animal	were VBD 0	terminated VBN B-verb.change	either RB 0	24 CD B-adj.all	h NN B-noun.quantity	or CC 0	3 CD B-adj.all	weeks NNS B-noun.time	after IN 0	the DT 0	DFP NNP 0	injection NN 0	. . 0	. . 0
a8231633.s5	The DT 0	convulsant JJ B-adj.all	activity NN B-noun.state	, , 0	the DT 0	time NN B-noun.time	of IN 0	latency NN B-noun.location	to TO 0	convulse VB B-verb.communication	and CC 0	the DT 0	mortality NN B-noun.attribute	rate NN B-noun.time	were VBD 0	assessed VBN B-verb.communication	in IN 0	each DT 0	group NN 0	. . 0	. . 0
a230316.s8	Isolated VBN B-verb.change	myelopathy JJ B-adj.all	or CC 0	peripheral_neuropathy JJ B-noun.possession	, , 0	or CC 0	these DT 0	manifestations NNS B-noun.communication	occurring VBG B-verb.stative	together RB B-adv.all	, , 0	were VBD B-verb.stative	infrequent NN B-noun.person	. . 0	. . 0
a869641.s11	It PRP 0	is VBZ 0	concluded VBN B-verb.cognition	that IN 0	L SYM 0	- : 0	dopa NN B-noun.person	enhances NNS B-noun.person	reflex VBP B-verb.perception	bradycardia NNS I-verb.perception	through IN 0	central JJ B-noun.body	alpha NN I-noun.body	- : 0	receptor NN B-noun.person	stimulation NN B-noun.artifact	. . 0	. . 0
a9334596.s18	in IN 0	1.86 CD 0	% NN 0	of IN 0	1,821 CD 0	patients NNS B-noun.person	, , 0	prolactinomas NNS B-noun.person	in IN 0	7 CD 0	, , 0	0.38 CD 0	% NN 0	) ) 0	. . 0	. . 0
a2312209.s0	Myocardial_infarction NN B-noun.artifact	following VBG B-verb.stative	sublingual JJ B-adj.all	administration NN B-noun.time	of IN 0	isosorbide_dinitrate NNP B-noun.other	. . 0	. . 0
a9334596.s7	Endocrine VB B-verb.stative	therapy PRP 0	consisted VBD B-verb.stative	of IN I-verb.stative	testosterone_heptylate JJ B-noun.cognition	or CC 0	human JJ B-adj.all	chorionic NN B-noun.person	gonadotropin NN B-noun.person	for IN 0	hypogonadism NN B-noun.artifact	and CC 0	bromocriptine NN B-noun.person	for IN 0	hyperprolactinemia NN B-noun.person	. . 0	. . 0
a15036754.s9	Atropine SYM 0	- : 0	MK801 NN B-noun.person	did VBD 0	not RB B-adv.all	offer VB B-verb.possession	any DT 0	additional JJ B-adj.all	protection NN B-noun.cognition	against IN 0	DFP NNP B-noun.group	toxicity NN B-noun.attribute	. . 0	. . 0
a16160878.s9	Whatever WDT 0	was VBD B-verb.stative	the DT 0	dose NN B-noun.person	, , 0	the DT 0	central JJ B-noun.body	administration NN I-noun.body	of IN 0	U NNP 0	- : 0	II NNP 0	had VBD 0	no DT 0	effect NN B-noun.cognition	on IN 0	body NN B-noun.object	temperature NN B-noun.attribute	, , 0	nociception NN 0	, , 0	apomorphine JJ B-noun.person	- : 0	induced VBN B-verb.creation	penile_erection NN B-noun.artifact	and CC 0	climbing VBG B-verb.motion	behavior NN B-noun.attribute	, , 0	and CC 0	stress NN B-noun.person	- : 0	induced VBN B-verb.creation	plasma NN B-noun.substance	corticosterone NN 0	level NN B-noun.attribute	. . 0	. . 0
a9334596.s22	CONCLUSIONS NNS B-noun.artifact	, , 0	Low JJ B-adj.all	prevalences NNS B-noun.person	and CC 0	effects NNS B-noun.phenomenon	of IN 0	low_testosterone JJ 0	and CC 0	high JJ B-adj.all	prolactin NN B-noun.artifact	in_erectile_dysfunction NN B-noun.act	can MD 0	not RB 0	justify VB B-verb.communication	their PRP$ 0	routine JJ B-adj.all	determination NN B-noun.cognition	. . 0	. . 0
a3187073.s11	This DT 0	was VBD 0	followed VBN B-verb.stative	by IN 0	ventricular_fibrillation NN B-noun.communication	in IN 0	one CD 0	patient NN B-noun.person	and CC 0	sudden_death JJ 0	in IN 0	another DT 0	. . 0	. . 0
a17175308.s15	Five CD 0	grafts NNS 0	were VBD 0	lost VBN B-verb.possession	and CC 0	the DT 0	patients NNS B-noun.person	returned VBD B-verb.communication	to TO 0	dialysis NN B-noun.person	. . 0	. . 0
a11897407.s0	99mTc SYM 0	- : 0	glucarate NN B-noun.person	for IN 0	detection NN B-noun.act	of IN 0	isoproterenol NN B-noun.feeling	- : 0	induced VBN B-verb.creation	myocardial_infarction NN B-noun.process	in IN 0	rats NNS B-noun.animal	. . 0	. . 0
a3676049.s4	Controlled VBN B-verb.social	hypotension NN 0	to TO 0	an DT 0	average JJ B-adj.all	MAP NNP B-noun.person	of IN 0	50 CD B-adj.all	- : 0	55 CD 0	mm NN 0	Hg NNP 0	was VBD 0	induced VBN B-verb.creation	by IN 0	increasing VBG B-verb.change	the DT 0	dose NN B-noun.quantity	of IN 0	isoflurane NN B-noun.shape	, , 0	and CC 0	maintained VBN B-verb.stative	at IN 0	an DT 0	inspired VBN B-verb.emotion	concentration NN I-verb.emotion	of IN 0	2.2 CD 0	+ CD 0	/- # 0	0.2 CD 0	% NN 0	. . 0	. . 0
a12483326.s3	Therefore RB 0	, , 0	patients NNS B-noun.person	with IN 0	glioblastoma NN B-noun.attribute	sometimes RB B-adv.all	have VBP B-verb.change	intracarotid JJ B-adj.all	injection NN B-noun.event	of IN 0	carcinostatics NNS B-noun.person	added VBD B-verb.communication	to TO 0	the DT 0	treatment NN B-noun.plant	regimen NNS B-noun.person	. . 0	. . 0
a1639466.s6	Enalapril NNP B-noun.person	but CC 0	not RB 0	nitrendipine VB 0	reduced VBN B-verb.change	blood NN B-adj.all	pressure NN B-noun.person	significantly RB B-adv.all	. . 0	. . 0
a7199841.s6	Of IN 0	the DT 0	15 CD B-adj.all	spinal JJ B-adj.all	cords NNS B-noun.quantity	of IN 0	the DT 0	animals NNS B-noun.artifact	that WDT 0	received VBD B-verb.possession	2-chloroprocaine JJ I-verb.possession	- : 0	CE NN 0	, , 0	13 CD 0	showed VBD B-verb.communication	subpial_necrosis NN B-noun.person	, , 0	the DT 0	nerve NN B-noun.attribute	roots NNS I-noun.attribute	and CC 0	subarachnoid JJ B-adj.all	vessels NNS B-noun.body	were VBD B-verb.stative	normal JJ B-adj.all	. . 0	. . 0
a18182964.s6	There EX 0	were VBD B-verb.stative	no DT 0	suggestions NNS B-noun.person	of IN 0	interactions NNS B-noun.shape	between IN 0	clonidine NN B-noun.person	and CC 0	methylphenidate NN B-noun.person	regarding VBG B-verb.change	cardiovascular JJ B-adj.all	outcomes NNS B-noun.artifact	. . 0	. . 0
a12443032.s3	In IN 0	particular JJ B-adj.all	, , 0	the DT 0	tendency NN B-noun.attribute	of IN 0	cocaine NN 0	to TO 0	produce VB B-verb.creation	chest_pain NNP B-noun.group	ought MD 0	to TO 0	be VB B-verb.stative	in IN 0	the DT 0	mind NN B-noun.time	of IN 0	the DT 0	emergency NN B-noun.state	nurse NN B-noun.attribute	when WRB 0	faced VBN B-verb.communication	with IN 0	a DT 0	young JJ B-adj.all	victim NN B-noun.person	of IN 0	chest_pain NN B-noun.person	who WP 0	is VBZ B-verb.stative	otherwise RB 0	at IN 0	low JJ B-adj.all	risk NN B-noun.person	. . 0	. . 0
a10704919.s0	Hemolysis NNP B-noun.person	of IN 0	human JJ B-adj.all	erythrocytes NNS B-noun.person	induced VBN B-verb.creation	by IN 0	tamoxifen NNS B-noun.person	is VBZ 0	related VBN B-verb.cognition	to TO 0	disruption NN B-noun.act	of IN 0	membrane NN B-noun.person	structure NN B-noun.person	. . 0	. . 0
a18208574.s1	OBJECTIVES NNS B-noun.artifact	, , 0	To TO 0	correlate VB B-verb.stative	optical JJ B-adj.all	density NN B-noun.state	and CC 0	percent NN B-noun.person	inhibition NN 0	of IN 0	a DT 0	two CD 0	- : 0	step NN B-noun.quantity	heparin RB 0	- : 0	induced VBN B-verb.creation	thrombocytopenia NN 0	( ( 0	HIT NNP 0	) ) 0	antigen NN 0	assay NN 0	with IN 0	thrombosis NN B-noun.food	, , 0	the DT 0	assay NN B-noun.cognition	utilizes VBZ B-verb.consumption	reaction NN B-noun.process	inhibition NN 0	characteristics NNS 0	of IN 0	a DT 0	high JJ B-adj.all	heparin NN B-noun.phenomenon	concentration NN B-noun.event	. . 0	. . 0
a11391224.s5	Native JJ B-adj.all	kidney NN B-noun.act	specimens NNS B-noun.artifact	included VBD B-verb.stative	a DT 0	wide JJ B-adj.all	range NN B-noun.state	of IN 0	glomerulopathies NNS B-noun.animal	as RB 0	well RB 0	as IN 0	cases NNS B-noun.event	of IN 0	thrombotic_microangiopathy JJ 0	, , 0	malignant_hypertension NN B-noun.person	, , 0	acute VB B-verb.communication	interstitial_nephritis NNP B-noun.person	, , 0	and CC 0	acute_tubular_necrosis NNP B-noun.person	. . 0	. . 0
a2549018.s0	Fluoxetine SYM 0	- : 0	induced VBN B-verb.creation	akathisia NN B-noun.artifact	, , 0	clinical JJ B-adj.all	and CC 0	theoretical JJ B-noun.body	implications NNS I-noun.body	. . 0	. . 0
a12627929.s1	STUDY NNP B-noun.group	OBJECTIVE NNP I-noun.group	, , 0	To TO 0	evaluate VB B-verb.communication	the DT 0	frequency NN B-noun.person	of IN 0	venous_thromboembolism NN B-noun.artifact	( ( 0	VTE NNP 0	) ) 0	in IN 0	patients NNS B-noun.person	with IN 0	advanced JJ B-adj.all	androgen NN B-noun.person	- : 0	independent JJ B-adj.all	prostate_cancer NN B-noun.person	who WP 0	were VBD 0	treated VBN B-verb.change	with IN 0	docetaxel NN B-noun.artifact	alone RB B-adv.all	or CC 0	in IN 0	combination NN 0	with IN 0	thalidomide NN 0	. . 0	. . 0
a6634932.s2	Both DT 0	anti NNS B-noun.person	- : 0	arrhythmic JJ B-adj.all	efficacy NN B-noun.person	and CC 0	bioavailability NN B-noun.cognition	were VBD 0	compared VBN B-verb.change	to TO 0	oral JJ B-adj.all	drug NN B-noun.person	. . 0	. . 0
a10704919.s9	Hemolysis NN 0	caused VBN B-verb.communication	by IN 0	TAM NNP B-noun.person	was VBD B-verb.stative	not RB B-adv.all	preceded VBN B-verb.creation	by IN 0	the DT 0	leakage NN B-noun.state	of IN 0	_ : 0	K(+ LS 0	) ) 0	from IN 0	the DT 0	cells NNS B-noun.body	, , 0	also RB B-adv.all	excluding VBG B-verb.stative	a DT 0	colloid NN B-noun.person	- : 0	osmotic JJ B-adj.all	type NN B-noun.person	mechanism NN B-noun.artifact	of IN 0	hemolysis NN B-noun.food	, , 0	according VBG 0	to TO 0	the DT 0	effects NNS B-noun.phenomenon	on IN 0	osmotic JJ B-adj.all	fragility NN B-noun.phenomenon	curves NNS B-noun.artifact	. . 0	. . 0
a18261172.s7	Before IN 0	the DT 0	switch NN B-noun.time	, , 0	11.5 CD 0	% NN 0	of IN 0	patients NNS B-noun.person	had VBD B-verb.social	high JJ I-verb.social	- : 0	grade NN B-noun.attribute	proteinuria NN I-noun.attribute	( ( 0	> $ 0	1.0 CD 0	g RB 0	/ JJ 0	day NN 0	) ) 0	, , 0	this DT 0	increased VBN B-verb.change	to TO 0	22.9 CD 0	% NN 0	postswitch NN B-noun.attribute	( ( 0	p IN 0	= SYM 0	0.006 CD 0	) ) 0	. . 0	. . 0
a3629586.s4	A DT 0	nonregenerative JJ B-adj.all	anemia NN B-noun.state	was VBD B-verb.stative	the DT 0	most JJS 0	compromising NN 0	of IN 0	the DT 0	cytopenias NNS B-noun.artifact	and CC 0	occurred VBD B-verb.contact	in IN 0	approximately RB B-adv.all	50 CD B-adj.all	% NN 0	of IN 0	dogs NNS B-noun.animal	receiving VBG B-verb.competition	400 CD 0	- : 0	500 CD 0	mg PRP 0	/ ( 0	kg IN 0	cefonicid NN B-noun.possession	or CC 0	540 CD 0	- : 0	840 CD 0	mg FW 0	/ FW 0	kg FW 0	cefazedone NN 0	. . 0	. . 0
a10704919.s5	Despite IN 0	inducing VBG B-verb.creation	extensive JJ B-adj.all	erythrocyte NN B-noun.person	lysis NN B-noun.person	, , 0	TAM NNP 0	does VBZ 0	not RB B-adv.all	shift VB B-verb.motion	the DT 0	osmotic JJ B-adj.all	fragility NN B-noun.phenomenon	curves NNS B-noun.event	of IN 0	erythrocytes NNS B-noun.time	. . 0	. . 0
a12615818.s1	BACKGROUND NN 0	, , 0	Cyproterone_acetate JJ 0	combined VBN B-verb.change	with IN 0	ethinyl_estradiol NN 0	( ( 0	CPA NNP 0	/ ( 0	EE NNP 0	) ) 0	is VBZ 0	licensed VBN B-verb.contact	in IN 0	the DT 0	UK NNP 0	for IN 0	the DT 0	treatment NN B-noun.communication	of IN 0	women NNS B-noun.person	with IN 0	acne NN B-noun.person	and CC 0	hirsutism NN B-noun.artifact	and CC 0	is VBZ B-verb.stative	also RB B-adv.all	a DT 0	treatment NN B-noun.plant	option NN B-noun.person	for IN 0	polycystic_ovary_syndrome NN 0	( ( 0	PCOS NNS 0	) ) 0	. . 0	. . 0
a11897407.s9	The DT 0	high JJ B-adj.all	image NN B-noun.phenomenon	quality NN B-noun.phenomenon	suggests VBZ B-verb.communication	that IN 0	high JJ B-adj.all	contrast NN B-noun.phenomenon	images NNS B-noun.attribute	can MD 0	be VB 0	obtained VBN B-verb.possession	in IN 0	humans NNS B-noun.animal	and CC 0	the DT 0	96 CD 0	h DT 0	stability NN B-noun.attribute	makes VBZ B-verb.change	it PRP 0	an DT 0	ideal JJ B-adj.all	agent NN B-noun.person	to TO 0	detect VB B-verb.cognition	, , 0	in IN 0	patients NNS B-noun.person	, , 0	early JJ B-adj.all	cardiac_infarction NN B-noun.group	. . 0	. . 0
a1468485.s4	The DT 0	bleeding NN B-noun.person	ceased VBD B-verb.change	completely RB B-adv.all	by IN 0	the DT 0	end NN B-noun.time	of IN 0	treatment NN B-noun.plant	and CC 0	the DT 0	patient NN B-noun.person	remained VBD B-verb.body	free JJ B-noun.person	of IN 0	hematuria NN 0	thereafter RB 0	. . 0	. . 0
a12202650.s4	Short JJ B-noun.body	- : 0	latency NN B-adv.all	reflex JJ B-adj.all	responses NNS B-noun.act	were VBD 0	evoked VBN B-verb.emotion	in IN 0	the DT 0	masseter NN B-noun.person	and CC 0	temporalis NN B-noun.body	muscles NNS B-noun.body	by IN 0	a DT 0	stretch JJ B-adj.all	device NN B-noun.person	with IN 0	different JJ B-adj.all	velocities NNS B-noun.artifact	and CC 0	displacements NNS B-noun.person	before RB 0	, , 0	during IN 0	, , 0	and CC 0	after IN 0	the DT 0	pain NN B-noun.cognition	. . 0	. . 0
a7269015.s1	A DT 0	case NN B-noun.state	of IN 0	a DT 0	busulfan NN B-noun.person	- : 0	induced VBN B-verb.creation	hemorrhage_cystitis NNP 0	is VBZ 0	reported VBN B-verb.communication	. . 0	. . 0
a20470218.s5	During IN 0	a DT 0	9-year JJ 0	period NN B-noun.person	, , 0	we PRP 0	retrospectively RB B-adv.all	collected VBD B-verb.possession	27 CD B-adj.all	neurological JJ B-adj.all	events NNS B-noun.cognition	( ( 0	11 CD B-noun.quantity	% NN 0	) ) 0	in IN 0	as RB 0	many JJ 0	patients NNS B-noun.person	, , 0	from IN 0	253 CD 0	children NNS B-noun.person	enrolled VBN B-verb.social	in IN 0	the DT 0	ALL NNP 0	front JJ 0	- : 0	line NN B-noun.communication	protocol NN B-noun.person	. . 0	. . 0
a20698227.s1	BACKGROUND NN 0	/ POS 0	AIMS NNPS B-noun.cognition	, , 0	Recently RB B-adv.all	ribavirin VBP B-verb.possession	has VBZ 0	been VBN 0	found VBN B-verb.cognition	to TO 0	inhibit VB B-verb.body	angiogenesis NN I-verb.body	and CC 0	a DT 0	number NN B-noun.quantity	of IN 0	angiogenesis NN 0	inhibitors NNS 0	such JJ 0	as IN 0	sunitinib NN B-noun.person	and CC 0	sorafenib NN B-noun.person	have VBP 0	been VBN 0	found VBN B-verb.cognition	to TO 0	cause VB B-verb.creation	acute JJ B-adj.all	hemolysis NN B-noun.cognition	. . 0	. . 0
a3125768.s7	In IN 0	five CD B-adj.all	rats NNS B-noun.time	that WDT 0	did VBD 0	not RB B-adv.all	become VB B-verb.stative	rigid JJ B-adj.all	, , 0	ICP NNP B-noun.group	and CC 0	CVP NNP B-noun.group	did VBD 0	not RB B-adv.all	change VB B-verb.change	following VBG 0	alfentanil RB B-adv.all	. . 0	. . 0
a6287825.s7	Isoniazid NNP B-noun.person	was VBD B-verb.stative	the DT 0	most RBS 0	frequent JJ B-adj.all	agent NN B-noun.person	in IN 0	drug NN B-noun.person	- : 0	induced VBN B-verb.creation	neuropathy JJ B-adj.all	. . 0	. . 0
a1987816.s3	Patients NNS B-noun.person	were VBD 0	admitted VBN B-verb.perception	to TO 0	the DT 0	hospital NN B-noun.artifact	for IN 0	measurement NN B-noun.attribute	of IN 0	lithium NN B-noun.phenomenon	level NN B-noun.attribute	, , 0	creatinine JJ B-adj.all	clearance NN B-noun.attribute	, , 0	urine NN 0	volume NN B-noun.artifact	, , 0	and CC 0	maximum JJ B-adj.all	osmolality NN B-noun.cognition	. . 0	. . 0
a17175308.s21	The DT 0	possibility NN B-noun.state	of IN 0	de FW 0	novo FW 0	glomerular JJ B-adj.all	pathology NN B-noun.artifact	under IN 0	SRL NNP 0	treatment NN B-noun.communication	requires VBZ B-verb.stative	further JJ B-adj.all	investigation NN B-noun.act	by IN 0	renal JJ B-adj.all	biopsy NN B-noun.cognition	. . 0	. . 0
a12907309.s5	Moreover RB B-adv.all	, , 0	it PRP 0	transiently RB B-adv.all	diminished VBD B-verb.change	the DT 0	methamphetamine NN B-noun.attribute	( ( 0	10 CD 0	mg PRP 0	/ ( 0	kg IN 0	sc)-induced JJ B-adj.all	hyperthermia NN B-noun.person	and CC 0	reduced VBN B-verb.change	basal NN B-adj.all	body NN B-noun.object	temperature NN B-noun.attribute	. . 0	. . 0
a20698227.s3	METHODS NNS B-noun.attribute	, , 0	Fourteen VBN B-verb.cognition	patients NNS B-noun.person	chronically_infected_with_hepatitis_C_virus WDT 0	were VBD 0	treated VBN B-verb.change	by IN 0	pegylated_interferon_alpha_2a NNP B-noun.person	and CC 0	ribavirin NN B-noun.body	. . 0	. . 0
a16160878.s3	injection NN B-noun.act	of IN 0	U NNP 0	- : 0	II NNP 0	causes VBZ B-verb.communication	hypertension NN B-noun.attribute	and CC 0	bradycardia NNS B-noun.person	and CC 0	stimulates VBZ B-verb.communication	prolactin NN B-noun.attribute	and CC 0	thyrotropin NN B-noun.body	secretion NN B-noun.act	. . 0	. . 0
a12202650.s3	Capsaicin NNP B-noun.person	( ( 0	10 CD B-adj.all	micro JJ B-adj.all	g NN 0	) ) 0	was VBD 0	injected VBN B-verb.change	into IN 0	the DT 0	masseter NN B-noun.attribute	muscle NN I-noun.attribute	to TO 0	induce VB B-verb.cognition	pain NN B-noun.person	in IN 0	11 CD B-adj.all	healthy JJ B-adj.all	volunteers NNS B-noun.person	. . 0	. . 0
a1436384.s6	The DT 0	protective JJ B-adj.all	effect NN B-noun.cognition	of IN 0	LY274614 NN B-noun.location	was VBD B-verb.stative	dose JJ B-adj.all	- : 0	dependent JJ B-adj.all	, , 0	being VBG B-verb.stative	maximum NN B-noun.person	at IN 0	10 CD B-adj.all	- : 0	40 CD B-adj.all	mgkg NN B-noun.quantity	( ( 0	i.p FW 0	. . 0	) ) 0	. . 0	. . 0
a16181582.s3	It PRP 0	is VBZ B-verb.stative	usually RB B-adv.all	but CC 0	not RB B-adv.all	necessarily RB B-adv.all	associated VBN B-verb.cognition	with IN 0	hyperammonemia NN B-noun.person	. . 0	. . 0
a7453952.s5	After IN 0	3 CD B-adj.all	days NNS B-noun.time	of IN 0	combined VBN B-verb.change	treatment NN I-verb.change	, , 0	a DT 0	marked JJ B-adj.all	elevation NN B-noun.person	in IN 0	plasma NN B-noun.substance	and CC 0	tissue NN B-noun.body	lithium NN B-noun.body	levels NNS B-noun.attribute	accompanied VBD B-verb.stative	a DT 0	reduction NN B-noun.act	in IN 0	water NN 0	intake NN 0	. . 0	. . 0
a2008831.s7	These DT 0	results NNS B-noun.communication	suggest VBP B-verb.communication	that IN 0	spasm NN B-noun.phenomenon	provocation NN I-noun.phenomenon	tests NNS B-noun.person	, , 0	which WDT 0	use VBP B-verb.consumption	an DT 0	intracoronary JJ B-adj.all	injection NN B-noun.act	of IN 0	a DT 0	relatively RB B-adv.all	low JJ B-adj.all	dose NN B-noun.quantity	of IN 0	methylergonovine NN B-noun.attribute	, , 0	have VBP 0	a DT 0	high JJ B-adj.all	sensitivity NN B-noun.feeling	in IN 0	variant_angina NNP B-noun.other	and CC 0	the DT 0	vasoreactivity NN B-noun.attribute	of IN 0	the DT 0	right JJ B-noun.body	coronary JJ I-noun.body	artery NN B-noun.group	may MD 0	be VB B-verb.stative	greater JJR B-adj.all	than IN 0	that DT 0	of IN 0	the DT 0	other JJ 0	coronary JJ B-adj.all	arteries NNS B-noun.group	. . 0	. . 0
a17042910.s13	3 LS 0	. . 0	. . 0
a19300402.s7	CONCLUSIONS NNS B-noun.artifact	, , 0	Results NNS B-noun.location	of IN 0	these DT 0	studies NNS B-noun.act	suggest VBP B-verb.communication	that IN 0	B1 : 0	and CC 0	B2 JJ B-adj.all	receptors NNS B-noun.person	are VBP 0	engaged VBN B-verb.cognition	in IN 0	transmission NN 0	of IN 0	nociceptive JJ B-adj.all	stimuli NNS B-noun.person	in IN 0	both DT 0	diabetic_and_toxic_neuropathy NNP B-noun.person	. . 0	. . 0
a15957009.s8	respectively RB B-adv.all	) ) 0	reversed VBD B-verb.stative	memory_deficits NNS B-noun.person	induced VBN B-verb.creation	by IN 0	scopolamine NN B-noun.person	and CC 0	TRP NNP 0	depletion NN 0	( ( 0	10 CD B-adj.all	mg FW B-noun.quantity	/ FW 0	kg FW 0	, , 0	i.p NNP B-noun.person	. . 0	, , 0	. . 0
a6287825.s5	Peripheral_neuropathy JJ 0	due JJ 0	to TO 0	nutritional_deficiency NN B-noun.quantity	of IN 0	thiamine NN 0	and CC 0	riboflavin NN B-noun.body	was VBD B-verb.stative	common JJ B-noun.person	( ( 0	10.1 CD 0	% NN 0	) ) 0	and CC 0	presented VBN B-verb.communication	mainly RB B-adv.all	as IN 0	sensory JJ B-noun.person	and CC 0	sensori NNS B-noun.person	- : 0	motor_neuropathy JJ 0	. . 0	. . 0
a16160878.s11	These DT 0	data NNS B-noun.cognition	suggest VBP B-verb.communication	that IN 0	U SYM 0	- : 0	II NNP 0	may MD 0	be VB 0	involved VBN B-verb.stative	in IN 0	some DT 0	aspects NNS B-noun.attribute	of IN 0	psychiatric_disorders NNS B-noun.person	. . 0	. . 0
a16298782.s7	L SYM 0	- : 0	NAME NN B-noun.group	reduced_gentamicin NN B-noun.group	- : 0	induced_hearing_loss NN 0	in IN 0	the DT 0	high JJ B-noun.group	- : 0	frequency NN B-noun.quantity	range NN B-noun.location	, , 0	but CC 0	gave VBD B-verb.possession	no DT 0	protection NN B-noun.person	in IN 0	the DT 0	middle NN B-noun.time	or CC 0	low JJ B-adj.all	frequencies NNS B-noun.person	. . 0	. . 0
a2096243.s3	Brain NNP B-noun.person	CT NNP I-noun.person	revealed VBD B-verb.communication	a DT 0	periventricular JJ B-adj.all	low JJ B-adj.all	density NN B-noun.phenomenon	area NN B-noun.attribute	in IN 0	the DT 0	frontal JJ B-adj.all	white JJ B-adj.all	matter NN B-noun.cognition	and CC 0	moderate JJ B-adj.all	dilatation NN B-noun.cognition	of IN 0	the DT 0	lateral JJ B-noun.body	ventricles NNS I-noun.body	especially RB B-adv.all	at IN 0	the DT 0	bilateral JJ B-adj.all	anterior JJ B-adj.all	horns NNS B-noun.animal	. . 0	. . 0
a1732369.s4	Graded VBN B-verb.contact	dobutamine NN 0	infusions NNS 0	of IN 0	0.5 CD 0	, , 0	2.5 CD 0	, , 0	5 CD B-adj.all	and CC 0	10 CD B-adj.all	micrograms NNS B-noun.quantity	/ : 0	kg PRP 0	per IN 0	min NN B-noun.animal	were VBD 0	administered VBN B-verb.perception	. . 0	. . 0
a2070391.s0	Reduction NN B-noun.person	in IN 0	injection NN B-noun.act	pain NN B-noun.person	using VBG B-verb.consumption	buffered VBN B-verb.change	lidocaine NN 0	as IN 0	a DT 0	local JJ B-adj.all	anesthetic JJ B-adj.all	before IN 0	cardiac JJ 0	catheterization NN 0	. . 0	. . 0
a17466854.s4	At IN 0	the DT 0	end NN B-noun.time	of IN 0	the DT 0	procedure NN B-noun.act	, , 0	Group NNP B-noun.person	A NNP 0	( ( 0	n UH 0	= $ 0	20 CD B-adj.all	) ) 0	had VBD B-verb.stative	20 CD B-adj.all	mg/0.5 CD B-adj.all	mL CD B-noun.quantity	of IN 0	methylprednisolone NN B-noun.attribute	and CC 0	10 CD B-adj.all	mg/0.5 CD B-adj.all	mL CD B-noun.quantity	of IN 0	gentamicin NN B-noun.communication	injected VBN B-verb.change	into IN 0	the DT 0	posterior JJ B-adj.all	sub NN B-noun.person	- : 0	Tenon NNP B-noun.person	's POS 0	space NN B-noun.location	and CC 0	Group NNP B-noun.group	B NNP B-noun.group	( ( 0	n UH 0	= $ 0	20 CD B-adj.all	) ) 0	had VBD 0	the DT 0	same JJ B-adj.all	combination NN B-noun.person	injected VBN B-verb.change	into IN 0	the DT 0	anterior JJ B-adj.all	sub NN B-noun.person	- : 0	Tenon NNP B-noun.person	's POS 0	space NN B-noun.location	. . 0	. . 0
a1130930.s0	Nephrotoxicity NN B-noun.person	of IN 0	combined JJ B-adj.all	cephalothin NN B-noun.person	- : 0	gentamicin NN B-noun.person	regimen NNS B-noun.person	. . 0	. . 0
a11027905.s4	Pain NNP B-noun.person	intensity NN I-noun.person	on IN 0	a DT 0	0 CD B-noun.quantity	to TO 0	10 CD B-adj.all	numerical JJ B-noun.quantity	scale NN B-noun.relation	, , 0	nausea NN B-noun.person	and CC 0	vomiting NN B-noun.act	, , 0	drowsiness NN B-noun.person	, , 0	confusion NN B-noun.cognition	, , 0	and CC 0	dry_mouth NNP B-noun.person	, , 0	using VBG B-verb.consumption	a DT 0	scale NN B-noun.event	from IN 0	0 CD B-noun.quantity	to TO 0	3 CD 0	( ( 0	not RB B-adv.all	at IN 0	all DT 0	, , 0	slight JJ B-adj.all	, , 0	a DT B-adv.all	lot NN I-adv.all	, , 0	awful JJ B-adj.all	) ) 0	, , 0	Mini NNP B-noun.person	- : 0	Mental NNP B-noun.other	State NNP I-noun.other	Examination NNP I-noun.other	( ( 0	MMSE NNP 0	) ) 0	( ( 0	0 CD B-noun.quantity	- : 0	30 CD B-adj.all	) ) 0	, , 0	and CC 0	arterial JJ B-adj.all	pressure NN B-noun.person	were VBD 0	recorded VBN B-verb.communication	before IN 0	administration NN B-noun.time	of IN 0	drugs NNS B-noun.animal	( ( 0	T0 NN 0	) ) 0	and CC 0	after IN 0	30 CD B-adj.all	minutes NNS B-noun.time	( ( 0	T30 NN 0	) ) 0	, , 0	60 CD B-adj.all	minutes NNS B-noun.time	( ( 0	T60 NN 0	) ) 0	, , 0	120 CD 0	minutes NNS B-noun.time	( ( 0	T120 NN 0	) ) 0	, , 0	and CC 0	180 CD 0	minutes NNS B-noun.time	( ( 0	T180 NN 0	) ) 0	. . 0	. . 0
a20621845.s3	After IN 0	12weeks NNS B-noun.time	, , 0	animals NNS B-noun.person	were VBD 0	euthanized VBN B-verb.change	, , 0	and CC 0	CaCl(2)-treated VBN B-verb.communication	, , 0	CaCl(2)-untreated VBD B-verb.stative	( ( 0	n=12 NN 0	) ) 0	and CC 0	NaCl NNP B-noun.person	- : 0	treated VBN B-verb.body	aortic JJ B-adj.all	segments NNS B-noun.person	( ( 0	n=12 NN 0	) ) 0	were VBD 0	collected VBN B-verb.contact	for IN 0	histological JJ B-adj.all	and CC 0	molecular JJ B-adj.all	assessments NNS B-noun.person	. . 0	. . 0
a3629586.s1	Cephalosporin NN B-noun.person	antibiotics NNS I-noun.person	cause VBP B-verb.communication	a DT 0	variety NN B-noun.cognition	of IN 0	hematologic_disturbances NNS B-noun.location	in IN 0	man NN B-noun.animal	, , 0	the DT 0	pathogeneses NNS B-noun.artifact	and CC 0	hematopathology NN B-noun.attribute	of IN 0	which WDT 0	remain VBP B-verb.stative	poorly RB B-adv.all	characterized VBN B-verb.communication	. . 0	. . 0
a2887062.s6	At IN 0	6 CD B-adj.all	h NN 0	after IN 0	injection NN B-noun.time	, , 0	serum NN B-noun.body	prolactin NN B-adj.all	levels NNS B-noun.state	were VBD B-verb.stative	still RB B-adv.all	considerably RB B-adv.all	lower JJR B-adj.all	than IN 0	in IN 0	controls NNS B-noun.artifact	. . 0	. . 0
a15278670.s10	Apamin NNP B-noun.person	, , 0	a DT 0	selective JJ B-adj.all	blocker NN B-noun.person	of IN 0	calcium NN B-noun.person	- : 0	dependent JJ B-adj.all	potassium NN B-noun.artifact	channels NNS B-noun.artifact	, , 0	was VBD 0	administered VBN B-verb.possession	intracerebroventricularly RB B-adv.all	in IN 0	rats NNS B-noun.animal	anesthetized VBN B-verb.communication	with IN 0	0.8 CD 0	% NN 0	sevoflurane NN 0	to TO 0	investigate VB B-verb.communication	the DT 0	mechanism NN B-noun.attribute	of IN 0	the DT 0	anticonvulsive JJ B-adj.all	effects NNS B-noun.phenomenon	. . 0	. . 0
a17466854.s5	Postoperatively RB B-adj.all	, , 0	all DT 0	patients NNS B-noun.person	were VBD 0	assessed VBN B-verb.social	for IN 0	symptoms NNS B-noun.relation	of IN 0	nausea,_vomiting VBG B-verb.cognition	, , 0	and CC 0	headache NN B-noun.state	. . 0	. . 0
a14698717.s3	This DT 0	case NN B-noun.state	suggests VBZ B-verb.communication	that IN 0	the DT 0	psychotic_symptoms NNS B-noun.plant	that WDT 0	occur VBP 0	following VBG 0	phenytoin NN B-noun.communication	treatment NN B-noun.communication	in IN 0	some DT 0	epileptic JJ B-adj.all	patients NNS B-noun.person	may MD 0	be VB B-verb.stative	the DT 0	direct JJ B-adj.all	result NN 0	of IN 0	medication NN B-noun.person	, , 0	unrelated JJ B-adj.all	to TO 0	seizures NNS B-noun.act	. . 0	. . 0
a16330766.s4	The DT 0	aim NN 0	of IN 0	this DT 0	study NN B-noun.artifact	was VBD 0	to TO 0	assess VB B-verb.cognition	the DT 0	effects NNS B-noun.phenomenon	of IN 0	gabapentin NN B-noun.food	, , 0	a DT 0	drug NN B-noun.person	effective JJ B-adj.all	in IN 0	neuropathic_pain JJ B-adj.all	patients NNS B-noun.person	, , 0	on IN 0	brain NN B-noun.artifact	processing NN B-noun.act	of IN 0	nociceptive JJ B-adj.all	information NN B-noun.cognition	in IN 0	normal JJ B-adj.all	and CC 0	central JJ B-noun.body	sensitization NN I-noun.body	states NNS B-noun.location	. . 0	. . 0
a3676049.s1	Cerebral JJ B-adj.all	blood NN B-noun.attribute	flow NN B-noun.process	and CC 0	cerebral JJ B-adj.all	metabolic JJ B-adj.all	rate NN B-noun.time	for IN 0	oxygen NN B-noun.person	were VBD 0	measured VBN B-verb.cognition	during IN 0	isoflurane NN B-noun.person	- : 0	induced VBN B-verb.creation	hypotension NN 0	in IN 0	10 CD B-adj.all	patients NNS B-noun.person	subjected VBD B-verb.social	to TO 0	craniotomy VB B-verb.motion	for IN 0	clipping NN B-noun.act	of IN 0	a DT 0	cerebral_aneurysm NN B-noun.artifact	. . 0	. . 0
a9334596.s17	These DT 0	data NNS B-noun.cognition	are VBP B-verb.stative	lower JJR B-adj.all	than IN 0	those DT 0	we PRP 0	found VBD B-verb.cognition	during IN 0	the DT 0	last JJ B-noun.communication	2 CD B-adj.all	decades NNS B-noun.time	( ( 0	overall JJ 0	prolactin NN 0	greater JJR B-adj.all	than IN 0	20 CD B-adj.all	ng./ml NNP B-noun.person	. . 0	. . 0
a10807237.s8	The DT 0	majority NN B-noun.quantity	of IN 0	these DT 0	aneurysms NNS B-noun.cognition	were VBD B-verb.stative	smaller JJR B-adj.all	than IN 0	those DT 0	of IN 0	the DT 0	control NN B-noun.location	group NN 0	( ( 0	8 CD B-adj.all	+ SYM 0	/- $ 0	6.08 CD 0	mm DT B-noun.quantity	versus NN B-noun.communication	11 CD B-noun.quantity	+ . 0	/- $ 0	5.4 CD 0	mm NN B-noun.quantity	, , 0	P NNP 0	= SYM 0	0.05 CD 0	) ) 0	. . 0	. . 0
a6634932.s0	Sublingual JJ B-adj.all	absorption NN B-noun.act	of IN 0	the DT 0	quaternary_ammonium JJ B-adj.all	antiarrhythmic JJ B-adj.all	agent NN B-noun.person	, , 0	UM-272 NN 0	. . 0	. . 0
a11569530.s12	These DT 0	data NNS B-noun.cognition	underline VBP B-verb.stative	the DT 0	need NN 0	to TO 0	maximize VB B-verb.change	the DT 0	therapeutic JJ B-adj.pert	ratio NN B-noun.person	with IN 0	respect NN B-noun.act	to TO 0	TDP NNP 0	in IN 0	potential JJ B-adj.all	development NN B-noun.process	candidates NNS B-noun.person	and CC 0	the DT 0	importance NN B-noun.state	of IN 0	using VBG B-verb.consumption	free JJ B-adj.all	drug NN B-noun.act	concentrations NNS I-noun.act	in IN 0	pharmacokinetic JJ B-adj.all	/ CC 0	pharmacodynamic JJ B-noun.body	studies NNS I-noun.body	. . 0	. . 0
a16298782.s6	Its PRP$ 0	effect NN B-noun.phenomenon	was VBD 0	determined VBN B-verb.communication	in IN 0	terms NNS B-noun.communication	of IN 0	attenuation NN B-noun.act	of_hearing_loss RB 0	, , 0	measured VBN B-verb.cognition	by IN 0	shifts NNS B-noun.act	in IN 0	the DT 0	auditory JJ B-adj.all	brainstem NN B-noun.communication	response NN B-noun.communication	threshold NN B-noun.artifact	. . 0	. . 0
a2670794.s8	Captopril NNP B-noun.person	may MD 0	, , 0	by IN 0	the DT 0	same JJ B-adj.all	mechanism NN B-noun.object	, , 0	reduce VB B-verb.change	the DT 0	increase NN B-noun.event	in IN 0	glomerular JJ B-adj.all	filtration NN B-noun.communication	that WDT 0	is VBZ 0	known VBN B-verb.cognition	to TO 0	occur VB B-verb.cognition	after IN 0	an DT 0	injection NN B-noun.act	of IN 0	thrombin NN B-noun.communication	, , 0	thereby RB 0	diminishing VBG B-verb.change	the DT 0	aggregation NN B-noun.time	of IN 0	fibrin NN B-noun.plant	monomers NNS B-noun.person	in IN 0	the DT 0	glomeruli NNS B-noun.person	, , 0	with IN 0	the DT 0	result NN B-noun.communication	that IN 0	less JJR B-adj.all	fibrin NN B-noun.act	will MD 0	be VB 0	deposited VBN B-verb.creation	and CC 0	thus RB B-adv.all	less JJR B-noun.quantity	kidney_damage NN B-noun.act	will MD 0	be VB 0	produced VBN B-verb.creation	. . 0	. . 0
a12483326.s8	Various JJ B-adj.all	ocular JJ B-adj.all	symptoms NNS B-noun.body	and CC 0	findings NNS B-noun.act	caused VBN B-verb.creation	by IN 0	carboplatin NN B-noun.substance	toxicity NN B-noun.state	were VBD 0	seen VBN B-verb.perception	. . 0	. . 0
a12090760.s2	Although IN 0	interleukin JJ B-adj.all	3 CD B-adj.all	( ( 0	IL-3 NN 0	) ) 0	and CC 0	erythropoietin NN B-noun.person	( ( 0	EPO NNP 0	) ) 0	are VBP 0	known VBN B-verb.cognition	to TO 0	act VB B-verb.social	synergistically RB B-adv.all	on IN 0	hematopoietic JJ B-adj.all	cell NN B-noun.body	proliferation NN 0	in IN 0	vitro NN B-noun.animal	, , 0	injection NN B-noun.act	of IN 0	IGF NNP B-noun.group	- : 0	IL-3 NN B-noun.other	and CC 0	EPO NNP B-noun.group	in IN 0	AZT NNP 0	- : 0	treated VBD B-verb.communication	mice NNS B-noun.person	resulted VBD B-verb.communication	in IN 0	a DT 0	reduction NN B-noun.act	of IN 0	red JJ B-noun.body	cells NNS I-noun.body	and CC 0	an DT 0	increase NN B-noun.event	of IN 0	plasma NN B-noun.substance	EPO NNP 0	levels NNS B-noun.attribute	as IN 0	compared VBN 0	to TO 0	animals NNS B-noun.person	treated VBN B-verb.social	with IN 0	IGF NNP B-noun.group	- : 0	IL-3 NN B-noun.other	or CC 0	EPO NNP 0	alone RB 0	. . 0	. . 0
a12820454.s11	The DT 0	development NN B-noun.process	of IN 0	severe JJ B-adj.all	anemia NN B-noun.state	at IN 0	6 CD B-adj.all	months NNS B-noun.person	post RB B-adv.all	- : 0	CAB NN B-noun.group	was VBD B-verb.stative	predictable JJ B-adj.all	by IN 0	the DT 0	reduction NN B-noun.act	of IN 0	Hb NNP 0	baseline NN 0	value NN B-noun.attribute	of IN 0	more JJR B-noun.quantity	than IN 0	2.5 CD 0	g FW 0	/ FW 0	dl FW 0	after IN 0	3 CD B-adj.all	months NNS B-noun.quantity	of IN 0	CAB NNP B-noun.group	( ( 0	p IN 0	= SYM 0	0.01 CD 0	) ) 0	. . 0	. . 0
a7444978.s0	Age SYM 0	- : 0	dependent JJ B-adj.all	sensitivity NN B-noun.feeling	of IN 0	the DT 0	rat NN 0	to TO 0	neurotoxic JJ B-adj.all	effects NNS B-noun.phenomenon	of IN 0	streptomycin NN B-noun.communication	. . 0	. . 0
a16330766.s2	Secondary_hyperalgesia JJ B-adj.all	shares NNS B-noun.phenomenon	clinical JJ B-adj.all	characteristics NNS B-noun.person	with IN 0	neurogenic_hyperalgesia NN B-noun.person	in IN 0	patients NNS B-noun.person	with IN 0	neuropathic_pain NN B-noun.person	. . 0	. . 0
a3676049.s6	After IN 0	the DT 0	clipping NN B-noun.act	of IN 0	the DT 0	aneurysm NN 0	the DT 0	isoflurane NN B-noun.phenomenon	concentration NN B-noun.event	was VBD 0	reduced VBN B-verb.change	to TO 0	0.75 CD 0	% NN 0	. . 0	. . 0
a9523805.s7	Details NNS B-noun.cognition	of IN 0	spinal JJ B-adj.all	puncture NN B-noun.act	, , 0	extension NN B-noun.act	and CC 0	regression NN B-noun.act	of IN 0	spinal JJ B-adj.all	block NN B-noun.location	, , 0	and CC 0	the DT 0	times NNS B-noun.event	to TO 0	reach VB B-verb.stative	discharge NN B-noun.person	criteria NNS I-noun.person	were VBD 0	noted VBN B-verb.perception	. . 0	. . 0
a7248170.s2	At IN 0	this DT 0	point NN B-noun.communication	it PRP 0	was VBD 0	assumed VBN B-verb.cognition	that IN 0	the DT 0	cytochrome NN 0	P450/CCl4 JJ 0	toxic JJ B-adj.all	state NN B-noun.state	was VBD B-verb.stative	both DT 0	maximal JJ B-adj.all	and CC 0	stable JJ B-adj.all	. . 0	. . 0
a11569530.s0	Pharmacokinetic JJ B-adj.all	/ CC 0	pharmacodynamic JJ B-adj.all	assessment NN B-noun.act	of IN 0	the DT 0	effects NNS B-noun.phenomenon	of IN 0	E4031 NNP B-noun.person	, , 0	cisapride NN 0	, , 0	terfenadine NN B-noun.person	and CC 0	terodiline NN B-noun.person	on IN 0	monophasic JJ B-adj.all	action NN B-noun.state	potential JJ B-adj.all	duration NN B-noun.act	in IN 0	dog NN B-noun.animal	. . 0	. . 0
a230316.s7	In IN 0	the DT 0	remaining VBG B-adj.all	cases NNS B-noun.state	, , 0	a DT 0	combination NN B-noun.event	of IN 0	myelopathy JJ B-adj.all	, , 0	visual_disturbance NN B-noun.location	, , 0	and CC 0	peripheral_neuropathy JJ B-noun.person	was VBD B-verb.stative	the DT 0	most RBS 0	common JJ B-noun.person	manifestation NN I-noun.phenomenon	. . 0	. . 0
a8073369.s12	In IN 0	summary NN B-noun.time	, , 0	the DT 0	chick JJ B-adj.all	embryo NN B-noun.person	provides VBZ B-verb.communication	a DT 0	reliable JJ B-adj.all	and CC 0	simple JJ B-adj.all	experimental JJ B-adj.all	animal NN 0	model NN 0	of IN 0	coniine NN B-noun.act	- : 0	induced VBN B-verb.creation	arthrogryposis NN B-noun.artifact	. . 0	. . 0
a2894766.s3	It PRP 0	is VBZ 0	suggested VBN B-verb.communication	that IN 0	the DT 0	patient NN B-noun.person	had VBD 0	sulfasalazine NN B-noun.person	- : 0	induced VBN B-verb.communication	lupus NN B-noun.person	, , 0	which WDT 0	manifested VBD B-verb.stative	with IN 0	serositis NN B-noun.body	and CC 0	pulmonary JJ B-adj.all	parenchymal JJ B-adj.all	involvement NN B-noun.person	in IN 0	the DT 0	absence NN B-noun.act	of IN 0	joint JJ B-adj.all	symptoms NNS B-noun.communication	. . 0	. . 0
a9523805.s9	RESULTS NNS B-noun.artifact	, , 0	Nine CD 0	of IN 0	30 CD B-adj.all	patients NNS B-noun.person	receiving VBG B-verb.communication	lidocaine NN B-noun.person	experienced VBD B-verb.communication	TNSs NNP B-noun.person	, , 0	1 CD 0	of IN 0	30 CD B-adj.all	patients NNS B-noun.person	receiving VBG B-verb.communication	prilocaine NN B-noun.person	( ( 0	P RB 0	= JJ 0	0.03 CD 0	) ) 0	had VBD 0	them PRP 0	, , 0	and CC 0	none NN 0	of IN 0	30 CD B-adj.all	patients NNS B-noun.person	receiving VBG B-verb.communication	bupivacaine NN B-noun.person	had VBD 0	TNSs NNP B-noun.person	. . 0	. . 0
a26094.s4	This DT 0	was VBD 0	accounted VBN B-verb.social	for IN 0	by IN 0	a DT 0	significant JJ B-adj.all	number NN B-noun.attribute	of IN 0	depressions NNS B-noun.state	occurring VBG B-verb.stative	in IN 0	methyl_dopa NN 0	treated VBN B-verb.communication	patients NNS B-noun.person	with IN 0	psychiatric JJ B-adj.all	histories NNS B-noun.cognition	. . 0	. . 0
a17175308.s17	Mean JJ B-adj.all	urinary JJ B-adj.all	protein NN B-noun.person	of IN 0	patients NNS B-noun.person	who WP 0	returned VBD B-verb.social	to TO 0	dialysis NN B-noun.person	was VBD B-verb.stative	1.26 CD 0	( ( 0	0.5 CD 0	to TO 0	3.5 CD 0	) ) 0	g PRP 0	/ : 0	d PRP 0	before RB 0	and CC 0	4.7 CD 0	( ( 0	3 CD 0	to TO 0	12 CD 0	) ) 0	g FW 0	/ FW 0	d FW 0	after IN 0	conversion NN B-noun.cognition	( ( 0	P UH 0	= : 0	.01 LS 0	) ) 0	. . 0	. . 0
a15458908.s10	LEVEL NN B-noun.group	OF IN 0	EVIDENCE NN B-noun.attribute	, , 0	I PRP 0	. . 0
a16680561.s10	CONCLUSION NN B-noun.group	, , 0	This DT 0	study NN B-noun.communication	demonstrates VBZ B-verb.communication	that IN 0	cinacalcet NN B-noun.person	is VBZ B-verb.stative	a DT 0	strong JJ B-adj.all	inhibitor NN B-noun.person	of IN 0	CYP2D6 NNP B-noun.person	. . 0	. . 0
a2611118.s3	The DT 0	patient NN B-noun.person	described VBD B-verb.communication	developed VBN B-verb.creation	chronic_active_hepatitis NNP 0	after IN 0	six CD B-adj.all	months NNS B-noun.person	therapy RB 0	with IN 0	diclofenac_sodium NN B-noun.artifact	which WDT 0	progressed VBD B-verb.cognition	despite IN 0	the DT 0	withdrawal NN B-noun.act	of IN 0	the DT 0	drug NN B-noun.artifact	, , 0	a DT 0	finding VBG 0	not RB B-adv.all	previously RB B-adv.all	reported VBN B-verb.communication	. . 0	. . 0
a9293063.s3	If IN 0	the DT 0	patient NN B-noun.person	develops VBZ B-verb.body	a DT 0	liver_mass NN B-noun.time	, , 0	because IN 0	of IN 0	non NN B-noun.person	- : 0	specific JJ B-adj.all	clinical JJ B-adj.all	features NNS B-noun.body	and CC 0	imaging NN B-verb.creation	appearances NNS I-verb.creation	, , 0	biopsy NN B-noun.cognition	may MD 0	be VB B-verb.stative	the DT 0	only JJ B-adj.all	way NN 0	to TO 0	achieve VB B-verb.social	a DT 0	definitive JJ B-adj.all	diagnosis NN B-noun.person	. . 0	. . 0
a3629586.s7	This DT 0	observation NN B-noun.communication	, , 0	along IN 0	with IN 0	the DT 0	rapid JJ B-adj.all	rate NN B-noun.time	of IN 0	decline NN B-noun.state	in IN 0	red JJ B-adj.all	cell NN B-noun.body	mass NN I-noun.body	parameters NNS B-noun.event	of IN 0	affected JJ B-adj.all	dogs NNS B-noun.artifact	, , 0	suggests VBZ B-verb.communication	that IN 0	a DT 0	hemolytic JJ B-adj.all	component NN B-noun.artifact	complicated VBD B-verb.change	the DT 0	red JJ B-adj.all	cell NN B-noun.body	production NN B-noun.communication	problem NN B-noun.communication	and CC 0	that IN 0	multiple JJ B-adj.all	toxicologic NN B-noun.plant	mechanisms NNS B-noun.person	contributed VBD B-verb.communication	to TO 0	the DT 0	cytopenia NN B-noun.state	. . 0	. . 0
a17242861.s2	Chromosome NNP 0	substitution NN 0	strains NNS B-noun.communication	( ( 0	CSS NNP 0	) ) 0	, , 0	in IN 0	which WDT 0	a DT 0	single JJ B-adj.all	chromosome NN B-noun.communication	from IN 0	one CD 0	inbred JJ B-adj.all	strain NN B-noun.person	( ( 0	donor NN 0	) ) 0	has VBZ 0	been VBN 0	transferred VBN B-verb.contact	onto IN 0	a DT 0	second JJ B-adj.all	strain NN B-noun.communication	( ( 0	host NN B-noun.animal	) ) 0	by IN 0	repeated JJ B-adj.all	backcrossing NN B-noun.act	, , 0	may MD 0	be VB 0	used VBN B-verb.consumption	to TO 0	identify VB B-verb.cognition	quantitative JJ B-adj.all	trait NN B-noun.communication	loci NN B-noun.communication	( ( 0	QTLs NNP B-noun.person	) ) 0	that WDT 0	contribute VBP 0	to TO 0	seizure VB B-verb.change	susceptibility NN I-verb.change	. . 0	. . 0
a11166519.s6	EEG NNP 0	recordings NNS B-noun.artifact	were VBD 0	made VBN B-verb.social	in IN 0	SJL NNP 0	, , 0	A DT 0	/ JJ 0	J NNP 0	and CC 0	C57BL/6J JJ B-adj.all	mice NNS B-noun.animal	revealing VBG B-verb.perception	a DT 0	close JJ B-adj.all	correspondence NN B-noun.state	between IN 0	electrical JJ B-adj.pert	activity NN B-noun.state	and CC 0	behavior NN B-noun.attribute	. . 0	. . 0
a3560095.s2	Improvements NNS B-noun.person	were VBD 0	seen VBN B-verb.perception	in IN 0	the DT 0	number NN B-noun.quantity	of IN 0	tender_joints NNS B-noun.artifact	, , 0	the DT 0	severity NN B-noun.attribute	of IN 0	swelling VBG B-verb.motion	and CC 0	tenderness NN B-noun.attribute	, , 0	the DT 0	time NN B-noun.time	of IN 0	walk NN B-noun.communication	50 CD B-adj.all	feet NNS B-noun.quantity	, , 0	the DT 0	duration NN 0	of IN 0	morning_stiffness NN B-noun.quantity	and CC 0	the DT 0	circumference NN B-noun.act	of IN 0	the DT 0	left JJ B-adj.all	knee NN B-noun.body	. . 0	. . 0
a11642480.s2	We PRP 0	report VBP B-verb.communication	a DT 0	favorable JJ B-adj.all	response NN B-noun.communication	to TO 0	treatment NN B-noun.person	with IN 0	citalopram NN B-noun.person	by IN 0	a DT 0	15-year JJ 0	- : 0	old JJ B-adj.all	boy NN B-noun.person	with IN 0	major_depression NN B-noun.person	who WP 0	exhibited VBD B-verb.body	palpebral_twitching VBG 0	during IN 0	his PRP$ 0	first JJ B-verb.competition	2 CD B-adj.all	weeks NNS B-noun.time	of IN 0	treatment NN B-noun.plant	. . 0	. . 0
a12820454.s9	This DT 0	CAB NNP B-noun.group	- : 0	induced VBN B-verb.creation	anemia NN B-noun.state	was VBD B-verb.stative	normochromic JJ B-adj.all	and CC 0	normocytic JJ B-adj.all	. . 0	. . 0
a17175308.s13	These DT 0	patients NNS B-noun.person	showed VBD B-verb.communication	persistently RB B-adv.all	good JJ B-adj.all	graft NN B-noun.phenomenon	function NN B-noun.act	. . 0	. . 0
a6888657.s2	Over IN 0	a DT 0	range NN B-noun.person	of IN 0	1 CD B-adj.all	- : 0	150 CD 0	days NNS B-noun.person	of IN 0	DES NNP B-noun.group	treatment NN B-noun.communication	, , 0	pairs NNS B-noun.quantity	of IN 0	control NN B-noun.act	and CC 0	DES NNP B-noun.group	- : 0	treated VBN B-verb.communication	rats NNS B-noun.person	were VBD 0	sacrificed VBN B-verb.communication	, , 0	and CC 0	their PRP$ 0	pituitaries NNS B-noun.communication	dissociated VBD B-verb.communication	enzymatically RB B-adv.all	into IN 0	single JJ B-noun.act	- : 0	cell NN B-noun.person	preparations NNS B-noun.person	. . 0	. . 0
a2894766.s1	Pneumonitis NNP B-noun.person	, , 0	bilateral JJ B-adj.all	pleural_effusions NNS B-noun.artifact	, , 0	echocardiographic JJ B-adj.all	evidence NN B-noun.attribute	of IN 0	cardiac_tamponade NN B-noun.food	, , 0	and CC 0	positive JJ B-adj.all	autoantibodies NNS B-noun.person	developed VBN B-verb.creation	in IN 0	a DT 0	43-year JJ 0	- : 0	old JJ B-noun.person	man NN I-noun.person	, , 0	who WP 0	was VBD 0	receiving VBG B-verb.communication	long RB B-adv.all	- : 0	term NN B-noun.time	sulfasalazine NN 0	therapy NN 0	for IN 0	chronic JJ B-adj.pert	ulcerative_colitis NN B-noun.state	. . 0	. . 0
a8073369.s13	Data NNS B-noun.cognition	from IN 0	this DT 0	model NN B-noun.person	support NN B-noun.person	a DT 0	mechanism NN B-noun.artifact	involving VBG B-verb.stative	nicotinic JJ B-adj.all	receptor NN B-noun.person	blockade NN B-noun.person	with IN 0	subsequent NN B-noun.person	decreased VBD B-verb.change	fetal JJ B-adj.all	movement NN B-noun.communication	. . 0	. . 0
a17491223.s1	BACKGROUND NN 0	, , 0	Electrocardiography NNP B-noun.person	has VBZ B-verb.possession	a DT 0	very RB B-adv.all	low JJ B-adj.all	sensitivity NN B-noun.feeling	in IN 0	detecting VBG B-verb.communication	dobutamine NN B-noun.person	- : 0	induced VBN B-verb.creation	myocardial_ischemia NNP B-noun.person	. . 0	. . 0
a7199841.s0	Neurologic JJ B-adj.pert	effects NNS B-noun.phenomenon	of IN 0	subarachnoid JJ B-noun.phenomenon	administration NN I-noun.phenomenon	of IN 0	2-chloroprocaine JJ B-noun.act	- : 0	CE NN 0	, , 0	bupivacaine NN B-noun.person	, , 0	and CC 0	low JJ B-adj.all	pH IN 0	normal JJ B-adj.all	saline NN B-noun.act	in IN 0	dogs NNS B-noun.animal	. . 0	. . 0
a17242861.s8	The DT 0	CSS NNP 0	for IN 0	Chromosomes NNP B-noun.communication	10 CD B-adj.all	and CC 0	18 CD B-adj.all	progressed VBD B-verb.communication	to TO 0	the DT 0	most RBS 0	severe JJ B-adj.all	stages NNS B-noun.state	, , 0	diverging VBG B-verb.motion	dramatically RB B-adv.all	from IN 0	the DT 0	B6 JJ B-adj.all	phenotype NN B-noun.person	. . 0	. . 0
a6692345.s3	FANFT NNP B-noun.group	- : 0	induced VBN B-verb.creation	cell NN B-noun.artifact	proliferation NN I-noun.artifact	in IN 0	the DT 0	bladder NN B-noun.person	was VBD B-verb.stative	significantly RB B-adv.all	suppressed VBN B-verb.social	by IN 0	aspirin NN B-noun.person	co SYM 0	- : 0	administration NN B-noun.time	after IN 0	4 CD B-adj.all	weeks NNS B-noun.time	but CC 0	not RB B-adv.all	after IN 0	12 CD B-adj.all	weeks NNS B-noun.time	. . 0	. . 0
a3358181.s2	Such JJ B-adj.all	interactions NNS B-noun.possession	may MD 0	result VB B-verb.stative	in IN 0	serious JJ B-adj.all	cardiovascular_complications NNS B-noun.artifact	even RB B-adv.all	after IN 0	cessation NN B-noun.time	of IN 0	an DT 0	infusion NN B-noun.cognition	of IN 0	ritodrine NN B-noun.act	. . 0	. . 0
a3560095.s1	Thirty SYM 0	- : 0	four CD 0	patients NNS B-noun.person	with IN 0	juvenile_rheumatoid_arthritis NN B-noun.food	, , 0	who WP 0	were VBD 0	treated VBN B-verb.change	with IN 0	flurbiprofen NN B-noun.person	at IN 0	a DT 0	maximum NN B-noun.person	dose NN B-noun.cognition	of IN 0	4 CD 0	mg FW 0	/ FW 0	kg FW 0	/ FW 0	day NN 0	, , 0	had VBD 0	statistically RB B-verb.change	significant JJ B-adj.all	decreases NNS B-noun.event	from IN 0	baseline NN B-noun.person	in IN 0	6 CD B-adj.all	arthritis NN B-noun.act	indices NNS B-noun.act	after IN 0	12 CD B-adj.all	weeks NNS B-noun.time	of IN 0	treatment NN B-noun.plant	. . 0	. . 0
a1732369.s9	End SYM 0	- : 0	systolic NN B-noun.person	left VBD B-verb.motion	ventricular JJ B-adv.all	posterior JJ B-adj.all	wall NN 0	dimension NN 0	at IN 0	the DT 0	5-micrograms NNS B-noun.time	/ : 0	kg FW 0	per FW 0	min FW 0	dobutamine NN 0	infusion NN 0	for IN 0	the DT 0	doxorubicin NN B-noun.person	- : 0	treated VBN B-verb.communication	group NN B-noun.person	was VBD B-verb.stative	14.1 CD 0	+ : 0	/- $ 0	2.4 CD 0	mm FW 0	versus FW 0	19.3 CD 0	+ : 0	/- $ 0	2.6 CD 0	mm NN B-noun.quantity	for IN 0	control NN B-noun.act	subjects NNS B-noun.person	( ( 0	p IN 0	less JJR B-noun.quantity	than IN 0	0.01).(ABSTRACT JJ B-noun.other	TRUNCATED VBN I-noun.other	AT IN I-noun.other	250 CD I-noun.other	WORDS NNS I-noun.other	) ) 0	. . 0
a2024540.s3	Trial NN B-noun.person	medication NN B-noun.person	was VBD B-verb.stative	2.5 CD 0	mg NN B-noun.quantity	enalapril NN B-noun.artifact	or CC 0	0.5 CD 0	prazosin NN B-noun.quantity	. . 0	. . 0
a15957009.s9	and CC 0	3 CD B-adj.all	mg NN B-noun.quantity	/ : 0	kg PRP 0	, , 0	p.o RB 0	. . 0	, , 0	. . 0
a435349.s2	to TO 0	36 CD 0	adult NN B-noun.act	males NNS B-noun.person	at IN 0	six CD B-adj.all	rates NNS B-noun.time	, , 0	0.25 CD 0	mg PRP$ 0	s-1 JJ 0	to TO 0	20 CD B-adj.all	mg DT B-noun.quantity	s-1 NN B-noun.person	. . 0	. . 0
a2440413.s6	In IN 0	vitro NN B-noun.animal	, , 0	gamma NN B-noun.act	- : 0	HCH NN 0	, , 0	pentylenetetrazol NN B-noun.person	and CC 0	picrotoxin NN B-noun.person	were VBD 0	shown VBN B-verb.perception	to TO 0	inhibit VB B-verb.stative	3H SYM 0	- : 0	TBOB NN B-noun.group	binding NN B-verb.social	in IN 0	mouse NN B-noun.animal	whole JJ B-adj.all	brain NN B-noun.person	, , 0	with IN 0	IC50 JJ B-adj.all	values NNS B-noun.attribute	of IN 0	4.6 CD 0	, , 0	404 CD 0	and CC 0	9.4 CD 0	microM NNS B-noun.quantity	, , 0	respectively RB B-adv.all	. . 0	. . 0
a6287825.s8	Migraine NNP B-noun.person	( ( 0	20 CD B-adj.all	% NN 0	) ) 0	was VBD B-verb.stative	not RB B-adv.all	an DT 0	uncommon JJ B-adj.all	cause NN B-noun.act	of IN 0	cranial_neuropathy JJ 0	although IN 0	malignancies NNS B-noun.person	arising VBG B-verb.stative	from IN 0	the DT 0	reticuloendothelial JJ B-adj.all	system NN B-noun.cognition	or CC 0	related VBN B-verb.cognition	structures NNS B-noun.cognition	of IN 0	the DT 0	head NN B-noun.location	and CC 0	neck NN B-noun.person	were VBD B-verb.stative	more RBR B-adv.all	frequent JJ B-adj.all	( ( 0	26 CD B-adj.all	% NN 0	) ) 0	. . 0	. . 0
a20882060.s4	METHODS NNS B-noun.attribute	, , 0	Behavioral JJ B-adj.all	experiments NNS B-noun.person	and CC 0	electrophysiological JJ B-adj.all	recordings NNS B-noun.artifact	were VBD 0	performed VBN B-verb.social	in IN 0	the DT 0	present JJ B-adj.all	study NN B-noun.artifact	. . 0	. . 0
a7423039.s0	Metabolic JJ B-adj.all	involvement NN B-noun.relation	in IN 0	adriamycin JJ B-adj.all	cardiotoxicity NN B-noun.state	. . 0	. . 0
a7269015.s0	Busulfan NNP B-noun.person	- : 0	induced VBN B-verb.creation	hemorrhagic_cystitis NNP B-noun.location	. . 0	. . 0
a8669433.s3	However RB 0	, , 0	three CD 0	case NN 0	control NN B-noun.act	studies NNS B-noun.artifact	, , 0	one CD 0	each DT 0	in IN 0	North NNP B-noun.other	Carolina NNP I-noun.other	, , 0	northern JJ B-adj.all	Maryland NNP B-noun.person	, , 0	and CC 0	West NNP B-noun.person	Berlin NNP I-noun.person	, , 0	Germany NNP B-noun.person	, , 0	showed VBD B-verb.communication	that IN 0	habitual JJ B-adj.all	use NN 0	of IN 0	acetaminophen NN B-noun.quantity	is VBZ B-verb.stative	also RB B-adv.all	associated VBN B-verb.cognition	with IN 0	chronic_renal_failure NN B-noun.food	and CC 0	ESRD NNP B-noun.other	, , 0	with IN 0	a DT 0	relative JJ B-adj.all	risk NN B-noun.person	in IN 0	the DT 0	range NN B-noun.location	of IN 0	2 CD 0	to TO 0	4 CD B-adj.all	. . 0	. . 0
a6386793.s2	Dothiepin NNP B-noun.person	and CC 0	amitriptyline NN B-noun.person	were VBD B-verb.stative	equally RB B-adv.all	effective JJ B-adj.all	in IN 0	alleviating VBG B-verb.communication	the DT 0	symptoms NNS B-noun.location	of IN 0	depressive_illness NN B-noun.feeling	, , 0	and CC 0	both DT 0	were VBD B-verb.stative	significantly RB B-adv.all	superior JJ B-adj.all	to TO 0	placebo VB B-verb.cognition	. . 0	. . 0
a12627929.s2	DESIGN NN B-noun.artifact	, , 0	Retrospective JJ 0	analysis NN 0	of IN 0	a DT 0	randomized JJ B-noun.state	phase NN I-noun.state	II NNP 0	trial NN 0	. . 0	. . 0
a11391224.s11	We PRP 0	suggest VBP B-verb.communication	that IN 0	repeated VBN B-verb.creation	endothelial_injury NNP B-noun.other	, , 0	including VBG B-verb.social	immunologic_injury JJ I-verb.social	, , 0	may MD 0	be VB B-verb.stative	the DT 0	cause NN B-noun.act	of IN 0	this DT 0	lesion NN B-noun.event	both DT 0	in IN 0	allografts NNS B-noun.animal	and CC 0	native JJ B-adj.all	kidneys NNS B-noun.person	. . 0	. . 0
a3125768.s8	These DT 0	observations NNS B-noun.act	suggest VBP B-verb.communication	that IN 0	rigidity NN B-noun.attribute	should MD 0	be VB 0	prevented VBN B-verb.cognition	when WRB 0	alfentanil NN B-noun.person	, , 0	and CC 0	, , 0	presumably RB B-adv.all	, , 0	other JJ 0	opiates NNS B-noun.person	, , 0	are VBP 0	used VBN B-verb.consumption	in IN 0	the DT 0	anesthetic JJ B-adj.all	management NN B-noun.act	of IN 0	patients NNS B-noun.person	with IN 0	ICP NNP B-noun.group	problems NNS B-noun.communication	. . 0	. . 0
a8231633.s4	dose NN B-noun.quantity	of IN 0	bupivacaine NN B-noun.location	. . 0	. . 0
a1420741.s9	Biochemically RB B-adv.all	, , 0	an DT 0	increase NN B-noun.act	in IN 0	alkaline JJ B-adj.all	phosphatases NNS B-noun.artifact	was VBD 0	noted VBN B-verb.perception	in IN 0	5 CD 0	of IN 0	8 CD B-adj.all	cases NNS B-noun.quantity	( ( 0	63 CD 0	% NN 0	) ) 0	, , 0	and CC 0	the DT 0	greatest JJS B-adj.all	increases NNS B-noun.event	were VBD 0	seen VBN B-verb.perception	in IN 0	those DT 0	who WP 0	had VBD 0	elevated VBN B-verb.social	levels NNS B-noun.state	prior RB 0	to TO 0	treatment NN B-noun.communication	. . 0	. . 0
a3358181.s6	After IN 0	delivery NN B-noun.group	of IN 0	the DT 0	infant NN B-noun.person	, , 0	there EX 0	should MD 0	be VB B-verb.stative	no DT 0	contraindication NN 0	to TO 0	the DT 0	use NN 0	of IN 0	an DT 0	alpha NN B-noun.person	- : 0	adrenergic JJ B-adj.all	vasopressor NN B-noun.attribute	such JJ 0	as IN 0	phenylephrine NN 0	to TO 0	treat VB B-verb.body	hypotensive JJ B-adj.all	patients NNS B-noun.person	with IN 0	tachycardia NN B-noun.person	. . 0	. . 0
a1420741.s2	Because IN 0	of IN 0	the DT 0	need NN B-noun.object	for IN 0	the DT 0	development NN B-noun.process	of IN 0	new JJ B-adj.all	treatments NNS B-noun.plant	for IN 0	Crohn's_disease NN B-noun.act	, , 0	a DT 0	pilot NN B-adj.all	study NN B-noun.artifact	was VBD 0	undertaken VBN B-verb.cognition	to TO 0	estimate VB B-verb.cognition	the DT 0	pharmacodynamics NNS B-noun.person	and CC 0	tolerability NN B-noun.attribute	of IN 0	fusidic_acid JJ B-noun.phenomenon	treatment NN I-noun.phenomenon	in IN 0	chronic JJ B-adj.all	active JJ B-adj.all	, , 0	therapy NN B-noun.person	- : 0	resistant JJ B-adj.all	patients NNS B-noun.person	. . 0	. . 0
a17175308.s20	Therefore RB 0	, , 0	conversion NN B-noun.group	should MD 0	be VB 0	considered VBN B-verb.cognition	for IN 0	patients NNS B-noun.person	who WP 0	have VBP 0	not RB B-adv.all	developed VBN B-verb.creation	advanced VBD B-verb.communication	CAN NNP B-noun.communication	and CC 0	proteinuria NN B-noun.person	. . 0	. . 0
a17042910.s7	Male NNP B-noun.person	SD NNP I-noun.person	rats NNS B-noun.animal	( ( 0	n UH 0	= $ 0	30 CD B-adj.all	) ) 0	were VBD 0	treated VBN B-verb.change	with IN 0	Ato NNP B-noun.person	( ( 0	50 CD 0	mg FW 0	/ FW 0	kg FW 0	per FW 0	day NN 0	in IN 0	drinking NN B-verb.consumption	water NN 0	) ) 0	or CC 0	tap VB B-verb.consumption	water NN I-verb.consumption	for IN 0	15 CD B-adj.all	days NNS B-noun.time	. . 0	. . 0
a17042910.s11	Endothelial JJ B-adj.all	function NN B-noun.act	was VBD 0	assessed VBN B-verb.cognition	by IN 0	acetylcholine NN B-noun.person	- : 0	induced VBN B-verb.creation	vasorelaxation NN B-noun.artifact	and CC 0	phenylephrine NN B-noun.person	- : 0	induced VBN B-verb.creation	vasoconstriction NN B-noun.process	in IN 0	aortic JJ B-adj.all	segments NNS B-noun.person	. . 0	. . 0
a17175308.s14	Serum NNP B-noun.person	creatinine NN I-noun.person	values NNS B-noun.attribute	did VBD 0	not RB B-adv.all	change VB B-verb.change	significantly RB B-adv.all	, , 0	1.98 CD 0	+ : 0	/- $ 0	0.8 CD 0	mg PRP B-noun.quantity	/ : 0	dL PRP 0	before IN 0	SRL NNP 0	therapy NN 0	and CC 0	2.53 CD 0	+ : 0	/- $ 0	1.9 CD 0	mg PRP B-noun.quantity	/ : 0	dL PRP 0	at IN 0	last JJ B-adj.all	follow NN B-noun.person	- : 0	up RB B-adv.all	( ( 0	P UH 0	= : 0	.14 LS 0	) ) 0	. . 0	. . 0
a17466854.s0	Side JJ 0	effects NNS B-noun.phenomenon	of IN 0	postoperative JJ B-adj.all	administration NN B-noun.time	of IN 0	methylprednisolone NN B-noun.attribute	and CC 0	gentamicin NN B-noun.artifact	into IN 0	the DT 0	posterior JJ B-adj.all	sub NN B-noun.person	- : 0	Tenon NNP B-noun.person	's POS 0	space NN B-noun.location	. . 0	. . 0
a12627929.s7	MEASUREMENTS NNS B-noun.attribute	AND CC 0	MAIN NNP B-noun.group	RESULTS NNS I-noun.group	, , 0	None NN 0	of IN 0	23 CD B-adj.all	patients NNS B-noun.person	who WP 0	received VBD B-verb.possession	docetaxel NN B-noun.communication	alone RB 0	developed VBD B-verb.creation	VTE NNP 0	, , 0	whereas IN 0	9 CD 0	of IN 0	47 CD 0	patients NNS B-noun.person	( ( 0	19 CD B-adj.all	% NN 0	) ) 0	who WP 0	received VBD B-verb.possession	docetaxel NN B-noun.communication	plus CC 0	thalidomide IN 0	developed JJ B-verb.creation	VTE NNP 0	( ( 0	p=0.025 NNP 0	) ) 0	. . 0	. . 0
a12615818.s2	Previous JJ B-adj.all	studies NNS B-noun.group	have VBP 0	demonstrated VBN B-verb.perception	an DT 0	increased VBN B-verb.change	risk NN 0	of IN 0	venous_thromboembolism NN B-noun.artifact	( ( 0	VTE NNP 0	) ) 0	associated VBN B-verb.cognition	with IN 0	CPA NNP 0	/ ( 0	EE NNP 0	compared VBN B-verb.cognition	with IN 0	conventional JJ B-adj.all	combined VBN B-verb.stative	oral_contraceptives NNS I-verb.stative	( ( 0	COCs NNP B-noun.person	) ) 0	. . 0	. . 0
a3693336.s1	Large JJ B-adj.all	doses NNS B-noun.event	of IN 0	triazolam NN B-noun.person	repeatedly RB B-adv.all	induced VBN B-verb.creation	brief JJ B-noun.artifact	episodes NNS I-noun.artifact	of IN 0	mania NN B-noun.food	in IN 0	a DT 0	depressed JJ B-adj.all	elderly JJ B-adj.all	woman NN B-noun.person	. . 0	. . 0
a11897407.s6	The DT 0	rat NN B-noun.phenomenon	biodistribution NN I-noun.phenomenon	studies NNS B-noun.person	showed VBD B-verb.communication	a DT 0	rapid JJ B-adj.all	blood NN B-noun.body	clearance NN I-noun.body	via IN 0	the DT 0	kidneys NNS B-noun.person	. . 0	. . 0
a17854040.s8	To TO 0	the DT 0	best JJS 0	of IN 0	our PRP$ 0	knowledge NN B-noun.artifact	, , 0	this DT 0	constitutes VBZ B-verb.stative	the DT 0	first JJ B-adj.all	report NN B-noun.communication	of IN 0	HBV NNP 0	lamivudine NN 0	- : 0	resistant JJ B-adj.all	strains NNS B-noun.communication	in IN 0	therapy NN B-noun.act	- : 0	na PRP 0	_ ( 0	ve IN 0	HBV NNP B-noun.group	- : 0	HIV_co SYM 0	- : 0	infected JJ B-adj.all	patients NNS B-noun.person	. . 0	. . 0
a8421099.s1	This DT 0	article NN B-noun.communication	reports VBZ B-verb.creation	the DT 0	changes NNS B-noun.artifact	in IN 0	gallbladder NN B-noun.animal	function NN B-noun.attribute	examined VBN B-verb.change	by IN 0	ultrasonography NN B-noun.person	in IN 0	20 CD B-adj.all	Chinese JJ B-adj.all	patients NNS B-noun.person	with IN 0	active JJ B-adj.all	acromegaly RB B-adv.all	treated VBN B-verb.change	with IN 0	sc DT 0	injection NN B-noun.act	of IN 0	the DT 0	somatostatin NN 0	analog JJ 0	octreotide NN 0	in IN 0	dosages NNS B-noun.quantity	of IN 0	300 CD 0	- : 0	1500 CD 0	micrograms NNS B-noun.quantity	/ : 0	day NN B-noun.person	for IN 0	a DT 0	mean NN B-noun.attribute	of IN 0	24.2 CD 0	+ CD 0	/- $ 0	13.9 CD 0	months NNS B-noun.quantity	. . 0	. . 0
a869641.s0	Mediation NNP B-noun.person	of IN 0	enhanced JJ B-adj.all	reflex JJ B-adj.all	vagal JJ B-adj.all	bradycardia NNS B-noun.person	by IN 0	L NNP 0	- : 0	dopa NN 0	via IN 0	central JJ B-adj.all	dopamine NN 0	formation NN B-noun.act	in IN 0	dogs NNS B-noun.animal	. . 0	. . 0
a7453952.s6	In IN 0	all PDT 0	the DT 0	experiments NNS B-noun.person	, , 0	the DT 0	attenuation NN B-noun.act	of IN 0	the DT 0	lithium NN B-noun.person	- : 0	induced VBN B-verb.creation	diabetes NNS B-noun.person	- : 0	insipidus NN B-noun.person	- : 0	like_syndrome JJ 0	by IN 0	amiloride NN B-noun.person	was VBD 0	accompanied VBN B-verb.stative	by IN 0	a DT 0	reduction NN B-noun.act	of IN 0	the DT 0	ratio NN B-noun.time	between IN 0	the DT 0	lithium NN B-noun.substance	concentration NN B-noun.cognition	in IN 0	the DT 0	renal JJ B-adj.all	medulla NN B-noun.person	and CC 0	its PRP$ 0	levels NNS B-noun.state	in IN 0	the DT 0	blood NN B-noun.act	and CC 0	an DT 0	elevation NN B-noun.act	in IN 0	the DT 0	plasma NN B-noun.plant	potassium NN B-noun.phenomenon	level NN B-noun.attribute	. . 0	. . 0
a3693336.s4	The DT 0	possible JJ B-adj.all	contribution NN B-noun.act	of IN 0	the DT 0	triazolo NN B-noun.location	group NN 0	to TO 0	changes NNS B-noun.act	in IN 0	affective JJ B-adj.all	status NN B-noun.state	is VBZ 0	discussed VBN B-verb.communication	. . 0	. . 0
a6287825.s4	Guillain NNP B-noun.person	- : 0	Barr___syndrome NN B-noun.person	was VBD B-verb.stative	the DT 0	commonest NN B-noun.person	identifiable JJ B-adj.all	cause NN B-noun.act	( ( 0	15.6 CD 0	% NN 0	) ) 0	, , 0	accounting VBG B-verb.communication	for IN 0	half NN B-noun.time	of IN 0	the DT 0	cases NNS B-noun.person	with IN 0	motor_neuropathy JJ 0	. . 0	. . 0
a1639466.s10	Furthermore RB B-adv.all	, , 0	glomerulosclerosis NN 0	index NN B-noun.communication	was VBD B-verb.stative	significantly RB B-adv.all	increased VBN B-verb.change	in IN 0	the DT 0	nitrendipine NN B-noun.person	- : 0	treated VBN B-verb.social	group NN 0	compared VBN B-verb.change	with IN 0	the DT 0	hypertensive JJ B-adj.all	controls NNS B-noun.cognition	( ( 0	0.38 CD 0	+ : 0	/- $ 0	0.1 CD 0	versus CC 0	0.13 CD 0	+ : 0	/- $ 0	0.04 CD 0	) ) 0	. . 0	. . 0
a20698227.s7	In IN 0	contrast NN 0	with IN 0	the DT 0	literature NN B-noun.act	, , 0	serum NN B-noun.body	levels NNS B-noun.attribute	of IN 0	angiogenesis NN B-noun.plant	factors NNS B-noun.person	did VBD 0	not RB B-adv.all	change VB B-verb.change	significantly RB B-adv.all	by IN 0	pegylated_interferon NNP B-noun.person	and CC 0	ribavirin NN B-noun.body	therapy NN I-noun.body	. . 0	. . 0
a7449470.s3	A DT 0	patient NN B-noun.person	is VBZ 0	reported VBN B-verb.communication	who WP 0	developed VBD B-verb.creation	progressive JJ B-adj.all	cardiomyopathy JJ B-adj.all	two CD 0	and CC 0	one CD 0	- : 0	half NN B-noun.time	years NNS I-noun.time	after IN 0	receiving VBG B-verb.competition	580 CD 0	mg PRP 0	/ $ 0	m2 CD 0	which WDT 0	apparently RB B-adv.all	represents VBZ B-verb.communication	late RB B-adv.all	, , 0	late JJ B-adj.all	cardiotoxicity NN B-noun.feeling	. . 0	. . 0
a6861444.s4	These DT 0	results NNS B-noun.communication	suggest VBP B-verb.communication	that IN 0	hypertension NN 0	after IN 0	chronic JJ B-adj.all	intrarenal JJ B-adj.all	noradrenaline NN 0	infusion NN 0	is VBZ 0	produced VBN B-verb.creation	by IN 0	relatively RB B-adv.all	higher JJR B-adj.all	levels NNS B-noun.attribute	of IN 0	circulating VBG B-verb.communication	noradrenaline NN B-noun.person	and CC 0	by IN 0	triggering VBG B-verb.social	of IN 0	an DT 0	additional JJ B-adj.all	intrarenal JJ B-noun.possession	pressor NN I-noun.possession	mechanism NN B-noun.act	. . 0	. . 0
a10739826.s0	Recurrent NN B-noun.person	use NN 0	of IN 0	newer JJR B-adj.all	oral_contraceptives NNS B-noun.plant	and CC 0	the DT 0	risk NN 0	of IN 0	venous_thromboembolism NN B-noun.artifact	. . 0	. . 0
a7269015.s2	Spontaneous JJ B-adj.all	resolution NN B-noun.act	occurred VBD 0	following VBG 0	cessation NN B-noun.communication	of IN 0	the DT 0	drug NN B-noun.artifact	. . 0	. . 0
a11642480.s0	Palpebral_twitching VBG B-verb.motion	in IN 0	a DT 0	depressed JJ B-adj.all	adolescent NN B-noun.person	on IN 0	citalopram NN B-noun.location	. . 0	. . 0
a19631624.s10	In IN 0	both DT 0	ecstasy NN B-noun.person	and CC 0	cannabis NN B-noun.person	groups NNS I-noun.person	brain VBP B-verb.stative	activation NN B-noun.person	was VBD 0	decreased VBN B-verb.change	in IN 0	the DT 0	right JJ B-adj.all	medial JJ B-adj.all	frontal JJ B-noun.body	gyrus NN I-noun.body	, , 0	left VBD B-verb.stative	parahippocampal JJ B-adj.all	gyrus NN B-noun.person	, , 0	left VBD B-verb.stative	dorsal JJ B-adj.all	cingulate NN B-noun.person	gyrus NN B-noun.person	, , 0	and CC 0	left VBD B-verb.motion	caudate NN B-noun.artifact	. . 0	. . 0
a6692345.s4	In IN 0	the DT 0	forestomach NN B-noun.act	, , 0	and CC 0	also RB B-adv.all	in IN 0	the DT 0	liver NN B-noun.person	, , 0	aspirin NN B-noun.person	did VBD 0	not RB B-adv.all	affect VB B-verb.change	the DT 0	FANFT NNP B-noun.group	- : 0	induced VBN B-verb.creation	increase NN B-noun.process	in IN 0	labeling VBG B-verb.communication	index NN B-noun.communication	. . 0	. . 0
a9334596.s10	The DT 0	prevalence NN B-noun.relation	of IN 0	repeatedly RB B-adv.all	low JJ B-adj.all	testosterone NN 0	increased VBN B-verb.change	with IN 0	age NN B-noun.person	( ( 0	4 CD B-adj.all	% NN 0	before IN 0	age NN B-noun.time	50 CD B-adj.all	years NNS B-noun.quantity	and CC 0	9 CD B-adj.all	% NN 0	50 CD B-adj.all	years NNS B-noun.time	or CC 0	older JJR B-adj.all	) ) 0	. . 0	. . 0
a6103707.s1	Flunitrazepam NNP B-noun.person	0.5 CD 0	, , 0	1.0 CD 0	or CC 0	2.0 CD B-noun.quantity	mg NN B-noun.quantity	was VBD 0	given VBN B-verb.possession	by IN 0	the DT 0	oral JJ B-adj.all	or CC 0	i.m RB 0	. . 0	. . 0
a1728522.s3	The DT 0	association NN B-noun.state	of IN 0	granulomas NNS B-noun.food	and CC 0	eosinophilia NNS B-noun.person	favor VBP B-verb.social	an DT 0	immunoallergic JJ B-adj.all	mechanism NN B-noun.object	. . 0	. . 0
a230316.s9	The DT 0	onset NN B-noun.event	of IN 0	all DT 0	manifestations NNS B-noun.communication	( ( 0	except IN 0	toxic JJ B-adj.all	encephalopathy JJ B-noun.relation	) ) 0	was VBD B-verb.stative	usually RB B-adv.all	subacute VBP B-verb.cognition	, , 0	with IN 0	subsequent JJ B-adj.all	partial JJ B-adj.all	recovery NN B-noun.process	. . 0	. . 0
a3341566.s7	The DT 0	delta NN 0	down RB 0	, , 0	which WDT 0	is VBZ B-verb.stative	the DT 0	measure NN B-noun.attribute	of IN 0	decrease NN B-noun.time	of IN 0	SBP NNP 0	after IN 0	a DT 0	mechanical JJ B-noun.person	breath NN I-noun.person	, , 0	was VBD B-verb.stative	20.3 CD 0	+ : 0	/- $ 0	8.4 CD 0	and CC 0	10.1 CD 0	+ : 0	/- $ 0	3.8 CD 0	mm NN B-noun.quantity	Hg NNP 0	in IN 0	the DT 0	HEM NNP 0	and CC 0	SNP NNP B-noun.group	groups NNS B-noun.group	, , 0	respectively RB B-adv.all	, , 0	during IN 0	hypotension NN 0	( ( 0	P NNP 0	less JJR 0	than IN 0	0.02 CD 0	) ) 0	. . 0	. . 0
a17242861.s1	Seizure NN B-noun.person	susceptibility NN B-noun.phenomenon	varies NNS B-noun.artifact	among IN 0	inbred JJ B-adj.all	mouse NN B-noun.body	strains NNS I-noun.body	. . 0	. . 0
a6387529.s1	The DT 0	effects NNS B-noun.phenomenon	of IN 0	oral JJ B-adj.all	doses NNS B-noun.event	of IN 0	diazepam NN B-noun.person	( ( 0	single JJ B-adj.all	dose NN B-noun.event	of IN 0	10 CD B-adj.all	mg NN B-noun.quantity	and CC 0	a DT 0	median JJ B-adj.all	dose NN B-noun.event	of IN 0	30 CD 0	mg RB 0	/ JJ 0	day NN 0	for IN 0	2 CD B-adj.all	weeks NNS B-noun.time	) ) 0	and CC 0	propranolol NN B-noun.person	( ( 0	single JJ B-adj.all	dose NN B-noun.event	of IN 0	80 CD B-adj.all	mg NNS B-noun.quantity	and CC 0	a DT 0	median JJ B-adj.all	dose NN B-noun.event	of IN 0	240 CD 0	mg RB 0	/ JJ 0	day NN 0	for IN 0	2 CD B-adj.all	weeks NNS B-noun.time	) ) 0	on IN 0	psychological JJ B-adj.all	performance NN B-noun.act	of IN 0	patients NNS B-noun.person	with IN 0	panic_disorders NNS B-noun.person	and CC 0	agoraphobia NNS B-noun.person	were VBD 0	investigated VBN B-verb.communication	in IN 0	a DT 0	double JJ B-adj.all	- : 0	blind NN B-noun.person	, , 0	randomized VBD B-verb.communication	and CC 0	crossover NN B-noun.act	design NN I-noun.act	. . 0	. . 0
a11679859.s3	Patients NNS B-noun.person	aged VBN B-verb.consumption	18 CD B-adj.all	years NNS B-noun.time	or CC 0	older JJR B-adj.all	treated VBN B-verb.change	with IN 0	prochlorperazine NN B-noun.person	for IN 0	headache NN B-noun.state	, , 0	nausea NN B-noun.person	, , 0	or CC 0	vomiting NN B-noun.act	were VBD B-verb.stative	eligible JJ B-adj.all	for IN 0	inclusion NN B-noun.act	. . 0	. . 0
a2951327.s5	Steady JJ B-adj.all	state NN B-noun.state	arterial JJ B-adj.all	plasma NN B-noun.person	concentrations NNS I-noun.person	of IN 0	atrial JJ B-adj.all	natriuretic JJ B-adj.all	factor NN B-noun.person	were VBD B-verb.stative	39 CD 0	+ SYM 0	/- $ 0	10 CD B-adj.all	pg FW 0	/ FW 0	ml FW 0	( ( 0	n UH 0	= $ 0	6 CD B-adj.all	) ) 0	during IN 0	infusions NNS B-noun.cognition	of IN 0	saline NN B-noun.act	and CC 0	284 CD 0	+ . 0	/- $ 0	24 CD B-adj.all	pg FW 0	/ FW 0	ml FW 0	( ( 0	n UH 0	= $ 0	6 CD B-adj.all	) ) 0	and CC 0	1520 CD 0	+ . 0	/- $ 0	300 CD 0	pg NN B-noun.quantity	/ : 0	ml PRP 0	( ( 0	n UH 0	= $ 0	9 CD B-adj.all	) ) 0	during IN 0	0.03 CD 0	and CC 0	0.1 CD 0	microgram NNS B-noun.quantity	/ : 0	kg PRP 0	/ `` 0	min NN 0	infusions NNS B-noun.cognition	of IN 0	the DT 0	factor.(ABSTRACT NN B-noun.other	TRUNCATED VBN I-noun.other	AT IN I-noun.other	250 CD I-noun.other	WORDS NNS I-noun.other	) ) 0	. . 0
a1732369.s2	To TO 0	develop VB B-verb.change	a DT 0	more RBR B-adv.all	sensitive JJ B-adj.all	echocardiographic JJ 0	screening NN 0	test NN 0	for IN 0	cardiac_damage NN 0	due JJ 0	to TO 0	doxorubicin VB B-verb.social	, , 0	a DT 0	cohort NN B-noun.artifact	study NN B-noun.artifact	was VBD 0	performed VBN B-verb.change	using VBG B-verb.consumption	dobutamine JJ 0	infusion NN 0	to TO 0	differentiate VB B-verb.change	asymptomatic JJ B-adj.all	long RB B-noun.body	- : 0	term NN B-noun.time	survivors NNS 0	of IN 0	childhood NN B-noun.state	cancer NN I-noun.state	treated VBN B-verb.change	with IN 0	doxorubicin NN B-noun.food	from IN 0	healthy JJ B-adj.all	control NN B-noun.act	subjects NNS B-noun.artifact	. . 0	. . 0
a15632880.s5	Cases NNS B-noun.person	were VBD B-verb.stative	patients NNS B-noun.person	who WP 0	developed VBD B-verb.creation	hyperkalemia NN 0	( ( 0	( ( 0	K(+ NNP 0	) ) 0	> $ 0	5.0 CD 0	mEq CD 0	/ IN 0	L NNP 0	) ) 0	or_renal_insufficiency NN B-noun.quantity	( ( 0	Cr FW 0	> FW 0	or=2.5 FW 0	mg FW 0	/ : 0	dL LS 0	) ) 0	, , 0	and CC 0	they PRP 0	were VBD 0	compared VBN B-verb.change	to TO 0	2 CD 0	randomly RB B-adv.all	selected VBN B-verb.cognition	controls NNS B-noun.artifact	per IN 0	case NN B-noun.state	. . 0	. . 0
a18182964.s1	OBJECTIVE NNP B-noun.group	, , 0	To TO 0	examine VB B-verb.communication	the DT 0	safety NN B-noun.artifact	and CC 0	tolerability NN B-noun.attribute	of IN 0	clonidine NN B-noun.person	used VBD B-verb.consumption	alone RB B-adv.all	or CC 0	with IN 0	methylphenidate NN B-noun.food	in IN 0	children NNS B-noun.animal	with IN 0	attention NN B-noun.act	- : 0	deficit NN B-noun.communication	/ : 0	hyperactivity_disorder NN B-noun.person	( ( 0	ADHD NNP B-noun.group	) ) 0	. . 0	. . 0
a18182964.s2	METHOD NNP B-noun.attribute	, , 0	In IN 0	a DT 0	16-week JJ 0	multicenter NN B-noun.person	, , 0	double RB 0	- : 0	blind JJ B-adj.all	trial NN B-noun.act	, , 0	122 CD 0	children NNS B-noun.person	with IN 0	ADHD NNP B-noun.group	were VBD B-verb.stative	randomly RB B-adv.all	assigned VBN B-verb.social	to TO 0	clonidine VB B-verb.social	( ( 0	n UH 0	= $ 0	31 CD 0	) ) 0	, , 0	methylphenidate NN B-noun.person	( ( 0	n UH 0	= $ 0	29 CD B-adj.all	) ) 0	, , 0	clonidine NN B-noun.person	and CC 0	methylphenidate NN B-noun.attribute	( ( 0	n UH 0	= $ 0	32 CD 0	) ) 0	, , 0	or CC 0	placebo NN B-noun.substance	( ( 0	n UH 0	= $ 0	30 CD B-adj.all	) ) 0	. . 0	. . 0
a12090760.s4	Bovine NNP B-noun.person	liver RB I-noun.person	erythroid JJ B-noun.body	cells NNS B-noun.body	were VBD 0	cultured VBN B-verb.communication	on IN 0	monolayers NNS B-noun.person	of IN 0	human JJ B-adj.all	bone NN 0	marrow VB B-verb.communication	endothelial JJ B-adj.all	cells NNS B-noun.body	previously RB B-adv.all	treated VBN B-verb.social	with IN 0	EPO NNP B-noun.group	and CC 0	IGF NNP B-noun.group	- : 0	IL-3 NN B-noun.other	. . 0	. . 0
a11679859.s8	RESULTS NNS B-noun.artifact	, , 0	One CD 0	hundred CD 0	patients NNS B-noun.person	were VBD 0	enrolled VBN B-verb.social	. . 0	. . 0
a17491223.s9	CONCLUSIONS NNS B-noun.artifact	, , 0	If IN 0	ECG NNP 0	alone RB 0	is VBZ 0	used VBN B-verb.consumption	for IN 0	specificity NN B-noun.possession	, , 0	the DT 0	combination NN B-noun.person	with IN 0	dP : 0	/ PRP$ 0	dtejc NN B-noun.body	improved VBD B-verb.change	the DT 0	sensitivity NN B-noun.time	of IN 0	the DT 0	test NN B-noun.communication	and CC 0	could MD 0	be VB B-verb.stative	a DT 0	cost NN B-noun.person	- : 0	savings NNS B-noun.act	alternative NN 0	to TO 0	cardiac VB B-verb.social	imaging NN B-noun.attribute	or CC 0	perfusion NN B-noun.possession	studies NNS B-noun.communication	to TO 0	detect VB B-verb.consumption	myocardial_ischemia NN I-verb.consumption	, , 0	especially RB B-adv.all	in IN 0	patients NNS B-noun.location	unable JJ B-adj.all	to TO 0	exercise VB B-verb.body	. . 0	. . 0
a6692345.s6	Also RB B-adv.all	, , 0	there EX 0	appears VBZ B-verb.perception	to TO 0	be VB B-verb.stative	an DT 0	adaptation NN B-noun.person	by IN 0	the DT 0	rats NNS B-noun.time	to TO 0	the DT 0	chronic JJ B-adj.all	ingestion NN B-noun.event	of IN 0	aspirin NN B-noun.person	. . 0	. . 0
a19631624.s6	Neuroimage RB 0	40 CD 0	, , 0	1328 CD 0	- : 0	1339 CD 0	) ) 0	. . 0	. . 0
a9034419.s5	DISCUSSION NN B-noun.artifact	, , 0	To TO 0	our PRP$ 0	knowledge NN B-noun.artifact	, , 0	this DT 0	is VBZ B-verb.stative	the DT 0	first JJ B-adj.all	reported VBN B-verb.communication	case NN B-noun.state	of IN 0	venlafaxine NN B-noun.artifact	overdose NN I-noun.artifact	that WDT 0	resulted VBD B-verb.stative	in IN 0	a DT 0	generalized JJ B-adj.all	seizure NN B-noun.act	. . 0	. . 0
a6308277.s7	Thus RB 0	the DT 0	mechanism NN B-noun.object	by IN 0	which WDT 0	acetaminophen NN B-noun.person	antagonizes VBZ B-verb.communication	the DT 0	actions NNS B-noun.act	of IN 0	caffeine NN B-noun.person	in IN 0	the DT 0	CNS NNP B-noun.group	remains VBZ B-verb.change	unknown JJ B-adj.all	. . 0	. . 0
a17042910.s9	or CC 0	saline NN B-noun.substance	was VBD 0	started VBN B-verb.creation	after RB 0	4 CD B-adj.all	days NNS B-noun.person	in IN 0	Ato NNP B-noun.person	- : 0	treated VBN B-verb.communication	and CC 0	non NN B-noun.person	- : 0	treated VBN B-verb.communication	rats NNS B-noun.person	and CC 0	continued VBD B-verb.stative	for IN 0	11 CD 0	- : 0	13 CD B-adj.all	days NNS B-noun.person	. . 0	. . 0
a17175308.s5	SRL NNP 0	was VBD 0	started VBN B-verb.change	at IN 0	a DT 0	mean NN B-noun.attribute	of IN 0	78 CD 0	+ SYM 0	/- $ 0	42 CD 0	( ( 0	15 CD 0	to TO 0	163 CD 0	) ) 0	months NNS B-noun.person	after IN 0	transplantation NN B-noun.act	. . 0	. . 0
a6861444.s0	Blood NNP B-noun.location	pressure NN I-noun.location	response NN B-noun.communication	to TO 0	chronic VB B-verb.consumption	low JJ I-verb.consumption	- : 0	dose NN B-noun.substance	intrarenal JJ B-noun.phenomenon	noradrenaline NN I-noun.phenomenon	infusion NN B-noun.cognition	in IN 0	conscious JJ B-adj.all	rats NNS B-noun.location	. . 0	. . 0
a14698717.s0	Acute_psychosis DT 0	due JJ 0	to TO 0	treatment NN B-noun.person	with IN 0	phenytoin NN B-noun.food	in IN 0	a DT 0	nonepileptic JJ B-adj.all	patient NN B-noun.person	. . 0	. . 0
a20882060.s0	Effects NNS B-noun.phenomenon	of IN 0	pallidal JJ B-adj.all	neurotensin NN B-noun.person	on IN 0	haloperidol NN B-noun.person	- : 0	induced VBN B-verb.creation	parkinsonian_catalepsy NNP B-noun.other	, , 0	behavioral JJ B-adj.all	and CC 0	electrophysiological JJ B-noun.body	studies NNS I-noun.body	. . 0	. . 0
a2894766.s4	Physicians NNS B-noun.person	who WP 0	use VBP B-verb.consumption	sulfasalazine NN 0	to TO 0	treat VB B-verb.body	patients NNS B-noun.person	with IN 0	inflammatory_bowel_disease NN 0	should MD 0	be VB B-verb.stative	aware JJ B-adj.all	of IN 0	the DT 0	signs NNS B-noun.communication	of IN 0	sulfasalazine NN B-noun.person	- : 0	induced VBN B-verb.creation	lupus_syndrome NN 0	. . 0	. . 0
a435349.s7	The DT 0	times NNS B-noun.event	to TO 0	first JJ B-adj.all	fasciculation NN B-noun.event	, , 0	twitch JJ B-adj.all	suppression NN B-noun.person	and CC 0	tetanus NN 0	suppression NN 0	were VBD B-verb.stative	inversely RB B-adv.all	related VBN B-verb.cognition	to TO 0	the DT 0	infusion NN B-noun.cognition	rates NNS B-noun.time	. . 0	. . 0
a1420741.s1	Fusidic JJ B-adj.all	acid NN B-noun.person	is VBZ B-verb.stative	an DT 0	antibiotic JJ B-adj.all	with IN 0	T SYM 0	- : 0	cell NN B-noun.animal	specific JJ B-adj.all	immunosuppressive JJ B-adj.all	effects NNS B-noun.phenomenon	similar JJ B-adj.all	to TO 0	those DT 0	of IN 0	cyclosporin NN B-noun.person	. . 0	. . 0
a18996674.s1	Priapism NN B-noun.attribute	is VBZ B-verb.stative	the DT 0	prolonged JJ B-adj.all	erection NN B-noun.cognition	of IN 0	the DT 0	penis NN B-noun.food	in IN 0	the DT 0	absence NN B-noun.act	of IN 0	sexual JJ B-adj.all	arousal NN B-noun.act	. . 0	. . 0
a11256525.s6	During IN 0	these DT 0	two CD 0	episodes NNS B-noun.communication	, , 0	his PRP$ 0	blood NN B-noun.act	pressure NN B-noun.act	diminished VBN B-verb.change	but CC 0	no DT 0	severe JJ 0	hypotension NN 0	was VBD 0	noted VBN B-verb.perception	. . 0	. . 0
a12907309.s3	A DT 0	selective JJ B-adj.all	antagonist NN B-noun.person	of IN 0	mGluR5 NNP B-noun.person	, , 0	2-methyl-6-(phenylethynyl)pyridine JJ 0	( ( 0	MPEP NNP B-noun.other	, , 0	5 CD 0	mg FW 0	/ FW 0	kg FW 0	ip NN 0	) ) 0	, , 0	when WRB 0	administered VBN B-verb.creation	five CD 0	times NNS 0	immediately RB B-adv.all	before IN 0	each DT 0	methamphetamine NN B-noun.location	injection NN B-noun.person	reversed VBD B-verb.change	the DT 0	above JJ 0	- : 0	mentioned VBN B-verb.communication	methamphetamine NN B-noun.person	effects NNS B-noun.phenomenon	. . 0	. . 0
a8302922.s3	The DT 0	hypotensive JJ B-adj.all	drug NN B-noun.person	was VBD 0	discontinued VBN B-verb.stative	at IN 0	the DT 0	completion NN B-noun.act	of IN 0	the DT 0	operative JJ B-adj.all	procedure NN B-noun.act	. . 0	. . 0
a6503301.s6	Published VBN B-verb.creation	cases NNS B-noun.artifact	from IN 0	the DT 0	literature NN B-noun.act	are VBP 0	reviewed VBN B-verb.change	and CC 0	pertinent JJ B-adj.all	features NNS B-noun.feeling	discussed VBN B-verb.communication	. . 0	. . 0
a2096243.s2	Symptoms NNS 0	such JJ 0	as IN 0	euphoria NN B-noun.person	, , 0	emotional JJ B-adj.all	lability NN B-noun.act	and CC 0	puerile JJ B-adj.all	attitude NN B-noun.person	noted VBD B-verb.perception	in IN 0	the DT 0	patient NN B-noun.person	were VBD 0	diagnosed VBN B-verb.communication	as IN 0	organic_personality_syndrome NN 0	according VBG 0	to TO 0	the DT 0	criteria NNS B-noun.communication	defined VBN B-verb.stative	in IN 0	the DT 0	DSM NNP B-noun.group	- : 0	III SYM 0	- : 0	R. SYM 0	It PRP 0	is VBZ 0	referred VBN B-verb.cognition	to TO 0	as IN 0	a DT 0	frontal_lobe_syndrome NN 0	. . 0	. . 0
a19631624.s1	It PRP 0	has VBZ 0	been VBN 0	consistently RB B-adv.all	shown VBN B-verb.perception	that DT 0	ecstasy NN B-noun.person	users NNS B-noun.person	display VBP B-verb.stative	impairments_in_learning_and_memory JJ B-adj.all	performance NN B-noun.act	. . 0	. . 0
a16680561.s9	Fewer JJR B-adj.all	subjects NNS B-noun.person	reported VBD B-verb.communication	adverse JJ 0	events NNS 0	following VBG 0	treatment NN B-noun.communication	with IN 0	desipramine NN 0	alone RB 0	than IN 0	when WRB 0	receiving VBG B-verb.communication	desipramine NN B-noun.person	with IN 0	cinacalcet NN B-noun.person	( ( 0	33 CD 0	versus NN B-noun.communication	86 CD 0	% NN 0	) ) 0	, , 0	the DT 0	most RBS 0	frequent JJ B-noun.person	of IN 0	which WDT 0	( ( 0	nausea NN B-noun.person	and CC 0	headache NN B-noun.body	) ) 0	have VBP 0	been VBN 0	reported VBN B-verb.communication	for IN 0	patients NNS B-noun.person	treated VBD B-verb.social	with IN 0	either DT 0	desipramine NN B-noun.location	or CC 0	cinacalcet NN B-noun.animal	. . 0	. . 0
a18261172.s2	The DT 0	novel NN 0	immunosuppressive JJ 0	( ( 0	IS VBZ 0	) ) 0	drug NN 0	sirolmus NN 0	( ( 0	Srl NNP 0	) ) 0	lacks VBZ B-verb.stative	nephrotoxic JJ B-adj.all	effects NNS B-noun.phenomenon	, , 0	however RB 0	, , 0	proteinuria NN B-noun.person	associated VBN B-verb.cognition	with IN 0	Srl NNP B-noun.person	has VBZ 0	been VBN 0	reported VBN B-verb.communication	following VBG B-verb.stative	renal JJ B-adj.all	transplantation NN B-noun.act	. . 0	. . 0
a16160878.s10	Taken VBN 0	together RB 0	, , 0	the DT 0	present JJ B-adj.all	study NN B-noun.communication	demonstrates VBZ B-verb.communication	that IN 0	the DT 0	central JJ B-noun.body	injection NN I-noun.body	of IN 0	U NNP 0	- : 0	II NN 0	at IN 0	doses NNS B-noun.act	of IN 0	1 CD B-adj.all	- : 0	10,000 CD 0	ng PRP 0	/ `` 0	mouse NN B-noun.animal	induces VBZ B-verb.creation	anxiogenic- JJ I-verb.creation	and CC 0	depressant NN B-noun.person	- : 0	like IN 0	effects NNS B-noun.phenomenon	in IN 0	mouse NN B-noun.animal	. . 0	. . 0
a891050.s3	This DT 0	case NN B-noun.state	emphasizes VBZ B-verb.change	the DT 0	possibility NN B-noun.state	that IN 0	HUS NNP 0	in IN 0	adults NNS B-noun.animal	is VBZ B-verb.stative	not RB B-adv.all	invariably RB B-adv.all	irreversible JJ B-adj.all	and CC 0	that IN 0	, , 0	despite IN 0	prolonged VBN B-verb.creation	oliguria NNS B-noun.person	, , 0	recovery NN B-noun.process	of IN 0	renal JJ B-adj.all	function NN B-noun.act	can MD 0	be VB 0	obtained VBN B-verb.possession	. . 0	. . 0
a1987816.s2	METHOD NNP B-noun.attribute	, , 0	This DT 0	was VBD B-verb.stative	a DT 0	cross NN B-noun.person	- : 0	sectional JJ B-adj.all	study NN B-noun.artifact	of IN 0	85 CD 0	patients NNS B-noun.person	from IN 0	a DT 0	lithium NN B-noun.artifact	clinic NN B-noun.person	who WP 0	received VBD B-verb.possession	different JJ B-adj.all	dose NN B-noun.act	schedules NNS B-noun.artifact	. . 0	. . 0
a1436384.s4	dose NN B-noun.quantity	of IN 0	( ( 0	+ PRP$ 0	/-)-amphetamine JJ B-adj.all	hemisulfate NN B-noun.attribute	, , 0	given VBN B-verb.possession	to TO 0	rats NNS B-noun.animal	pretreated VBN B-verb.contact	with IN 0	iprindole NN B-noun.person	, , 0	resulted VBD B-verb.stative	in IN 0	persistent JJ B-adj.all	depletion NN B-noun.act	of IN 0	dopamine NN B-noun.act	in IN 0	the DT 0	striatum NN B-noun.communication	1 CD B-adj.all	week NN 0	later RB B-adv.all	. . 0	. . 0
a11198499.s4	The DT 0	authors NNS B-noun.person	present VBP B-verb.stative	a DT 0	10-year JJ 0	- : 0	old JJ B-adj.all	boy NN B-noun.person	chronically RB B-adv.all	treated VBN B-verb.change	with IN 0	lisinopril NN B-noun.body	, , 0	an DT 0	angiotensin NN B-noun.person	converting VBG B-verb.possession	enzyme JJ B-adj.all	inhibitor NN B-noun.person	, , 0	to TO 0	control VB B-verb.social	hypertension NN B-noun.person	who WP 0	developed VBD B-verb.creation	hypotension NN 0	following VBG 0	the DT 0	addition NN B-noun.act	of IN 0	tizanidine NN B-noun.location	, , 0	an DT 0	alpha-2 JJ B-adj.all	agonist NN B-noun.person	, , 0	for IN 0	the DT 0	treatment NN B-noun.communication	of IN 0	spasticity NN B-noun.phenomenon	. . 0	. . 0
a18208574.s8	None NN 0	of IN 0	these DT 0	groups NNS B-noun.group	showed VBD B-verb.communication	significant JJ B-adj.all	difference NN B-noun.cognition	in IN 0	percent NN 0	inhibition NN 0	. . 0	. . 0
a19631624.s0	Learning_and_memory_deficits NNS B-noun.person	in IN 0	ecstasy JJ B-adj.all	users NNS B-noun.person	and CC 0	their PRP$ 0	neural JJ B-adj.all	correlates NNS B-noun.artifact	during IN 0	a DT 0	face NN B-noun.act	- : 0	learning VBG B-verb.cognition	task NN 0	. . 0	. . 0
a18261172.s11	Srl NNP B-noun.person	should MD 0	be VB 0	used VBN B-verb.consumption	with IN 0	ACEi NNP B-noun.person	/ NNP I-noun.person	ARB NNP I-noun.person	therapy NN I-noun.person	and CC 0	patients NNS B-noun.person	monitored VBD B-verb.perception	for IN 0	proteinuria NN B-noun.person	and CC 0	increased VBD B-verb.change	renal_dysfunction NN B-noun.act	. . 0	. . 0
a12483326.s7	He PRP 0	complained VBD B-verb.stative	of IN 0	pain_and_visual_disturbance_in_the_ipsilateral_eye JJ 0	30 CD B-adj.all	h NN B-noun.quantity	after IN 0	the DT 0	injection NN B-noun.act	. . 0	. . 0
a6287825.s11	Some DT 0	of IN 0	the DT 0	factors NNS B-noun.person	related VBN B-verb.communication	to TO 0	the DT 0	clinical JJ B-adj.all	presentation NN B-noun.communication	and CC 0	pathogenesis NN B-noun.person	of IN 0	the DT 0	neuropathies NNS B-noun.person	are VBP 0	briefly RB B-adv.all	discussed VBN B-verb.communication	. . 0	. . 0
a12483326.s6	CASE NN B-noun.state	, , 0	A DT 0	58-year JJ 0	- : 0	old JJ B-adj.all	man NN B-noun.person	received VBD B-verb.possession	an DT 0	intracarotid JJ B-adj.all	injection NN B-noun.event	of IN 0	carboplatin NN B-noun.food	for IN 0	recurrent NN B-noun.act	glioblastomas NNS B-noun.communication	in IN 0	his PRP$ 0	left JJ B-adj.all	temporal JJ B-adj.all	lobe NN B-noun.person	. . 0	. . 0
a84204.s2	In IN 0	order NN 0	that IN 0	this DT 0	syndrome NN 0	might MD 0	be VB 0	investigated VBN B-verb.creation	changes NNS B-noun.artifact	in IN 0	mental JJ B-adj.all	status NN B-noun.state	( ( 0	M.S. NNP 0	) ) 0	were VBD 0	correlated VBN B-verb.stative	with IN 0	serum NN B-noun.body	concentrations NNS B-noun.attribute	and CC 0	renal JJ B-noun.body	and CC 0	hepatic JJ B-adj.all	function NN B-noun.act	in IN 0	36 CD 0	patients NNS B-noun.person	, , 0	30 CD B-adj.all	patients NNS B-noun.person	had VBD 0	no DT 0	M.S. NNP 0	change NN B-noun.artifact	on IN 0	cimetidine NN B-noun.act	and CC 0	6 CD 0	had VBD 0	moderate JJ 0	to TO 0	severe JJ 0	changes NNS B-noun.phenomenon	. . 0	. . 0
